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Abstract: 
 
Background: Ataxia-telangiectasia (A-T) is a rare, recessive disorder that develops in the 
absence of Ataxia-Telangiectasia Mutated protein kinase (ATM). This complex disease is 
characterised by neurodegeneration, increased risk of cancer, a high incidence of insulin 
resistance and Type 2 diabetes (T2D) as well as cardiovascular disease. Mitochondrial 
dysfunction is associated with the development of cardiomyopathy and T2D. Obesity and 
insulin resistance contribute towards the development of cardiac dysfunction, and have 
been linked with mitochondrial disturbances. ATM has previously been associated with 
mitochondria, and the absence thereof results in decreased mitochondrial respiration and 
ATP synthesis as well as structural abnormalities.  
This study aimed to investigate the role of ATM in mitochondrial oxidative phosphorylation 
and mitophagy as possible contributors towards cardiovascular dysfunction in obesity. 
Methodology: The effects of high palmitic and oleic acid, either alone or in combination 
with insulin or high glucose on ATM expression levels were investigated in an H9c2 
cardiomyoblast model. Insulin signal transduction intermediates were determined by 
western blotting and glucose uptake by [3H]2-deoxyglucose accumulation. Mitoplasts were 
prepared from cardiac mitochondria of male Wistar rats with digitonin and the quality 
thereof confirmed with transmission electron microscopy (TEM). The location of ATM was 
determined with Super-resolution structured illumination microscopy (SR-SIM) and western 
blotting.  
Oxidative phosphorylation (oxphos) analysis was performed polarographically (Clark-type 
electrode) on  mitochondria obtained from 1) young male Wistar rat hearts perfused with 
the ATM specific inhibitor, KU60019 or vehicle (DMSO), and 2) chow fed age-matched 
controls and diet induced obese (DIO) rat hearts perfused ex vivo with either DMSO or ATM-
specific activators and its inhibitor (KU60019 ± insulin or KU60019 ± chloroquine). Oxphos 
was determined in carbohydrate (glutamate+malate) or fatty acid (palmitoyl-L-
carnitine+malate) substrates while protein expression levels of ATM as well as markers of 
mitophagy and mitochondrial fission were measured (western blotting). The redox status of 
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NAD(P)H was determined with 2-photon fluorescence lifetime imaging microscopy in H9c2 
cells ± KU60019. 
Results: This study showed that: (i) high levels of fatty acids and insulin affects the 
expression levels of ATM; (ii) ATM is located on the inner mitochondrial membrane of 
cardiac mitochondria. iii) Inhibition of ATM decreased carbohydrate-stimulated oxidative 
phosphorylation in cardiac mitochondria (p=0.0024), potentially through Complex I. This 
was supported by the observation that ATM inhibition decreased NADPH (p=0.02) and 
increased NADH accumulation in H9c2 cells. iv) The effect of ATM inhibition on oxidative 
phosphorylation was not influenced by diet; v) ATP synthesis as well as respiratory control 
index improved with the addition of insulin (p<0.005). vi) The inhibition of ATM was 
associated with decreased fission (p=0.0038). vii) The decrease in the autophagosomal 
membrane marker, LC3-II (p<0.0001) seems to be associated with the cytosolic role of ATM. 
Conclusion: ATM is located on the inner mitochondrial membrane and inhibition thereof 
influences mitochondrial ATP synthesis, potentially through Complex I substrate oxidation. 
Inhibition of ATM did not affect oxidative phosphorylation in obesity, but resulted in 
mitochondrial autophagy disruption as well as decreased fission. 
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Opsomming: 
 
Agtergrond: Ataxia-telangiectasia (A-T) is ‘n raar, resessiewe siekte wat in die afwesigheid 
van  Ataxia-Telangiectasia gemuteerde proteïen kinase (ATM) ontwikkel. Hierdie komplekse 
siekte word gekarakteriseer deur neuronale afwykings, ‘n verhoogde risiko vir ontwikkeling 
van kanker, verhoogde insidensie van insulien weerstandigheid en Tipe 2 diabetes (T2D) 
sowel as kardiovaskulêre siektes. Mitokondriale afwykings kan lei tot die ontwikkeling van 
kardiomiopatie en T2D. Vetsug sowel as insulien weerstandigheid dra by tot mitokondriale 
afwykings. Vorige studies het aangedui dat ATM by die mitokondrion betrokke is, en dat die 
afwesigheid daarvan kan lei tot ‘n afname in mitokondriale respirasie, ATP sintese, en 
strukturele veranderinge.  
Die doel van hiedie studie was om die die rol van ATM in die hart te bepaal met spesifieke 
fokus op mitokondriale oksidatiewe fosforilasie en mitofagie as moontlike bydraende 
faktore tot kardiovaskulêre disfunksie in vetsug.  
Metodiek: ATM uitdrukking is ondersoek in ‘n H9c2 kardiomioblast sel model met die 
vetsure, palmitaat en oleaat, alleen of in kombinasie met hoë insulien en hoë glukose. 
Insulien seintransduksie proteïene is deur middel van Western-klad tegniek ondersoek en 
glukose opname met [3H]2-deoksieglukose. Lokalisering van ATM in die mitokondriale 
binnemembraan is bepaal in mitoplaste berei uit hartweefsel van manlike Wistar rotte met 
behulp van digitonien. Kwaliteit van die mitoplaste is met behulp van transmissie elektron 
mikroskopie (TEM) gekontroleer, en die posisie van ATM is met super resolusie 
gestruktureerde beligte mikroskopie (SR-SBM) en Western-klad bepaal.  
Oksidatiewe fosforilasie is polarografies (Clark-tipe elektrode) bepaal in mitokondriē 
geïsoleer uit (i) harte van jong, kontrole manlike Wistar rotte, geperfuseer met of die draer 
(DMSO) of die ATM inhibitor, KU60019;  (ii) harte van ouderdoms-gepaarde kontrole rotte 
of rotte gevoer met ‘n hoë kalorie diëet wat vetsug bevorder (DIO), ex vivo geperfuseer met 
of DMSO, of KU60019 ± insulien of KU60019 ± klorokien. Oksidatiewe fosforilasie is bepaal 
met koolhidraat (glutamaat+malaat) of vetsuur (palmitoyl-L-karnitien+malaat) substrate en 
proteïen uitdrukkingsvlakke van ATM asook merkers van mitofagie en mitokondriale fissie is 
bepaal met Western-klad. Die redoks status van NAD(P)H is bepaal met 2-foton fluoresensie 
leeftyd visualiserings mikroskopie in H9c2 selle met  of KU60019 óf DMSO. 
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Resultate: Hierdie studie het getoon dat (i) hoë vetsuur vlakke asook insulien die 
uitdrukking van ATM beïnvloed; ii) ATM op die mitokondriale binnemembraan gelokaliseer 
is; iii) Inhibisie van ATM onderdruk mitokondriale koolhidraat-geïnduseerde mitokondriale 
oksidatiewe fosforilasie (p=0.0024), moontlik deur Kompleks I. Hierdie waarneming is 
gesteun deur die bevinding dat ATM inhibisie NADPH vlakke (p=0.02) laat afneem en NADH 
vlakke laat toeneem in H9c2 selle. iv) Die effek van ATM onderdrukking op oksidatiewe 
fosforilasie is onafhanklik van diēet. v) ATP sintese asook die respiratoriese kontrole indeks 
het verbeter in die teenwoordigheid van insulien(p<0.005). vi) Die onderdrukking van ATM 
met KU60019 het ook mitokondriale fissie verlaag (p=0.0038). vii) Die afname in autofagie 
membraan merker, LC3-II (p<0.0001), blyk weens die sitosoliese rol van ATM te wees. 
Gevolgtrekking: ATM is gelokaliseer op die mitokondriale binnemembraan en die inhibisie 
daarvan beïnvloed mitokondriale ATP sintese, moontlik deur Kompleks I substraat verbruik. 
Die inhibsie van ATM het nie ‘n rol gespeel in mitokondriale oksidatiewe fosforilasie in 
vetsug nie, maar het wel mitofagie ontwrig as ook mitokondriale fissie verlaag.  
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List of abbreviations: 
 
Å: ångström (0.1 nanometer) 
AA: amino acid 
A-T: Ataxia Telangiectasia 
ATM: Ataxia Telangiectasia Mutated protein kinase 
ATMIN: ATM Interactor 
AMPK:  5' adenosine monophosphate-activated protein kinase 
ATP: adenosine triphosphate 
ATR: Ataxia Telangiectasia and RAD3 related protein kinase 
ATX/SMG1: human suppressor of morphogenesis in genitalia 1 
BER: base excision repair 
BNIP3: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 
BRCA1: breast cancer type 1 susceptibility protein  
BSA: Bovine serum albumin 
CACT: carnitine acylcarnitine translocase 
CHK1: cell cycle check point kinase 1 
CHK2: cell cycle check point kinase 2 
CPT1: carnitine palmitoyltransferase I 
Cryo-EM: cryo- electron microscope 
DDR: DNA damage response 
DNA: Deoxyribonucleic acid 
DNA-PKcs: DNA-dependent protein kinase catalytic subunit 
Dox: doxorubicin 
DSB: double strand breaks 
ETC: electron transfer chain 
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ERK1/2:  extracellular signal-regulated kinases 1/2 
FADH2: flavin adenine dinucleotide 
FCCP: arbonilcyanide p-triflouromethoxyphenylhydrazone 
FAT: conserved sequence in FRAP, ATM and TRRAP 
FFA: free fatty acid 
FOXO3: Forkhead Box O3 
FRAP: FKBP12-rapamycin–associated protein 
FUNDC1: FUN 14 domain containing 1 
G6PD: glucose-6-phosphate dehydrogenase 
GAPDH: Glyceraldehyde 3-phosphate dehydrogenase 
GSH: glutathione 
H2AX: histone H2A variant   
H2O2: Hydrogen peroxide 
HAT:  histone acetylase transferase 
HEAT: huntingtin, elongation factor 3, protein phosphatase 2A, TOR1 
HDL: High density lipoproteins 
HIF-1α:  Hypoxia-inducible factor 1  
HOCl: hypochlorous acid 
IR: ionizing radiation 
LBE: LST8-binding element  
LC3: microtubule-associated proteins 1A/1B light chain 3 (LC3)/GABAA receptor-associated 
protein (GABARAP) 
LDL: Low density lipoproteins 
LKB1: Liver kinase B1  
LIR: LC3 interacting region 
MDC1: Mediator Of DNA Damage Checkpoint 1 
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MMS: Methyl methanesulfonate  
mnSOD: mitochondrial Superoxide dismutase 
MRN: Mre11, Rad50 and Nbs1 complex 
mTOR: mammalian Target of Rapamycin 
NAC: N-acetylcysteine 
NAD: Nicotinamide adenine dinucleotide 
NADPH: nicotinamide adenine dinucleotide phosphate 
NBS1: Nuclear poly (A)-binding protein 1 
NCD: Non-communicable disease 
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NO: nitric oxide 
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O2•-: oxygen radicals 
ᶦO2: single oxygen 
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•OH: hydroxyl  
ONOOH: peroxynitrite  
PCNA: Proliferating cell nuclear antigen 
PDH: pyruvate dehydrogenase 
PDK: pyruvate dehydrogenase kinase 
PI3-K: phosphatidylinositol 3-kinase 
PIKK: phosphatidylinositol (PI) 3-kinase-like kinases 
PRD: PIKK regulatory domain  
PPP: Pentose phosphate pathway 
REDD1: Regulated in development and DNA-damage response 1 
RICTOR: rapamycin-insensitive companion of mTOR 
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RO•: alkoxyl 
RO2•:  peroxyl 
RNS: Reactive Nitrogen Species 
ROS: Reactive oxygen species 
S6K: protein S6 kinase 
SIRT1: Sirtuin 1 
SSB: single strand break 
T2D: Type 2 Diabetes 
TIM: translocase of the inner membrane 
TOM70: translocase of outer membrane 70 
TRAPP: transformation/transcription domain associated protein 
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Chapter 1 :  General introduction 
 
Ataxia-telangiectasia (A-T) is a rare, recessive disorder that develops in the absence of 
Ataxia-Telangiectasia Mutated protein kinase (ATM). This complex disease is characterised 
by neurodegeneration, ataxia, oculocutaneous telangiectasia, an increased risk of cancer, 
premature ageing, radiosensitivity, a high incidence of insulin resistance and Type 2 
diabetes (T2D) as well as cardiovascular disease (Taylor et al. 2015; Ambrose & Gatti 2013; 
Espach et al. 2015). The degree of disease severity is dependent on the type of mutation in 
the ATM gene (single or bi-allelic), and heterozygous patients, which make up as much as 
1.4-2% of the general population,  also exhibit a high incidence of ischaemic heart disease 
and insulin resistance  (Su & Swift 2000; Connelly et al. 2016).  
The absence of ATM has been associated with increased visceral obesity, glucose 
homeostasis dysfunction (Takagi et al. 2015) and metabolic syndrome (Schneider et al. 
2006). Obesity is one of the hallmarks of metabolic syndrome, which is collectively 
characterised by increased low-density lipoprotein (LDL) cholesterol and decreased high-
density lipoprotein (HDL) cholesterol, as well as hypertension and insulin resistance. All of 
these  are major risk factors for Type 2 Diabetes (T2D) and cardiovascular disease (Qatanani 
& Lazar 2007). In light of the rapid increase in the incidence of obesity and its associated 
non-communicable diseases (NCDs) such as cardiovascular disease, diabetes and cancer 
worldwide, and more so in developing countries, there is a need to understand the 
underlying molecular pathogenesis associated with obesity, insulin resistance and 
cardiovascular disease. 
Cellular oxidative stress is a recurrent theme in obesity, insulin resistance and the 
pathogenesis of cardiac dysfunction. Moreover, oxidative stress underlies metabolic 
syndrome and has been associated with obesity due to low-grade inflammation (Hopps et 
al. 2010). It is also a contributing factor to both insulin resistance and coronary artery 
disease (Ceriello & Motz 2004). Diabetes-linked cardiac dysfunction is associated with 
mitochondrial dysfunction and increased oxidative stress due to impaired insulin signalling 
(Boudina et al. 2009), the latter of which can contribute directly to mitochondrial 
dysfunction in obesity (Westermeier et al. 2015). 
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 ATM acts as an important sensor of oxidative stress in cells and regulates defences against  
redox stress (Guo et al. 2010). ATM also regulates mitochondrial biogenesis and DNA 
content (Eaton et al. 2007), and can lead to mitochondrial dysfunction when absent 
(Ambrose et al. 2007; Valentin-Vega et al. 2012). It was shown that anti-oxidative treatment 
that targets the mitochondria can decrease metabolic syndrome, which supports the notion 
that A-T might be a mitochondrial disease (Mercer et al. 2012; D’Souza et al. 2012).  
Importantly, ATM also contributes to glucose homeostasis (Takagi et al. 2015), and is 
required for the phosphorylation of the insulin-dependent protein kinase, Akt (Viniegra et 
al. 2005; Halaby et al. 2008). Interestingly, ATM also mediates the rerouting of glycolysis to 
the pentose phosphate pathway in response to oxidative stress (Cosentino et al. 2011).  
Our laboratory recently demonstrated that a high caloric diet resulted in decreased ATM 
expression in rat cardiac mitochondria (Huisamen et al. 2014), which possibly identifies a 
potential link between obesity and ATM. Moreover, in a previous study conducted within 
our laboratory where the role of ATM in cardiovascular dysfunction was investigated; it was 
found that acute chemical inhibition of ATM did not contribute significantly towards cardiac 
dysfunction, but could potentially play a significant role in vasoconstriction (Espach 2017). 
Interestingly, activation of ATM by insulin increased phosphorylation, which was decreased 
when administered in combination with the ATM specific inhibitor, KU60019. However, 
ATM activity could not be manipulated with insulin in a high caloric diet (HCD) rat model.  
However, haplodeficiency of ATM is sufficient to accelerate heart failure after myocardial 
infarction (Jia et al. 2017) whilst ATM deficiency exacerbated left ventricular dysfunction 
and remodelling late after myocardial infarction in mice (Daniel et al. 2016). This suggests 
that a chronic rather than an acute absence or decrease in ATM expression results in 
myocardial dysfunction, and implies that ATM expression can be influenced by chronic 
conditions such as obesity and insulin resistance.  
In light of the importance of mitochondrial dysfunction associated with the development of 
cardiovascular disease due to obesity, insulin resistance and T2D, this study investigated the 
role of ATM both in vitro in H9c2 cardiomyoblasts and ex vivo within a well-characterised 
high caloric diet-induced obese (DIO) rat model. The aims of this study were as follows:  
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1) Investigate the potential role of ATM in insulin resistance in rat cardiomyoblasts 
exposed to a high free fatty acid (FFA) environment, specifically in the insulin 
sensitive Akt and insulin insensitive AMPK pathways. 
2) Determine whether ATM expression or regulation influences mitochondrial function 
by investigating: i) oxidative phosphorylation, ii) mitofusion and mitophagy as well as 
iii) redox status in the mitochondria. 
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Chapter 2 : Literature review 
 
2.1 Ataxia-Telangiectasia (A-T) and Ataxia Telangiectasia Mutated Protein Kinase 
(ATM): 
 
Ataxia-telangiectasia (A-T) was initially identified in 1926 (Syllaba & Henner 1926) and 
described as a clinical entity in 1958 (Boder & Sedgwick 1958).  The disease is  named for 
characteristic cerebral ataxia that is associated with dilated blood vessels present in the 
conjunctivae of the eyes, also known as telangiectasia (Pickup and Pugh, 1960; reviewed by 
Gatti et al., 2001).  Ataxia telangiectasia is one of several genomic instability syndromes, and 
most notably include cerebral neurodegeneration, metabolic disease including insulin 
resistance and Type 2 diabetes (T2D), cardiovascular disease, premature ageing, 
radiosensitivity and an increased risk of developing cancer (reviewed by Shiloh, 2003; Shiloh 
and Ziv, 2013).  
Due to the pleiotropic nature of A-T, it was postulated that different genes could mediate 
the disease, but linkage analysis mapped the causal region to chromosome 11q22-23 (Gatti 
et al. 1988). This led to the identification and complete sequencing of a single gene, ataxia-
telangiectasia mutated (Atm) as the causative agent (Uziel et al. 1996; Savitsky et al. 1995a). 
The identification of ATM at the core of such a complex disease drove rapid progress in the 
elucidation of the multi-faceted molecular basis that is responsible for A-T. Whilst the 
majority of the mutations responsible for A-T results in the truncation and consequent 
reduction or abolishment of protein transcription (Buzin et al. 2003), a significant number of 
patients carry one of several missense or  splice site mutations which maintains some ATM 
activity (Taylor et al. 2015).  It is estimated that more than 80% of over 300 distinct 
mutations in the Atm gene, are base substitutions or insertions and deletions that result in 
premature termination or splicing abnormalities in gene transcription (Ahmed & Rahman 
2006).  
The Atm gene encodes for a conserved 350 kDa protein kinase (Savitsky et al. 1995b; Chen 
& Lee 1996) that can regulate signal transduction through the phosphorylation (Hunter 
1995) of either a serine or threonine residue followed by a glutamine (SQ/TQ motif; Kim et 
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al. 1999). Consequently, ATM protein kinase (henceforth referred to as ATM) can potentially 
phosphorylate more than 400 substrates implicated in over 700 biological functions 
(Matsuoka et al. 2007).   
This remarkable feat of ATM is achieved by its structure and post-translational modifications 
(Fig 2.1). The protein belongs to the super family of phosphatidylinositol (PI) 3-kinase-like 
kinases (PIKK; Savitsky  et al., 1995a). The PIKKs are a family of six large signalling proteins 
that contain a catalytic domain with homology to phosphatidylinositol 3-kinase (PI3-K). This 
catalytic domain consists of what was traditionally referred to as the conserved FAT (FRAP 
[FKBP12-rapamycin–associated protein], ATM and TRRAP [transformation/transcription 
domain associated protein]), and FAT-C (FAT-C-terminal) domain in conjunction with a 
kinase domain, and is present as a single unit in all known PIKK proteins (Jiang et al. 2006).  
This region constitutes approximately half of the PIKK and is referred to as FATKIN (Baretić 
et al. 2017; Imseng et al. 2018). 
The PIKK family consists of the following six members:  i) ATM (Fig 2.1), ii) Ataxia 
Telangiectasia and RAD3 related protein kinase (ATR), and  iii) deoxyribonucleic acid -
dependent protein kinase catalytic subunit (DNA-PKcs) that are responsible for DNA repair 
and genome maintenance;  iv) mammalian Target of Rapamycin (mTOR) that coordinates 
cell growth, proliferation and protein synthesis; v) ATX/SMG1 (human suppressor of 
morphogenesis in genitalia) which is responsible for nonsense mediated mRNA decay, and 
vi) TRAPP that forms part of several complexes with histone acetylase transferase (HAT) 
complexes (Rivera-Calzada et al. 2015). The last protein, TRAPP, is the exception to the rule, 
and contains an inactive kinase domain that does not contain the conserved amino acids 
that is required for adenosine triphosphate (ATP) binding and catalytic activity.  
Although several attempts have been made to resolve the structure of ATM (Llorca et al. 
2003; Lau et al. 2016), the most recent report is by far the most detailed. The use of cryo-
electron microscopy (cryo-EM) resolved human ATM protein structure at a resolution of 4.4 
Å (Baretić et al. 2017).  The latter study showed that the protein is present as an 
enzymatically active dimer that can be divided into two types: a closed dimer with 
symmetric FATKIN domains, and an open dimer, with asymmetric FATKIN domains, the 
latter of which seem to be more active (Baretić et al. 2017).  The FATKIN domain of ATM is 
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responsible for ATM dimerization, and is essential for ATM activation. Currently, it is 
accepted that ATM is present as an inactive dimer that is activated by DNA damage through 
autophosphorylation at Ser1981 that results in dimer dissociation (monomerisation) and 
consequent activation (Bakkenist & Kastan 2003).  
However, Baretić et al. (2017) could not find any evidence of free monomers in solution, 
although these might have been present but were not detected. They identified open and 
closed dimer conformations, which differ from each other in the complexity of the 
intermolecular interface between the monomers.  The open dimer has a different and less 
complex intermolecular interface when compared to the less active closed dimer, but the 
Baretić et al. (2017) reported both the open and closed states in solution. Interestingly, they 
found that the dimeric ATM was enzymatically active in the presence of the ATM substrate, 
p53. 
 
Figure 2.1: ATM protein kinase structure. The image (not drawn to scale) depicts an N-terminal (aa 
1-1983) that contains binding sites for proteins such as p53, BRCA1 and LKB1 as well as NBS1 
within the spiral (indicated with arrows at aa 90-97, and spiral/N-pillar interface). The C-terminal 
contains the FAT (aa 1893-2612), kinase and FATC domains (aa 3023-3056). Combined, these 
domains are referred to as FATKIN, and are essential for kinase activity. Activation of ATM is 
mediated by the autophosphorylation of Ser1981 due to DNA damage or through oxidative stress at 
Cys2991 through the formation of a disulphide bond. ATM can also be modified post-translationally 
through, for example, acetylation at Lys3016 (adapted from Bhatti et al. 2017; Baretić et al. 2017) 
Both the closed and open dimer conformations of ATM have two interfaces: an upper 
interface where the tetratricopeptide repeat domain (TRD) 3 interacts with the kinase 
domain of its dimeric partner, and a lower interface where TRD2 interacts with TRD2 and 
TRD3 of the ATM partner.  
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The FATKIN domain is comprised of 1) three TRD domains  and 2) a HEAT (huntingtin, 
elongation factor 3, protein phosphatase 2A, TOR1) repeat domain (HRD) that forms the FAT 
domain (amino acid[aa] 1893-2612), which is followed by the kinase domain (aa 2613-3056). 
The FAT-C domain is a unique, highly conserved sequence spanning approximately 33 aa 
sequence in the extreme C-terminus. Combined with the LST8-binding element (LBE), an 
activation loop (aa 2888-2910), and the PIKK regulatory domain (PRD; helices kα9b, kα9c 
and kα9d, aa 2966-2979), it forms a compact arrangement that is essential for the 
regulation of ATM. Baretić et al. (2017) suggest that the TRD3 helices (α21 and α22) interact 
with all of the components of this compact arrangement, and acts as a binding element in 
the closed conformation. The TRD3 binding element pushes on the PRD helices (kα9c and 
kα9d) of the dimeric partner, causing the helices to enter the active site. This prevents other 
peptide substrates from entering the active site that results in a closed and less active 
dimer.   
When ATM is in an open dimer conformation, no intermolecular contacts can be observed 
in between the compact arrangement and TRD3 in the upper interface. The PRD helices 
become disordered and open up sufficiently to allow a substrate to bind. However, in the 
lower interface conformation of the open dimer, some of the contacts between TRD2 and 
TRD3 are partially retained. 
The N-terminal, that consists of six domains (aa 1-1161), binds substrates, regulators and 
adaptors. It forms a spiral that wraps around a 30 Å cavity and is supported by several short 
helices that form part of the N-pillar. The N-terminal also offers several binding sites for 
proteins such as NBS1 (Nuclear poly (A)-binding protein 1) that maps approximately to the 
border region between the spiral and the N-pillar (Baretić et al. 2017) whilst amino acid 
residues, 90-97,  form the binding site for several ATM substrates including p53, BRCA1 and 
LKB1 (Fernandes et al. 2005).  
This suggests that the p53 site, for example, is exposed in both the open and closed dimer 
format. Baretić et al. (2017) propose that there may be another binding partner present that 
stabilises the closed dimer conformation, which is removed when activated. This could then 
allow for the binding of proteins such as p53. This notion supports evidence that found that 
although ATM phosphorylates p53 in response to DNA damage, binding of p53 to ATM could 
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only be detected after ATM activation. Moreover, the authors suggest that activating 
partners such as NBS1 and ATMIN (ATM Interactor), both of which are essential in the DNA 
damage response, might bind to this N-terminal region to lock ATM in an open 
confirmation. 
This complex protein, whether in monomer or dimer form, is an apex protein kinase that is 
best known for its role in DNA damage. 
2.2 ATM and the DNA Damage Response Pathway: 
 
DNA is found in every cell and is, in essence, the keystone of life. Nonetheless, these 
molecules are in constant peril from exogenous and endogenous threats that include 
carcinogens, mutagens, reactive oxygen species (ROS) and spontaneous chemical changes 
during cellular replication.  
Alterations that can range from a single basepair substitution in a DNA sequence to major 
chromosomal aberrations are sufficient to disrupt cellular homeostasis and pave the way for 
the development of cancer (Shiloh 2003).   However, a cell has strict safeguards in place to 
protect itself against this constant barrage of existential threats. These safeguards, which 
include ATM as a key component, are cell cycle checkpoints that ensure timing, sequence 
and integrity of vital cell cycle events and mediate cellular responses to exogenous 
genotoxic stress (Sarkaria et al. 1999). If these fail, programmed cell death (apoptosis) 
follows.  
Structurally intact and functional ATM is vital to this process: a single mutation in the kinase 
region of ATM is sufficient to disrupt the stability of ATM and drive the development of A-T 
(R2849P) or leukemia (R2186P) (Baretić et al. 2017).  
ATM is consequently best known for its role in the prevention, signalling and repair of 
double strand breaks (DSB) in nuclear DNA and has been reviewed extensively (Shiloh 2001; 
Rotman & Shiloh 1998; Shiloh 2006; Paull 2015; Shiloh & Ziv 2012).  DSB’s can occur during 
eukaryotic mitosis and meiosis when forming replication forks, or in response to ionizing 
radiation (IR) and ultra violet (UV) light. There are two major pathways for DSB repair: 
homologous repair (HR) or non-homologous end-joining (NHEJ) (Hartlerode & Scully 2009), 
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and both are essential during the synthesis (S)-phase of mitotic cell replication.  In a 
nutshell, nuclear ATM protein kinase prevents the formation of DSBs by restricting the 
replication of DNA containing single strand breaks (Khoronenkova & Dianov 2015). Should 
that fail, it can mobilize one of the most extensive cellular signalling networks, the so-called 
DDR (DNA damage response), in response to DSB’s (Tomimatsu et al. 2007). The type of 
DNA damage determines the DDR response, and in cases where agents such as IR and free 
radicals inflict sufficient damage, the cell mounts a rapid, decisive response that activates 
ATM (Shiloh 2003). The absence of ATM, however, does not limit the rate of DSB repair: up 
to approximately 85% of all DSB’s can be repaired through other cellular mechanisms, whilst 
only 15% of DSB’s, such as radiation-induced breaks, necessitates ATM (Goodarzi et al. 
2010). 
DNA-PKcs play a role in NHEJ, which is also the predominant, albeit not the most accurate 
pathway for DSB repair in human cells, whilst ATM promotes the HR pathway that results in 
more accurate corrections of DSBs (Shiloh & Ziv 2012; Zhou et al. 2017).  It is, however not 
clear how pathways are chosen in response to DSBs during the G1, S and G2 phase of cell 
replication. A recent study by Zhou et al. (2017) shows that crosstalk between DNA-PKcs and 
ATM might cooperatively initiate signalling and repair through the phosphorylation of ATM 
at multiple sites, which in turn negatively regulates the catalytic activity of ATM. 
Consequently, this might provide a mechanism for the DSB repair pathway choice as well as 
ATM inactivation upon repair.  
Briefly, the DDR, which includes both the HR and NHEJ pathways, consists of four phases:  1) 
sensor proteins detect the DNA lesion or chromatin aberration immediately following a 
break; 2) the broken ends are processed in order to determine the type of response 
required based on the chemical nature of the breaks; 3) proteins, also known as 
transducers, that can quickly affect the operation of many pathways and often form part of 
the repair complexes at the site of damage, are recruited and activated; 4) once activated, 
transducers, can activate so-called effector proteins that determine cell-cycle checkpoints, 
activate the stress-response pathway or drive repair enzymes and complexes to repair DNA. 
The PIKK proteins,  ATM, ATR and DNA-PKcs are initial and primary transducers in DSBs and 
phosphorylate many down-stream effectors, which, in the case of ATM, include proteins 
such as the cell cycle check point kinases, CHK1, CHK2, histone H2A variant  (H2AX), breast 
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cancer type 1 susceptibility protein (BRCA1) and the tumour suppressor protein,  p53 (Shiloh 
2003; Bensimon et al. 2011).  
Immediately following a DSB, nuclear ATM is catalytically activated, undergoes 
autophosphorylation at Ser1981 and is monomerised (Bakkenist & Kastan 2003). This is the 
initial step in ATM activation and requires the MRN (Mre11, Rad50 and Nbs1) protein 
complex to be fully completed (Paull 2015). The MRN complex is a large, multifunctional 
protein assembly; the Mre11 component contributes endo-and exonucleolytic activity whilst 
the Rad50 component provides ATP binding, hydrolysis, and adenylate kinase activity, which 
also determines its two different conformational states (Lee et al. 2013). The complex, that 
can bind to DNA through multiple interfaces such as DNA without sticky ends,  only forms 
stable complexes with DNA ends in the presence of ATP, and is a requirement for ATM 
activation (Paull 2015).  In addition to the interface between Nbs1 and ATM (mentioned in 
Section 2.1), Mre11-Rad50, that is bound through coiled-coil domains and a zinc-hook, 
allows for association with ATP and Nbs1, and binds to ATM through an interface located in 
the Rad50 protein (Lee et al. 2013; Paull 2015).  Once bound, the complex can stimulate 
ATM activity by facilitating stable binding to its substrates (Lee & Paull 2004). Interestingly, 
the Nbs1 phosphorylation is critical for MRN mediated stimulation of ATM activity with 
regards to CHK2 but not to p53 (Lee & Paull 2004), whilst downstream p53 signalling is 
dependent on ATM activity and DSB repair efficiency that differs in different cell types and 
tissues (Stewart-Ornstein & Lahav 2017).  
Although this sets the stage for the carefully orchestrated role of ATM in the DDR, the 
recruitment of the protein and maintenance of the ATM-MRN complex is still being 
elucidated. It is known that phosphorylation of Ser1981, as well as the conserved sites, Ser367, 
Ser1893 and Ser2996 are required for full activation of ATM in response to DSBs (Lavin 2008); 
nonetheless, mutations in mice analogues of these sites have no effect on the ATM 
dependent response (Daniel et al. 2008; Pellegrini et al. 2006). Autophosphorylation at 
Ser1981 is required for stabilisation of ATM at DSBs and allows for interaction with MDC1 
(Mediator Of DNA Damage Checkpoint 1) resulting in prolonged association of ATM with 
DSBs (So et al. 2009). MDC1 tethers ATM to the DNA and binds directly to the 
phosphorylated tail of H2AX, which drives the recruitment of proteins to the DSB.  Almost 
immediately following a DSB, ATM phosphorylates H2AX at Ser139, which results in 
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chromatin decondensation and is essential for efficient DNA repair and protein recruitment 
such as BRCA1 and p53 (Burma et al. 2001).  
Moreover, prior to autophosphorylation of ATM at Ser1981, the protein undergoes 
acetylation at Lys3016 by Tip60 which is essential for the conversion of an inactive dimer to 
monomer (Sun et al. 2007).  This process is mediated by Forkhead Box O3 (FOXO3a) and 
Tip60: the carboxy-terminal of domain of FOXO3a binds directly to the FATC-domain of ATM 
(Tsai et al. 2008) and forms a complex with ATM and Tip60 that in turn, binds to the MRN 
complex. This can be inhibited by NOTCH1 that competes with FOXO3 binding to ATM 
(Adamowicz et al. 2016). Concomitantly, Tip60 interacts directly with the chromodomain of 
histone H3 trimethylated on lysine 9 (H3k9me3) at DSBs, which in turn activates the 
acetyltransferase activity of Tip60 (Sun et al. 2009). Interestingly, Tip60 is recruited to 
H3k9me3 by the MRN complex, but is dependent on the initial displacement of 
heterochromatin protein 1β (HP1β) from H3k9me3.  Tip60  can thus  regulate the activation 
of both ATM and DNA-PKcs through the conserved FATC domain present in both proteins  
(Jiang et al. 2006). These observations can explain why chromatin alterations, rather than 
direct DNA contact, can act as a signal for ATM mediated DDR, as was noted originally by 
Bakkenist & Kastan (2003).  
Baretić et al. (2017) suggests that Lys3016 is close enough to either Glu3021 or Tyr2864, both of 
which have been implied in the closed dimer conformation of ATM, that their side-chains 
might interact prior to and break upon Lys3016 acetylation, resulting in a conformational 
change that could potentially favour an open dimer conformation.  Interestingly, ATM can 
also be phosphorylated at Tyr370 by the nuclear epidermal growth factor receptor (EGFR) 
which  translocates to  and co-localizes with ATM at the site of a DSB (Lee et al. 2015). This 
implies that sites within the N-terminal spiral could also be required for ATM activation in 
response to DSBs, and not just the FATC kinase domain. This notion is supported by the 
recent study where it was found that DNA-PKcs can phosphorylate Thr86 and Thr373 within 
the ATM N-terminal HEAT repeat and is required, together with Thr370, Ser794 and Ser1403,  
for the regulation of ATM activity (Zhou et al. 2017). Phosphorylation of Thr86 by DNA-PKc 
peaks approximately 2-4 hours after DNA damage, which suggests that the phosphorylation 
of this site might offer a critical mechanism for ATM inactivation after DNA repair. 
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Moreover, phosphorylation of DNA-PKcs by ATM at Thr2609 is essential for effective DNA 
repair, suggesting a cooperative relationship between these two PIKKs (Chen et al. 2007) 
ATM, which can also repair DSBs in heterochromatic regions (Goodarzi et al. 2010), initiates 
a cascade of phosphorylation events as well as protein recruitment of major cellular role-
players (effectors) that can either arrest the cell cycle, repair DNA or initiate apoptosis 
(Bhatti et al. 2011).  
 
Figure 2.2: Simplified schematic diagram of the role of ATM in the DNA damage response pathway. 
Briefly, ATM is recruited to DSB mainly through the MRN complex where it binds to Rad50 and 
Nbs1 (Lee et al. 2013). Prior to this the ATM dimer is acetylated by FOXO3a and Tip60, which in 
turn interacts with H3K9me3(Sun et al. 2007). Monomerised ATM phosphorylates H2AX at Ser139, 
which in turn binds to Mdc1(So et al. 2009). Mdc1 tethers ATM to DNA, and through the activation 
of H2AX, and can drive the recruitment of BRCA1 for DNA repair. ATM can phosphorylate, and in 
turn be phosphorylated by, DNA-PKcs which mediates a cooperative relationship of 
regulation(Zhou et al. 2017). ATM also phosphorylates effectors such as (but not limited to) Chk1 
and 2 to modulate cell cycle checkpoints or p53 to determine cell fate(Shiloh & Ziv 2012).  
ATM can also be activated in response to DNA damaging agents that cause base oxidation 
such hydrogen peroxide (H2O2) (Guo et al. 2010) as well as alkylation (Adamson et al. 2002). 
Alkylated and oxidised DNA bases are mainly repaired by the base excision repair (BER) 
pathway. The pathway generates single strand breaks (SSBs) as intermediate products when 
a damaged base pair is excised, in order to create an abasic site (AP site) that can be 
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processed by a DNA polymerase and ligated (Dianov & Hübscher 2013). ATM is activated in 
response to SSBs  generated during  the repair of oxidative or alkylating DNA lesions, and 
result in a G1 cycle delay that allows for the ligation of SSBs (Khoronenkova & Dianov 2015). 
These base lesions do not activate ATM directly, but both oxidative stress and methyl 
methanesulfonate (MMS) can activate ATM through autophosphorylation (Khoronenkova & 
Dianov 2015).  
This section briefly summarises (Figure 2.2) the fine-tuned role of ATM in the DDR. The 
number of substrates phosphorylated directly and indirectly by ATM spans across a network 
that counts into the hundreds. ATM is at the apex of cell cycle checkpoints, apoptosis, 
immune response, gene transcription and cell fate modulation pathways (Shiloh & Ziv 2012). 
Many of these responses stretch past the nucleus, and highlight the key question of ATM’s 
role in cellular metabolism independently of the DDR.  
Whilst the elucidation of ATM as a vital DDR transducer contribute towards a clearer picture 
of the severe radiosensitivity and increased cancer predisposition seen in A-T patients, it is 
the observation that ATM can be activated by oxidative stress (Guo et al. 2010) that might 
explain the plethora of metabolic and cardiovascular effects (reviewed by Espach et al. 
2015) observed in the absence of ATM protein kinase.   
2.3 Cytosolic ATM and oxidative stress 
 
Shortly after the description of ATM as a single protein kinase, Barlow et al. (1996) noted 
oxidative stress markers in Atm deficient (ATM-/-) mice organs that could not be explained 
on a histological level. The authors suggested an alternative pathway independent from p53 
(DDR pathway) which was also reiterated by Shackelford et al. (2001), who found that 
phosphorylated ATM responds to certain aspects of oxidative stress. It was suggested that 
increased oxidative stress observed in the cerebella of these mice correspond with the 
degeneration of cerebellar neurons in A-T patients (Kamsler et al. 2001).  
Constant oxidative stress is a common denominator in many of the A-T clinical and cellular 
phenotypes (Barzilai et al. 2002). This results in prolonged activation of stress response 
pathways in the cerebellum, but not in the cerebrum or liver (Watters 2003). More 
importantly, this suggests a cytoplasmic rather than nuclear role for ATM. Whereas ATM 
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resides predominantly in the nucleus of dividing cells (Shiloh 2003), ATM is found mainly in 
the cytoplasm of non-dividing neuronal cells where it maintains basal metabolic flux 
(Alexander & Walker 2011). In these types of cells, ATM maintains autophagy, a catabolic 
process in which cells deliver cytoplasmic components for degradation to the lysosome, as 
well as redox homeostasis rather than genomic stability and apoptosis. Moreover, 
Alexander & Walker (2011) suggested that these divergent pathways could be a result of 
ATM’s subcellular localisation, as well as different mechanisms of activation and cell survival 
outcomes.  
This observation was based on the seminal research of (Guo et al. 2010) who reported the 
direct activation of ATM by oxidative stress (H2O2). Previous research showed that ATM can 
be activated in response to oxidative stress and hypoxic conditions (Shackelford et al. 2001; 
Bencokova et al. 2009), but the question remained whether these events were initiated  
independently of the MRN pathway. (Guo et al. 2010) generated oxidative stress conditions 
with H2O2 and DSB with bleomycin, a well-known genotoxic agent, in human fibroblasts.  
Although p53 was phosphorylated at Ser15 and Thr68 in response to H2O2 and bleomycin, 
H2AX was only phosphorylated in response to the latter. Inhibition of ATM ablated p53, 
ATM and Chk2 phosphorylation in the presence of H2O2, whilst activation of ATM by H2O2 
was inhibited in the presence of the strong hydroxyl scavenger, N-acetylcysteine (NAC). The 
authors found that oxidation resulted in a conformational change in ATM, but not the 
monomerisation observed in response to a DSB. Moreover, they found that ATM forms a 
reversible disulphide bond at the only cysteine site, Cys2991 within the FATKIN region. 
Mutation of this site from Cys2991 to Ala2991 resulted in a construct that could be activated in 
the presence of DSBs but not oxidative stress. Although ATM contains several disulphide 
bonds, it is the covalent disulphide bond at Cys2991 through which ROS modulates its effects. 
Low levels of ROS are sufficient to activate ATM at this residue, independently of DSBs and 
the MRN complex (Paull 2015), and these distinct activation mechanisms allow ATM to 
respond to different stresses and control different cytoplasmic pathways (Shiloh & Ziv 
2013).  
However, it should be noted that the interplay between oxidised ATM and DSB-activated 
ATM is complicated: (Guo et al. 2010) suggested that oxidative stress disrupts DNA binding 
at the MRN complex and can therefore inhibit consequent ATM activation by DSBs, resulting 
Stellenbosch University  https://scholar.sun.ac.za
 
 
24 
 
in the oxidation of ATM under high ROS conditions. A more recent study showed that excess 
endogenous ROS represses ATM-dependent HR repair in cells obtained from patients with 
ataxia with oculomotor apraxia type 3 (AOA3 cells) which has implications for both 
neurodegeneration and tumorigenesis (Kobayashi et al. 2015).  Irrespective of the lack of 
consensus regarding the oxidation of ATM under either high or low ROS conditions, many of 
the ATM substrates identified with proteomic analyses, implies ATM in metabolic signalling 
pathways (Ditch & Paull 2012). 
2.3.1 Reactive oxygen and nitrogen species: 
 
Under normal physiological conditions, ROS act as signalling intermediates in many cellular 
processes to induce redox homeostasis. On the other hand, elevated ROS levels, aptly 
described as oxidative stress, have been linked with over 150 diseases, most notably 
atherosclerosis, diabetes and cancer (Alexander et al. 2010). Moreover, it has been 
suggested that A-T might in essence be an oxidative stress disorder (Ambrose & Gatti 2013).  
In order to understand how ATM contributes towards the maintenance of basal metabolic 
flux and redox homeostasis, a short overview of oxidants and their cellular targets is 
required.  
Briefly, ROS derive from the reduction of molecular oxygen which most notably includes 
oxygen radicals (O2
•-), hydroxyl (•OH), peroxyl (RO2•) and alkoxyl (RO•), as well as certain 
non-radicals that are either oxidising agents or which can be converted into radicals such as 
hypochlorous acid (HOCl), ozone (O3), single oxygen (ᶦO2) and H2O2 (Bedard & Krause 2007). 
Metabolism of nitric oxide (NO) results in the formation of reactive nitrogen species (RNS) 
that can either contribute to oxidation, nitrosation or nitration (Patel et al. 1999). The 
enzymatic action of nitric oxide synthase (NOS) results in nitric oxide (NO), but can also 
produce O2
•- under the right circumstances. A rapid reaction between NO and O2
•- results in 
the formation of peroxynitrite (ONOOH) which is involved in oxidation, nitrosation and 
nitration.  In the case of nitration, nitrotyrosine can be formed and can alter cell signalling 
pathways. For example, nitrite together with HOCl, has been detected in diseased human 
vascular tissue and drives the formation of artherogenic LDL which is implicated in 
artheroschlerosis (Podrez et al. 1999). 
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There are numerous sources of endogenous ROS, including the cytoplasm, cell membrane, 
endoplasmic reticulum (ER), peroxisome, mitochondria and the NOX-family (nicotinamide 
adenine dinucleotide phosphate [NADPH] oxidases) of which the latter two are the most 
important (Finkel 2011). NOX1, -2, -4 and -5 are expressed throughout the cardiovascular 
system and are one of the best known sources of cytoplasmic ROS, which in itself has been 
described as the cornerstone of cellular signalling and disease pathophysiology (Forrester et 
al. 2018). This is made possible by the large number of molecules that ROS can interact with, 
including small organic molecules, proteins, lipids, carbohydrates and nucleic acids. These 
interactions can either destroy or irreversibly change the function of the target molecule 
and can accordingly contribute towards pathogenesis (Bedard & Krause 2007).  
Most redox reactions, however, occur through the reversible reduction and oxidation of 
crucial reactive cysteine residues that can form thiolate anions at a physiological pH 
(Holmström & Finkel 2014). Oxidation of this residue, as is the case for ATM at Cys2991, 
results in a sulfenic residue (SOH), which is further modified to form an intramolecular 
disulphide bond. As mentioned previously, the addition of exogenous H2O2 in vitro forms an 
active ATM dimer of two covalently-linked monomers. Possible in vivo sources of oxidants, 
that are capable of reducing thiol and oxidizing disulphide bonds, are generated by the 
membrane bound NOX-family of NADPH oxidases. These enzymes produce extra-cellular 
super-oxide anions, that can be dismutated into H2O2 and selectively re-enter the cell 
through aquaporin channels (Finkel 2011).  
NOX-4, which is located in close proximity of the nucleus in a wide range of human cells, 
produces ROS innately and is elevated in A-T cells (Weyemi et al. 2015). Specific inhibition of 
both NOX-4 and NOX-2 alleviates increased cancer risk in A-T null mice to that of control 
animals, whilst the inhibition of ATM increases NOX-4 expression in normal cells. NOX-4 is 
thus potentially a critical mediator of ROS and senescence in the development of A-T.  On 
the other hand, mitochondrial oxidants that are produced as part of normal respiration, also 
participate in signalling events as well as the regulation of hypoxia-inducible factor 1 (HIF-
1α) during low oxygen conditions.  
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2.3.2 ATM and oxygen sensing: 
 
The transcription factor complex, HIF-1α, is a master regulator of oxygen sensing and 
mediates a genetic response to restore oxygen supply under low oxygen conditions 
(Fandrey et al. 2006). The complex can restore oxygen homeostasis by either increasing 
anaerobically stimulated glycolytic flux or by improving tissue oxygenation via stimulation of 
angiogenesis, vasodilation and erythropoiesis.  However, the underlying mechanisms of 
oxygen sensing remain elusive. Guzy et al. (2005) found that cytosolic ROS is released by 
complex III of the mitochondrial electron transfer chain (ETC) and is required for hypoxic 
stabilization of HIF-1α in response to low oxygen conditions. 
Interestingly, the absence of ATM leads to increased expression of HIF-1α which results in 
the transcription of genes involved in angiogenesis e.g., VEGF (vascular endothelial growth 
factor) as well as  cellular metabolism e.g., GLUT-1 (Ousset et al. 2010). Additionally, it was 
suggested in this study that the absence of ATM increases HIF-1 protein biosynthesis, and 
that this effect is dependent on oxidative stress. ATM might thus act as an oxygen sensor - 
cells lacking ATM show a blunted response to mild hypoxia and cannot up- regulate HIF-1α 
due to impaired oxygen sensing (Mongiardi et al. 2011). Hypoxia also leads to the 
phosphorylation and activation of ATM in the absence of DNA damage and increase 
mitochondrial ROS production (Bencokova et al. 2009). 
In line with this finding, Cam et al. (2010) showed that ATM phosphorylates HIF-1α on Ser696 
and directly regulates the stabilisation of this protein under hypoxic conditions, 
consequently leading to the downregulation of mTORC1 (mammalian Target of Rapamycin 
Complex 1). Moreover, both Cam et al. (2010) and Bencokova et al. (2009) found that 
translocation of HIF-1α to the nucleus is attenuated in Atm-deficient cells, where  it 
regulates the expression of hypoxia-inducible genes such as REDD1 (Regulated in 
development and DNA-damage response 1). REDD1 acts as a negative regulator of mTORC1 
by binding to the inhibitory 14-3-3α proteins which enables dissociation from the tuberous 
sclerosis complex 2 (TSC2 complex) and results in the inhibition of mTORC1.  
This mechanism implicates a cytosolic role for ATM in cancer where the down regulation of 
ATM drives elevated mTORC1 activity in hypoxic tumour tissue (Stagni et al. 2013). This also 
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holds for childhood sarcoma, where a negative feedback loop was identified between 
mTORC1 and ATM; mTORC1 negatively regulates ATM expression through upregulation of 
the small microRNAs 18a and 421 (Hu et al. 2010), both  of which targets ATM for 
degradation (Shen & Houghton 2013).  
This has important implications for cancer, since increased autophagy in hypoxic tumour 
tissue is associated with treatment resistance, for example in the case of glioblastoma 
(Jawhari et al. 2016). More importantly, autophagy is negatively regulated by mTORC1, and 
concomitantly increases in cells treated with H2O2.  
2.3.3 ATM, autophagy and the peroxisome: 
 
In light of the hypoxic and oxidative stress induced activation of ATM , as well as the 
pathophysiology associated with elevated ROS in Atm-deficient cells, Alexander et al. (2010) 
found that the activation of oxidised ATM increases autophagy through the activation of 
TSC2 via the Liver kinase B1 (LKB1)/ 5' adenosine monophosphate-activated protein kinase 
(AMPK) pathway, and results in the repression of mTORC1. Moreover, inhibition of mTORC1 
with rapamycin results in the concomitant improvement of ROS levels in ATM-/- mice.  The 
authors found that low concentrations of H2O2 rapidly induced mTORC1 repression that 
could, in turn, be rescued by the addition of NAC or pretreatment with catalase. Of 
relevance as well, is that chemical mitochondrial uncoupling which depletes glutathione, 
also repressed mTORC1 signalling, indicating that both exogenous and endogenous ROS 
activation of ATM can induce mTORC1 repression.  
The same research group found that nitrosative stress (nitric oxide, NO) also activates ATM 
and results in the phosphorylation of AMPK through LKB1, activation of the TSC2 complex 
and consequent repression of mTORC1 (Tripathi et al. 2013). ATM-mediated repression of 
mTORC1 decreased phosphorylation of direct target proteins of mTORC1 such as 4E-BP1 
(4E-binding protein 1), S6K (ribosomal S6 kinase) and ULK1 (Unc-51 like autophagy activating 
kinase). Consequently, nitrosative stress-mediated activation of ATM can increase 
autophagy by decreasing mTORC1-mediated phosphorylation of ULK1 at Ser757, and 
increasing ULK1- phosphorylation at Ser317 by AMPK. However, the precise mechanism 
through which NO activates ATM is still unknown. Induction of autophagy by NO also 
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resulted in decreased cell viability, which suggests a cytotoxic response. This is summarised 
in Fig 2.3. 
LKB1 can be phosphorylated directly at Thr366  by active ATM in response to ionising 
radiation (IR) (Sapkota et al. 2002) as well as through oxidative stress as discussed 
previously; consequently activating AMPK directly to modulate apoptosis (Shaw et al. 2004) 
or autophagy in the event of energetic stress.  
 
Figure 2.3: ROS can activate cytosolic ATM. ATM is activated in response to both endogenous and 
exogenous ROS, as well as NO. Once activated, it phosphorylates LKB1 at Thr366 which 
phosphorylates AMPK and drives the inhibition of mTORC1 through TSC2. The inhibition of 
mTORC1 down regulates S6K, 4E-BP1 and ULK1, which is also phosphorylated by AMPK. This 
initiates autophagy, and the formation of an autophagosome that targets peroxisomes specifically 
for degradation through the ATM-mediated ubiquitination of PEX5. 
On the other hand, one of the key roles of AMPK in cardiac muscles is the response to 
hypoxia/ ischaemia, which is also under the direct control of LKB1; in the absence of LKB1, 
mice hearts show increased  mTORC1 signalling which increases protein synthesis and can 
lead to hypertrophy (Ikeda et al. 2009). Interestingly, Emerling et al. (2009) showed that the 
hypoxic activation of AMPK in mouse fibroblasts is dependent on mitochondrial oxidative 
stress that is generated through the ETC and not the cytosolic adenosine monophosphate 
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(AMP)/ adenosine triphosphate (ATP) ratio. Although the authors did not evaluate the role 
of ATM in their study, it supports the notion that the oxidative activation of ATM, due to 
increased mitochondrial dysfunction, can potentially mediate the activation of AMPK in 
response to hypoxic stress.  The total effect of AMPK activation results in the inhibition of 
lipid and glycogen synthesis, whilst concurrently activating free fatty acid oxidation and 
glycolysis (Kim et al. 2016).  
Peroxisomes utilise β-oxidation to reduce long-chain fatty acids into medium length fatty 
acids that can be shuttled to the mitochondria. These highly metabolic organelles generate 
ROS during β-oxidation, and require homeostatic maintenance to prevent oxidative stress.  
ATM binds to the peroxisome importer receptor, PEX5, in response to excessive ROS and 
mediates peroxisome-specific autophagy (pexophagy) by phosphorylating PEX5 at Ser141 and 
promoting mono-ubiquitylation at Lys209, whilst simultaneously inducing autophagy through 
the activation and phosphorylation of TSC2 and ULK1   (Zhang et al. 2015; Tripathi et al. 
2016) and is shown in Fig 2.3. Ubiquitylated PEX5 is recognized by the autophagy adapter 
protein, p62, which directs the autophagosome to the peroxisomes for pexophagy. It is 
currently not known whether ATM binds PEX5 as a monomer or dimer. 
Pexophagy is an example of selective autophagy that only targets peroxisomes, whereas 
macroautophagy is responsible for the general sequestering of organelles, proteins and 
portions of the cytoplasm for delivery to, and degradation by, the lysosome (He & Klionsky 
2009). The importance of ATM in autophagy is highlighted by the accumulation of 
lysosomes, as well as increased oxidative stress in the cerebellum of ATM-null mice (Barlow 
et al. 2000). Loss-of function mutations in ATM, such as the ability to sense oxidative stress, 
can result in a reduction in mitochondrial antioxidant defences, lead to the accumulation of 
ROS and oxidative damage to mitochondria and other cellular components (Zhang et al. 
2018), as well as protein aggregation (Lee et al. 2018). Selective autophagy seems to be 
mainly mediated by ubiquitination which is essential for conferring selectivity (Kraft et al. 
2010), as is the case of ATM-mediated pexophagy.  This also implies a potential role for ATM 
in aggrephagy (degradation of damaged or misfolded proteins) that is dependent on p62 
ubiquitination (Evans et al. 2017). Proteasomal degradation is required for the maintenance 
of autophagy at physiological levels as is the case with ULK1; it is specifically ubiquitinated 
by the E3 ligase NEDD44 that marks it for proteasomal degradation, whilst still actively 
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translating and transcribing ULK1 mRNA that is inhibited by mTOR during prolonged 
autophagy (Nazio & Cecconi 2017). This maintains ULK1 protein at basal levels within the 
cell, and makes it available if needed. 
It is possible that ATM can play a more active role in ULK1 phosphorylation through p32. 
Although p32 was first recognized as a novel substrate of ATM in cardiac DNA damage (Kato 
et al. 2008), it has recently been identified as a regulator of ULK1 stability (Jiao et al. 2015). 
Moreover, the phosphorylation of ULK1 by AMPK regulates the translocation of ULK1 to 
mitochondria in response to hypoxia (Tian et al. 2015) where it phosphorylates FUNDC1 and 
regulates mitophagy (Wu et al. 2014). Although ATM was not investigated in this context, it 
is tempting to hypothesize that ATM could influence ULK1 potentially through the 
phosphorylation of p32 in the heart.  
Protein aggregation is classically associated with neurodegeneration but has been observed 
in nearly every cardiometabolic disease (Evans et al. 2017). It is, of course, well known that 
the accumulation of proteins and dysfunctional organelles contribute to the development of 
pathology in almost all tissues, and thus require a very fine balance between apoptosis and 
autophagy. There seems to be synergistic roles for ATM and p53 with regards to the 
regulation of autophagy, where ATM regulates mitochondrial homeostasis and oxidative 
stress in order to prevent cells from undergoing apoptosis in response to non-genotoxic p53 
activation (Sullivan et al. 2015) 
In a nutshell, autophagy is a catabolic process that is responsible for the degradation and 
recycling of damaged organelles, and is central to the maintenance of cellular homeostasis. 
The activation of ATM through ROS and NO places ATM directly upstream of AMPK, which in 
turn, drives the inhibition of mTORC1 and upregulation of autophagy through ULK1. This 
allows cells to eliminate damaged organelles that can drive increased oxidative stress and 
recycle these components to maintain nutrient and energy homeostasis.  
Constitutive autophagy plays a protective role in mitochondrial rich cardiomyocytes, where 
accumulation of abnormal proteins and organelles, especially mitochondria, may directly 
cause cardiac dysfunction (Nishida et al. 2009). 
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2.3.4 ATM, glycolysis and the pentose phosphate pathway: 
 
Overall, A-T patients’ exhibit increased oxidative stress that can be improved by reducing 
mitochondrial ROS (D’Souza et al. 2012). Moreover, ATM promotes the overall antioxidant 
capacity in human cells by stimulating glucose-6-phosphate dehydrogenase (G6PD), a key 
enzyme in the pentose phosphate pathway (PPP), which leads to increased production of 
NADPH (nicotinamide adenine dinucleotide reduced; antioxidant co-factor) and nucleotide 
synthesis (Cosentino et al. 2011). This is mediated through ATM-mediated phosphorylation 
of p38 that can in turn phosphorylate Heat Shock Protein 27 (HSP27) in response to DNA 
damage (and is shown in Fig 2.4).  
 
Figure 2.4: ATM acts as a cytosolic redox sensor in response to oxidative stress. ATM promotes 
glucose-6-phosphate dehydrogenase activity through the promotion of HSP27 phosphorylation  by 
p38, and binding to G6PD in response to DNA damage to increase nucleotide production through 
ribose 5-phosphate (Cosentino et al. 2011). However, ATM can stimulate glucose flux through the 
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PPP by increasing the abundance of G6PD in response to mitochondrial ROS and drive the 
regeneration of TRX1 which is potentially required for the reduction of ATM dimers, suggesting a 
negative feedback loop (Zhang et al. 2018). 
Interestingly, when investigating G6PD and NADPH levels in the context of obesity (Zucker 
rats), Serpillon et al. (2009) found significantly higher G6PD activity in obese Zucker rats 
(fa/fa) whereas superoxide dismutase (SOD) and glutathione peroxidase activity was 
significantly lower. Superoxide levels were elevated in the diabetic heart, and could be 
blocked by either a specific NOX inhibitor, through the inhibition of the mitochondrial ETC 
with either antimycin or rotenone, or through the inhibition of G6DP activity. It was found 
that in a model of severe hyperlipidaemia and hyperglycaemia, NOX-derived O2
- generation 
was fuelled by elevated levels of PPP-derived NADPH production. Keeping in mind that NOX-
4 is upregulated in A-T patient derived cells (Weyemi et al. 2015), it is might suggest a more 
specific role for ATM in the PPP when switching between oxidative to non-oxidative PPP, the 
latter of which drives NADPH production. 
A progressive decrease in NADH, NAD+ and NADP+ have been observed in the cerebellum of 
ATM-null mice, whilst significantly higher levels of mitochondrial respiration was measured 
in the cerebrum of these mice compared to normal mice (Stern et al. 2002). Interestingly, 
NAD+ replenishment improved DNA repair as well as mitochondrial homeostasis in ATM-null 
mice, and contributed towards the inhibition of thymic lymphoma development as well as 
increased lifespan (Fang et al. 2016).  
Together with the pool of cytosolic NADH/NAD+, glutathione (GSH) and thioredoxin (TRX) as 
well as NADPH/NADP+ in the cytosol, there are also separate but interacting pools of these 
redox couples present in the mitochondrial intermembrane space and matrix. The GSH/TRX 
systems in the mitochondria are essential for the maintenance of H2O2 (Aon et al. 2012), and 
raise the question whether ATM can influence these redox couples in the mitochondria as 
well. 
2.4. ATM, mitochondria and mitophagy: 
 
Mitochondrial dysfunction that is linked to increased oxidative stress, defective energy 
metabolism or defective autophagy, seems to lie at the heart of ATM-deficiency. In light of 
the emerging role of ATM as a redox sensor and the role of oxidative stress in the 
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development of cardiovascular disease, a better understanding of ATM’s role in 
mitochondria is required. 
2.4.1 Mitochondrial morphology and function: 
 
Mitochondria are essential, highly dynamic organelles which play an essential role in 
metabolism that goes beyond oxidative phosphorylation and includes fatty acid metabolism, 
amino acid catabolism, biosynthesis of heme and iron sulphur clusters as well as calcium 
storage to name but a few (Shadel & Horvath 2015; Roberts Stein & Shin-ichiro 2012). 
Cardiomyocytes are rich in mitochondria, and the normal heart can produce as much as 95% 
of the ATP required through oxidative phosphorylation (Lopaschuk et al. 2010). The vast 
amount of ATP produced in the heart is required for contractility, maintaining basal 
metabolic processes and ionic homeostasis. However, mitochondria are also the foremost 
source of ROS, and if dysfunctional, can contribute to cardiomyocyte death and heart failure 
(Tong & Sadoshima 2016).  
These organelles are complex, both in form and function. Briefly, the outer mitochondrial 
membrane (OMM) surrounds the organelle and separates the inner mitochondrial 
membrane (IMM) and intermembrane space from the cytosol. The outer mitochondrial 
membrane acts as a permeability barrier for proteins larger than 1.5 kDa, whilst the inner 
mitochondrial membrane plays host to the electron transfer chain (ETC), phosphorylation 
apparatus, and membrane transporters. Parts of the inner membrane run parallel to the 
outer membrane, whilst the majority of the membrane forms invaginations into the matrix, 
known as cristae. The areas where the cristae connect to the inner mitochondrial 
membrane are known as pedicles or cristae junctions (Figure 2.5) (reviewed by Lesnefsky et 
al. 2001). The IMM and OMM also fuse to form contact sites, which are essential for protein 
import, energy coupling and the import of fatty acids.  
Stellenbosch University  https://scholar.sun.ac.za
 
 
34 
 
 
Figure 2.5: Electron micrograph of cardiac mitochondria isolated from a male Wistar rat. The 
arrows indicate the outer mitochondrial membrane (OMM) that encapsulates the mitochondrion 
and the inner mitochondrial membranes (IMM) that runs in parallel to the OMM, except where it 
forms invaginations into the matrix, known as cristae. The region where the cristae connect to the 
inner membrane is known as pedicles or cristae junctions (image generated at the National Health 
and Laboratory Services, Tygerberg Hospital, South Africa, courtesy of Mrs. N Muller). 
The matrix contains metabolic enzymes, mitochondrial DNA and RNA, as well as the 
enzymes required for the tricarboxylic acid (TCA) cycle and fatty acid oxidation, all of which 
are critical for the maintenance of cellular energy metabolism (reviewed by Roberts Stein & 
Shin-ichiro 2012).  
The mammalian mitochondrial genome is circular, double-stranded DNA that consists of 
approximately 16 600 base pairs which encodes for 13 coding genes that are transcribed 
into the protein subunits of the ETC,  and a further 24 genes that specify ribosomal as well 
as transfer RNAs which are required for the synthesis of the 13 ETC proteins (Schon & 
Manfredi 2003). It has been suggested that the absence of ATM can lead to mtDNA copy 
number depletion, which suggests a role for ATM in either mtDNA replication or 
maintenance through dNTP synthesis (Eaton et al. 2007; Shadel 2008). Moreover, the 
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absence of ATM results in decreased mitochondrial DNA integrity and mitochondrial 
dysfunction that has been associated with defective mitochondrial DNA repair (Sharma et al. 
2014). Interestingly, the latter study showed that whilst the mitochondrial DNA repair 
proteins were essentially normal, the absence of ATM specifically reduced DNA ligase III, 
which is involved in the mitochondrial base excision repair (BER) pathway. In light of the 
study by Khoronenkova & Dianov (2015) who showed that ATM is activated in response to 
single strand breaks in the BER pathway in nuclear DNA, the future study can address 
whether ATM can be activated in response to mtDNA breaks. Yhis has not yet been 
determined.  
2.4.2 Electron transfer chain (ETC) and mitochondrial metabolism: 
 
Mitochondria are best known for the ETC which consists of 5 complexes (shown in Fig 2.6): 
Complex I (NADH:ubiquinone-oxireductase), membrane bound Complex II (succinate 
ubiquinone oxidoreductase, also known as succinate dehydrogenase), Complex III 
(Coenzyme Q-cytochrome C oxireductase), Complex IV (cytochrome C oxidase, COX) and 
Complex V (ATP synthase also known as F1F0 complex).   A proton gradient is generated 
across the inner mitochondrial membrane by the three large membrane complexes, 
Complex I, III and IV. Complex I feeds electrons (e-) from NADH into the respiratory chain 
and transfers them to Coenzyme Q (ubiquinone) in the membrane. This releases energy that 
is used to pump four protons from the matrix to the inner membrane space where it 
maintains the proton gradient. Complex III receives the electrons from the reduced 
Coenzyme Q and transfer them to the electron carrier protein, Cytochrome c, which pumps 
one proton across the IMM in the process. Complex IV transfers the electrons from 
Cytochrome c to molecular oxygen and contributes to the proton gradient by using up to 
four protons per consumed O2 molecule. Complex II transfers electrons directly to 
Coenzyme Q from succinate and does not contribute to the proton gradient (Figure 2.6, 
reviewed by Kühlbrandt 2015). The electrons are thus sequentially relayed through the 
complexes to reduce oxygen to water to generate the proton gradient required for ATP 
production.  
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Figure 2.6: A simplified, schematic representation of the electron transfer chain (ETC) and 
oxidative phosphorylation. The figure (not drawn to scale) represents the ETC on the inner 
mitochondrial membrane, as well as the tricarboxylic acid cycle (TCA) that produces NADH which 
is oxidised by Complex I. Electrons are sequentially relayed from Complex I to Complex III and IV 
via Coenzyme Q (CoQ) and Cytochrome c (CytC), where molecular oxygen is converted to water. 
The proton gradient drives ATP production by ATP synthase (Complex V), which is exported out of 
the mitochondria in exchange for ADP by adenine nucleotide translocase (ANT). The voltage-
dependent anion channel (VDAC) mediates the permeability of the outer membrane and can form 
contact sites with ANT to form a channel for Cytochrome c release which signals apoptosis 
(Williams et al. 2015). 
The proton gradient, which changes the pH between the matrix and intermembrane space, 
together with the free energy released during the oxidation of NADH or flavin adenine 
dinucleotide (FADH2) is stored as an electric potential, and is collectively responsible for the 
proton motive force (pmf) which drives proton leakage and ATP turnover (Brand & Nicholls 
2011). 
Complex I is the largest (1 MDa) and most complex of the three proton pumping complexes 
and consists of a matrix and a membrane arm. It also plays a central role in cellular 
bioenergetics and metabolism, and any defects in this complex result in a plethora of 
diseases, most notably neurodegenerative diseases (Sazanov 2015). The membrane arm of 
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Complex I contains eight Fe-S clusters that conduct the electrons from NADH to Coenzyme 
Q (Kühlbrandt 2015). It is however, still largely unknown how the transfer of electrons is 
coupled to proton translocation. Combined, the proton pumping complexes drive the 
translocation of ten protons for each NADH molecule that is oxidized. The coupling between 
the electron transfer and proton translocation can either be direct and involve chemical 
redox reaction intermediates that can be protonated or deprotonated and drives proton 
translocation, or indirectly through the mediation of long-range conformational changes 
(Sazanov 2015). Together, the three proton pumping complexes assemble into super 
complexes often referred to as respirasomes. Incorrect assembly of these respirasomes has 
been linked to decreased oxidative phosphorylation and the development of heart failure 
(Rosca et al. 2008). 
The TCA cycle (also known as the Krebs cycle) generates NADH through NAD+  which gains 
two electrons and a proton from several steps in the TCA cycle, and is reduced to NADH that 
is required for the ETC (Figure 2.6, adapted from Williams et al. 2015). In the healthy heart 
the TCA cycle utilizes acetyl-Coenzyme A (acetyl-CoA) that is generated mainly through the 
oxidation of fatty acids and glucose-pyruvate (Dorn et al. 2015). The rate of flux through the 
metabolic pathways is determined by the requirement for ATP to maintain the rate of ATP 
hydrolysis and the power generated by the myocardium, which is in turn is controlled by the 
expression of metabolic proteins and pathway regulation that is dependent on enzyme 
regulation and the substrate/product relationships (Stanley et al. 2005). Fatty acid oxidation 
is mediated by the carnitine-palmitoyl transferase shuttle (CPT) that imports fatty acids into 
the matrix where it can undergo β-oxidation that reduces FAD+ and NAD+ to FADH2 and 
NADH, respectively, while producing acetyl-CoA (Cole et al. 2011).  
Substrate-specific pathways are very important in the functioning of cardiac mitochondria, 
and have at least partially been associated with defects in cardiac oxidative capacity during 
pressure overload-induced heart failure (Bugger et al. 2010). Impaired metabolism also 
contributes to contractile dysfunction and left ventricular remodelling: a downregulation is 
observed in fatty acid oxidation, ETC activity and decreased mitochondrial flux whilst 
glycolysis and glucose oxidation increases in heart failure (Stanley et al. 2005). Furthermore, 
a high rate of  β-oxidation serves as a cardiac metabolic hallmark of diabetes and obesity 
(Fukushima & Lopaschuk 2016). It is thus important to assess the ETC complexes in terms of 
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different substrates as this can give a good indication of potential mitochondrial 
dysfunction.  
It is also possible to assess the function of isolated mitochondria with substrates specific to 
Complex I, II or III where the combination of glutamate and malate assesses the aspartate 
shuttle, and pyruvate and malate assesses the monocarboxylate and dicarboxylate 
transporters and pyruvate dehydrogenase (Rosca et al. 2008). Both substrate combinations 
produce NADH, which donates electrons to Complex I. The use of succinate in the presence 
of a Complex I inhibitor, such as rotenone, can be used to investigate Complex II, whereas 
palmitoyl-L-carnitine can be used to assess β-oxidation.  Complex III, which is the major ROS 
producer and oxygen sensor during hypoxia (Guzy et al. 2005), can be inhibited with 
Antimycin C, which makes it possible to investigate to substrate utilization and individual 
complexes. 
2.4.3 Mitochondrial oxidative stress: 
 
Whereas most of the oxygen that is consumed is reduced to water, Complexes I and III can 
leak electrons, which leads to the generation of  O2
- due to the partial reduction of oxygen 
(Druzhyna et al. 2009). Superoxide can rapidly be dismutated into H2O2 by manganese 
superoxide dismutase (mnSOD), and is kept at minimal levels by the GSH/Trx ROS 
scavenging systems (Aon et al. 2012). Complex I and III are the major sites of ROS 
production in mitochondria (Finkel 2011). The inhibition of Complex I can reduce ROS 
production during ischaemia, whereas a blockade of electron flow to COX-IV can increase 
ROS production and oxidative damage (Chen et al. 2003).  
The chronic oxidative stress observed in A-T has led to the suggestion that A-T might be a 
mitochondrial disease (Ambrose & Gatti 2013) and has also been linked with intrinsic 
mitochondrial dysfunction (Ambrose et al. 2007). The latter study found that 
lymphoblastoid cells from A-T patients contain an increased population of mitochondria 
with a decreased membrane potential, when compared to control cells. Proteins with 
specific roles in mitochondrial DNA damage and/or ROS scavenging, including mnSOD, 
peroxiredoxin 3 and mitochondrial topoisomerase, I are also elevated in these cells. Indeed, 
the decreased membrane potential translated into decreased respiratory activity in the A-T 
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cells compared to the wild type controls. This study was the first to show that ATM might be 
required for mitochondrial function. However, there are discrepancies between studies with 
regards to the role of ATM in mitochondrial content (Eaton et al. 2007; Ambrose et al. 
2007).  This was highlighted in the study by Valentin-Vega et al. (2012) who found increased 
mitochondrial content, contrary to the studies of Eaton et al. (2007) and Ambrose et al. 
(2007). 
Concomitantly, the authors showed that the in vivo loss of ATM in mice resulted in 
mitochondrial dysfunction in thymocytes that was accompanied by increased mitochondrial 
content and mitochondrial ROS due to a decrease in mitophagy. Interestingly, they observed 
a significant decrease in Complex I activity as well as ATP production, and an increase in 
oxygen consumption. They also found that autophagy was not affected by the absence of 
ATM, and suggested that mitochondrial dynamics such as fission and fusion could contribute 
towards defective mitophagy. The authors concluded that the observed defects in the 
absence of ATM suggest that ATM might localise directly to mitochondria. Returning to a 
cellular model, fractionation studies revealed that the mitochondrial fraction of HepG2 cells 
was enriched with ATM and activated ATM in response to H2O2 treatment (Morita et al. 
2014).  In contrast to a previous study that found that ATM associates with the peroxisomal 
fraction (Watters et al. 1999), Morita et al. (2014) detected almost no ATM. However, we 
now know that ATM binds to and is imported into peroxisomes in response to oxidative 
stress (Zhang et al. 2015), and raises the question whether this is a cell-type specific 
phenomenon. This reverberates with the suggestion by Valentin-Vega et al. (2012) that both 
the cell type and culture conditions of immortalized A-T cells can affect mitochondrial 
homeostasis and autophagic responses which explain the differences in mitochondrial 
content reported in A-T deficient cell lines.  
Mitochondrial respiration inhibition can also lead to increased mitochondrial ROS 
production.  Treatment of HeLa cells with either rotenone or Antimycin C failed to increase 
mitochondrial hydrogen peroxide production although it did increase mitochondrial super 
oxide production (Zhang et al. 2018). Superoxide in itself failed to drive ATM dimerization, 
and suggests that mitochondrial super oxide must be converted to H2O2 in order to activate 
ATM in either the cytosol or nucleus of HeLa cells.  
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Taken together, these studies suggest very strongly that ATM could be localised to the 
mitochondria, but the effect of the absence of ATM seems to be context specific.  
Moreover, ATM might have an effect on the ETC: ATM-/- thymocytes exhibit decreased 
complex I activity (Valentin-Vega et al. 2012), whereas the chemical inhibition of ATM 
results in a post-translational decrease of COX-IV (Patel et al. 2011). This is interesting 
because the inhibition of COX-IV has been associated with increased ROS production at 
Complex I, albeit in the mitochondrial matrix (Chen et al. 2003). 
Interestingly, Beclin-1 heterozygosity in ATM-/- mice reduces mtROS and complex I 
abnormalities in thymocytes (Valentin-Vega et al. 2012). Beclin-1 forms part of the complex 
required for the induction of autophagy (Kobayashi & Liang 2015), but is also required for 
the recruitment of Parkin to the mitochondrial membrane where it induces ubiquitination 
and proteasomal degradation of proteins on the outer mitochondrial membrane which 
leads to the inhibition of fusion and the trafficking of dysfunctional mitochondria (Choubey 
et al. 2014). It is still unclear why the allelic loss of Beclin-I would promote improvement of 
mitochondrial dysfunction in ATM-/- mice, but it has led to the suggestion that Beclin-1 
might have additional functions together with its role in autophagy (Valentin-Vega et al. 
2012).  
2.4.4 Mitophagy and mitochondrial dynamics: 
 
Similarly to Valentin-Vega et al. (2012), Fang et al. (2016) reported increased mitochondrial 
content in ATM-knockdown (ATM-KD) rat neurons and increased ROS production, but also 
noted a higher mitochondrial membrane potential in contrast to that reported by Ambrose 
et al. (2007). They did however suggest that this could reflect decreased ATP production, 
and either inadequate or inefficient mitophagy. Moreover, the study showed that 
mitophagy is suppressed in ATM-KD HeLA cells and rat neurons, but that the phenotype 
could be rescued by replenishing NAD+ in the cells which significantly improve life-span in 
ATM-/- mice (Fang et al. 2016). 
Spermidine is a natural polyamine that is involved in several biological processes including 
cell-proliferation and apoptosis, and tends to decline with age (Eisenberg et al. 2009). 
Spermidine also elicits mitochondrial depolarization that elicits the formation of 
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mitophagosomes and mitochondrial targeted lysosomes, which has been suggested to be 
through ATM- dependent activation of the PINK/Parkin mitophagy pathway (Qi et al. 2016). 
Spermidine-induced mitochondrial depolarization is abrogated in the presence of the 
chemical ATM inhibitor, KU55933. Moreover, spermidine promotes the co-localisation of 
phosphorylated ATM and PINK on the outer mitochondrial membrane, which together with 
the translocation of Parkin can be blocked by the ATM inhibitor. The authors suggest a 
model whereby the addition of spermidine results in ROS which activates ATM and drives 
PINK1 accumulation as well as Parkin translocation with consequent mitophagy (Figure 2.7). 
Terminally differentiated cells such as cardiomyocytes are dependent on the efficient 
removal and replacement of dysfunctional mitochondria to ensure cell survival and to 
maintain cardiac homeostasis (Moyzis et al. 2015). A decrease in ATP production and 
increased ROS production as a measure of mitochondrial dysfunction can result in either the 
release of apoptotic proteins or the selective clearance of the damaged mitochondria.  
Mitophagy thus serves as an early cardioprotective response through the removal of 
damaged mitochondria, and if this fails, apoptosis can be induced in response to excessive 
oxidative stress (Kubli & Gustafsson 2012). Moreover, reduced autophagy together with the 
accumulation of dysfunctional mitochondria have been associated with heart failure and 
aging (Moyzis et al. 2015). Inefficient mitophagy  can, at least partially, contribute to 
diabetic cardiomyopathy (Liang & Kobayashi 2016).   
The best established model of mitophagy involves the accumulation of PINK (which is 
normally degraded in healthy mitochondria) on the outer mitochondrial membrane (Valente 
et al. 2004) that drives the recruitment and translocation of Parkin (Kitada et al. 1998) to 
damaged mitochondria.  Parkin is an E3 ubiquitin ligase that is phosphorylated by PINK, 
which stimulates its translocation to the mitochondria where it ubiquinates several OMM 
proteins. This promotes further PINK phosphorylation and the formation of ubiquitin chains 
that simultaneously bind ubiquitin-binding domains (UBDs) and microtubule-associated 
proteins 1A/1B light chain 3 (LC3)/GABAA receptor-associated protein (GABARAP) attached 
to autophagosomal membranes that can then envelop the damaged mitochondria 
(reviewed by Nguyen et al. 2016). PINK also phosphorylates the fusion protein, mitofusin 2 
(Mfn2), which then can serve as a mitochondrial receptor for Parkin, promoting its 
ubiquination (Chen & Dorn II 2013). The loss of Mfn2 prevents the translocation of Parkin in 
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depolarized mitochondria and supresses mitophagy, which drives the accumulation of 
dysfunctional mitochondria and respiration in mouse cardiomyocytes.  
 
Figure 2.7: A schematic overview of mitophagy and autophagic clearance of damaged 
mitochondria. ATM have been implied in the PINK/Parkin mitophagy pathway in response to 
spermidine treatment, which induces ROS and consequently activate ATM, which is then recruited 
to the permeabilised mitochondrial membrane where it co-localise with PINK. This drives the 
recruitment of Parkin which is ubiquitinated. The ubiquitin chain binds to LC3 (shown as balls) on 
the autophagosome, which then engulfs damaged mitochondria for lysosomal degradation (not 
shown). Hypoxia or mitochondrial uncoupling can also activate ULK1, driving its translocation to 
the damaged mitochondrion membrane where it phosphorylates FUNDC1, which enhances its 
binding to LC3, whereas the dephosphorylation of FUNDC1 by PGAM5 also allows FUNDC1 to 
directly interact with LC3. BNIP and NIX can act as mitochondrial receptors in response to hypoxia 
when the mitochondrial membrane is not permeabilised and bind to LC3 on the autophagosome. 
Damaged mitochondria produce less ATP that activates AMPK, which in turn phosphorylates ULK1 
and activates the Beclin1-VSP34-VSP15 complex and drives the formation of an autophagosome. 
Damaged mitochondria can also produce ROS which inhibits mTOR and leads to the activation of 
autophagy. Whether ATM is involved in either the activation of AMPK or suppression of mTOR in 
response to ROS to induce mitophagy is still unknown (indicated with a question mark).  
The recent discovery that ULK1 and the autophagy protein (Atg), Atg9a are recruited directly 
to the damaged mitochondria during the early stages of Parkin-mediated autophagy, 
suggests that the autophagosomal membrane can also be formed de novo by the damaged 
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mitochondria opposed to a pre-formed isolation membrane that recognizes the damaged 
mitochondria (Itakura et al. 2012). In the event of hypoxia or FCCP-mediated mitochondrial 
uncoupling, ULK1 is upregulated and translocates to fragmented mitochondria upon 
mitophagy induction (Wu et al. 2014). In brief, once ULK1 translocates to the mitochondria, 
it interacts with FUNDC1 and phosphorylates it at Ser17, which in turn enhances FUNDC1 
binding to LC3. The authors conclude that FUNDC1 is crucial for ULK1 recruitment to 
damaged mitochondria, where its phosphorylation of FUNDC is essential for mitophagy in 
response to hypoxia and mitochondrial uncoupling. Moreover, the loss of either AMPK or 
ULK1 results in the accumulation of the autophagy adapter protein, p62 and defective 
mitophagy, whereas the loss of ULK1 phosphorylation by AMPK results in dysfunctional 
mitochondrial homeostasis during starvation, which collectively link nutrient status with 
autophagy and cell survival (Egan et al. 2011).   
A very comprehensive review by Moyzis et al. (2015) is depicted in Figure 2.7, and 
summarises four pathways through which mitophagy can be mediated. Briefly, the first 
pathway is the PINK/Parkin ubiquitin-dependent pathway described previously. The second 
is mitochondrial receptor-mediated autophagy, where the pro-apoptotic proteins, BNIP3 
and NIX localize to the outer mitochondrial membrane and act as receptors for targeting 
autophagosomes through direct interaction of conserved LC3-interacting regions (LIRs) with 
LC3 on the autophagsome, often in response to hypoxia (Zhang & Ney 2009), and in the 
absence of mitochondrial membrane permeabilization (Rikka et al. 2011). The third pathway 
is through FUNDCI, which has been mentioned previously in this document.  FUNDCI is an 
outer mitochondrial membrane protein that has been implicated in hypoxia-mediated 
mitophagy in mammalian cells (Moyzis et al. 2015). Similar to BNIP3 and NIX, FUNDC1 acts 
as a receptor for the autophagosomal membrane and interacts directly with LC3 through LIR 
(Wei et al. 2015). The serine/threonine protein phosphatase, PGAM5 dephosphorylates 
FUNDC1 during hypoxia or mitochondrial membrane depolarization and promotes 
interaction with LC3 with consequent mitophagy. Lastly, cardiolipin, which is located on the 
inner mitochondrial membrane where it maintains the function of several proteins involved 
in mitochondrial metabolism, redistributes to the outer mitochondrial membrane during 
mitophagy where it binds to LC3. It has been suggested that the redistribution of cardiolipin 
can act as a signal for the elimination of damaged mitochondria, but this has only been 
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observed in neurons thus far and still needs to be evaluated in cardiomyocytes (Moyzis et al. 
2015).    
Mitophagy, together with mitochondrial biogenesis, fusion and fission, collectively classified 
as mitochondrial dynamics, balance the need for nutrients with energy demand (Vásquez-
Trincado et al. 2016). Mitophagy is also dependent on the fission/fusion cycle, whilst many 
of the fission/fusion cycle proteins, including Drp1, Mfn1, Mfn2 and Opa1 have been linked 
with the transcriptional activation of PGC1α, which regulates mitochondrial biogenesis 
(Martin et al. 2014). Mitochondrial fission is accelerated prior to mitosis to ensure equal 
mitochondrial distribution, but can also participate in the removal of damaged mitochondria 
through mitophagy by packaging the damaged DNA and proteins into one daughter 
organelle whilst directing the undamaged components into the other daughter organelle, 
ensuring the destruction of the dysfunctional components (Dorn & Kitsis 2015). Mitophagy 
can also be triggered in response to mild oxidative stress in a Drp1-dependent manner, 
triggering selective mitophagy, whilst starvation and increased ROS induces both non-
selective autophagy and to a lesser extent, mitophagy (Frank et al. 2012). Interestingly, 
inhibition of Drp1 results in hyperfusion which triggers cellular replication stress and results 
in delays in the G2/M cell cycle, consequently activating ATM and the G2 to M cell cycle 
checkpoint (Qian et al. 2012). Normal cardiac mitochondrial fusion on the other hand, 
seems to be a much slower process, albeit essential for both organelle function and 
homeostasis (Chen et al. 2011). 
Currently, ATM has not yet been implicated in the regulation of either fission or fusion, but 
is known to play a role in mitophagy (Valentin-Vega et al. 2012; Qi et al. 2016), 
mitochondrial homeostasis (Ambrose et al. 2007) and mitochondrial biogenesis (Fu et al. 
2008). It was shown in the latter study that ATM can be activated by etoposide, an 
apoptosis-inducing agent, which can lead to mitochondrial biogenesis through the activation 
of AMPK. The authors suggest that ATM-dependent mitochondrial biogenesis may play a 
role in the DDR and ROS regulation, and that combined, this can lead to the development of 
A-T.  
In conclusion, studies have shown that ATM is activated directly by mitochondrial ROS, and 
more specifically mitochondrial-derived H2O2 (Zhang et al. 2018). ATM can also be recruited 
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to, and co-localize with PINK at the mitochondrial membrane in response to spermidine 
induced mitochondrial depolarization (Qi et al. 2016). Moreover, ATM activates ULK1 
through AMPK phosphorylation (Zhang et al. 2015) in response to oxidative stress, and this 
could imply a possible link between ATM and ULK1/FUNDC1 mitophagy due to hypoxia (Wu 
et al. 2014), another activator of ATM (Cam et al. 2010). Collectively, this suggests a role for 
ATM in mitochondrial dynamics. 
Of relevance though is that the absence of functional ATM can increase oxidative stress and 
drive mitochondrial dysfunction. Heterozygous ATM (ATM+/-) in an apolipoprotein ApoE-/- 
mouse model can accelerate the development of atherosclerosis as well as multiple features 
of metabolic syndrome. This could respectively be alleviated with transplantation of ATM+/+ 
bone marrow (Mercer et al. 2010), and treatment with the mitochondrial specific ROS 
scavenger, MitoQ (Mercer et al. 2012).   
2.5 ATM and insulin signalling 
 
Collectively, risk factors such as hypertension, insulin resistance, excess visceral fat and 
hyperlipidaemia are known as the metabolic syndrome (Roberts & Sindhu 2009) and the 
cumulative contribution can increase the risk of developing cardiovascular dysfunction 
(Kahn et al. 2005). Ren et al. (2010) have suggested that literature indicates  that decreased 
myocardial mitochondrial fatty acid metabolism, biogenesis and antioxidant defence 
mechanisms can lead to reduced cardiac substrate flexibility, cardiac energy efficiency, and 
diastolic dysfunction. It is also becoming clear that mitochondrial dysfunction can play an 
important role in the development and pathogenesis associated with cardiac contractile 
dysfunction in obesity, insulin resistance and Type 2 diabetes (Bugger & Abel 2010). Altered 
insulin signalling in the heart can contribute directly to mitochondrial dysfunction and result 
in hyperglycaemia-induced oxidative stress, which can lead to the onset of diabetic cardiac 
myopathy (Boudina et al. 2009). 
A-T patients have elevated glycaemia and decreased insulin sensitivity (Connelly et al. 2016) 
that can develop into severe insulin resistance (Bar et al. 1978). It is suggested that as many 
as 1.4-2% of the general US/Canadian population are heterozygous carriers of ATM 
mutations, significantly elevating their risk to develop ischaemic heart disease (Su & Swift 
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2000). Moreover, and as mentioned previously, targeting mitochondrial ROS specifically in 
heterozygous ATM+/- ApoE-/- mice, reduced oxidative damage to mitochondrial DNA and 
inhibited the development of various features of metabolic syndrome (Mercer et al. 2012). 
In knock-out mouse studies of ATM, it has been shown that the absence of ATM induces 
both structural and functional changes such as increased myocardial fibrosis and myocyte 
hypertrophy in the heart (Foster et al. 2012). Increased myocyte apoptosis and expression 
of fibrosis-related genes in the absence of ATM was also observed in the same study. 
Furthermore, it was demonstrated that ATM activates the tumour suppressor, p53, in 
response to β-adrenergic receptor stimulation, and plays a protective role against cardiac 
remodelling (Foster et al. 2011).  Taken together, these studies suggest a potential role for 
ATM in both insulin signalling and ischaemic heart disease.  
ATM was first implicated in the insulin-response pathway in the context of protein 
synthesis. Yang & Kastan (2000) found that ATM phosphorylates eukaryotic translation 
initiation factor 4E-binding protein 1 (4E-BP1) at Ser111 in vitro and in vivo in response to 
insulin treatment. The authors also demonstrated that insulin enhances the specific kinase 
activity of ATM and that the absence of ATM significantly decreases the dissociation of 4E 
binding protein 1 (4E-BP1) from eukaryotic translation initiation factor 4E, which is required 
for translation initiation and mRNA stability. This led Schneider et al. (2006) to hypothesise 
that ATM might be involved in insulin signalling, and the authors consequently 
demonstrated that the absence of ATM results in insulin resistance as well as vascular 
disease in high-fat diet fed mice. Activation of ATM with a low dose of chloroquine (7 
mg/kg/week) decreased features of metabolic syndrome, such as increased visceral fat and 
decreased adiponectin, as well as atherosclerosis. Endogenous glucose production could not 
be suppressed by insulin in an ATM+/- ApoE-/- mouse model, and insulin-induced 
phosphorylation of Akt at Ser473 and Thr308 was decreased in this model. The absence of 
ATM also increased insulin receptor substrate 1 (IRS-1) as well as Jun-C-kinase (JNK) in 
aortas (Schneider et al. 2006). JNK has been implicated in obesity and the development of 
Type 2 diabetes (Solinas & Becattini 2017; Han et al. 2013). Lastly, Schneider et al. (2006) 
found that chloroquine improved both fasting and non-fasting glucose metabolism through 
ATM-mediated p53 Ser15 activation in fat, muscle and aortas of ob/ob (leptin deficiency) and 
db/db mice (leptin receptor mutation) (Schneider et al. 2006).  Interestingly, the activation 
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of ATM with chloroquine in p53+/+ ApoE-/- and p53-/- ApoE-/- mice improved atheroprotection 
in a p53-dependent manner, but improved glucose intolerance and insulin-sensitivity 
independent of the p53-pathway (Razani et al. 2010). The tumour-suppressor, p53, is also 
activated and phosphorylated by ATM in response to DNA damage caused by hypoxia and 
UV- or ionizing radiation, and can mediate cell survival, angiogenesis inhibition or apoptosis 
(Kastan & Lim 2000). In a mouse model with a germline p53 mutation (Ser18 changed to 
alanine; murine Ser15),  increased metabolic stress and glucose homeostasis defects were 
observed, and led to the development of insulin resistance (Armata et al. 2010). N-Acetyl 
cysteine (NAC) treatment restored insulin signalling in late-passage primary mouse 
fibroblasts, whereas an antioxidant in the diet of the p53 Ser18-deficient mice made them 
glucose tolerant, which led the authors to conclude that p53 phosphorylation by ATM plays 
an important role in glucose homeostasis (Armata et al. 2010).  
Insulin-like growth factor 1 (IGF-1) is a potent activator of the insulin sensitive Akt-pathway, 
and stimulates ATM phosphorylation, which is important for AMPK-α subunit 
phosphorylation during IGF-1 signalling, and most interestingly, does this in an LKB1-
independent manner (Suzuki et al. 2004). Moreover, it has been reported that ATM 
phosphorylates Akt at Ser 473 in response to insulin or ionizing radiation (Viniegra et al. 
2005), which led to the suggestion that ATM might  play a role in IGF-1 signalling through 
the Akt/mTOR pathway (Ching et al. 2014). In differentiated C2C12 cells as well as in 
isolated soleus muscle from ATM-/- mice results support the suggestion that ATM might be a 
modulator of IGF-1 signalling downstream of IRS-1 to stimulate phosphorylation of Akt at 
Ser473 and Thr308 as well as mTOR and S6K (Ching et al. 2014).  
In an insulin resistant high-fat fed rat model, ATM expression was significantly decreased in 
isolated gastrocnemius muscle tissue, and Akt Ser473 phosphoprylation decreased 
correspondingly in response to intraperitoneal insulin treatment (Halaby et al. 2008). In 
contrast to Schneider et al. (2006), no differences in JNK expression in muscle from either 
control chow-fed rats or high-fat fed rats were observed. The authors also showed that 
phosphorylation at ATM-mediated Akt Ser473 are important for the subsequent 
phosphorylation of Thr308 in mouse fibroblast cells. The authors observed the same result in 
L6-myoblast cells, and showed that insulin-induced Akt phosphorylation by ATM, as well as 
glucose transporter 4 (GLUT4) translocation to the cellular membrane can be abrogated in 
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the presence of the ATM inhibitor, KU55933. However, the same result was not observed in 
L6-myotubes (C2C12 and RD cells), where the use of KU55933 abrogated GLUT4 transport 
and decreased AS160 (Akt substrate of 160 kDa) phosphorylation, but did not affect the 
insulin-stimulated phosphorylation of Akt at Ser473 (Jeong et al. 2010). The latter study 
suggested that this might have been due to the use of a lower concentration of KU55933 (1 
μM compared to 10 μM) or the use of myotubes compared to a myoblast cell-line, 
suggesting that the cellular model could play an important role in the evaluation of specific 
protein activity.  Similarly, ATM inhibition failed to interfere with insulin-stimulated 
phosphorylation of Akt at Ser473 or Thr308 in 3T3-L1 adipocyte cells, which was mediated by 
mTOR complexed to RICTOR (rapamycin-insensitive companion of mTOR) (Hresko & 
Mueckler 2005).  
Irrespective, cytoplasmic ATM plays an important role in glucose homeostasis because of its 
role in i) protein translation through the phosphorylation of 4E-BP1 (cytoplasmic translation-
regulatory protein) (Yang & Kastan 2000); ii) mediating full activation of Akt in certain cell 
types (Viniegra et al. 2004; Halaby et al. 2008; Jeong et al. 2010; Hresko & Mueckler 2005); 
and iii) regulating glucose transporter 4 (GLUT4) translocation, which is responsible for 
glucose uptake in response to  insulin (Halaby et al. 2008). Glucose can be  imported into 
cells by GLUT4  either in an insulin-dependent manner (mediated by the Akt-pathway; Ditch 
& Paull 2012), or insulin-independent manner through the AMPK-pathway (O’Neill 2013) in 
response to  low glucose, hypoxia or ischaemic conditions. The translocation of the GLUT4 
vesicle, which is also the main isoform present in fully differentiated cardiomyocytes, is 
severely limited both in the absence of ATM (Halaby et al. 2008) and in insulin resistance. 
However, the underlying mechanisms of GLUT4 translocation in response to ATM and 
insulin, are still unclear (Ditch & Paull 2012). The cytoplasmic role of ATM is presented 
schematically in Fig 2.8. 
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Figure 2.8: A schematic representation of the cytosolic role of ATM in response to insulin. Insulin-
like growth factor 1 (IGF-1), which is a potent activator of the Akt-pathway, stimulates ATM 
phosphorylation which is required for AMPK-α phosphorylation during IGF-1 signalling,  in an 
LKB1-independent manner. ATM also enhances protein synthesis through the phosphorylation of 
4E-BP1 in response to insulin stimulation both in vivo and in vitro.  ATM is required for the 
phosphorylation of Akt at Ser473 in response to insulin or ionizing radiation, and can phosphorylate 
AS160 independently of Akt in certain cell types. As described elsewhere, ATM is sensitive to 
endogenous ROS, as well as hypoxia, and can phosphorylate as well as mediate HIF1-α 
translocation. It also plays a role in the PPP either through HSP27 or direct interaction with G6PD. 
Obesity and its associated ROS is an early marker of metabolic syndrome (Hopps et al. 
2010). Insulin resistance is a frequent complication observed in obesity (Kahn et al. 2006), 
whereas A-T patients often exhibit with poor weight gain and a progressive decrease in 
body mass index and can still develop diabetes (Schubert et al. 2005). This paradox led 
Takagi et al. (2015) to investigate adipose tissue distribution in ATM-/- mice in order to 
determine whether defective adipose tissue development might be responsible for the 
lipoatrophic diabetes observed in A-T patients. Two major role players in adipocyte 
differentiation are CCAAT/enhancer binding protein 1 (C/EBP1) and peroxisome proliferator 
activated receptor γ (PPARγ). Furthermore, it is well-known that alterations in adiposity 
Stellenbosch University  https://scholar.sun.ac.za
 
 
50 
 
differentiation can impact glucose homeostasis (Takagi et al. 2015). It was found in this 
study, similarly to Schneider et al. (2006), that ATM+/- mice did not exhibit glucose 
intolerance or insulin resistance, but quickly developed both pathologies when fed a high fat 
diet.  Conversely, ATM-/- mice that were fed a high fat diet had increased visceral fat, 
decreased adiponectin and decreased leptin levels. This was suggested to be due to a 
redistribution of fat that led to decreased subcutaneous fat whilst increasing visceral fat, as 
well as an increased appetite due to decreased leptin levels. Mouse embryonic fibroblasts 
(MEFs) derived from ATM-/- mice were defective in adipocyte differentiation and had 
significantly reduced glucose uptake compared to MEFs from ATM+/+ mice. Similarly, both 
caffeine and the ATM inhibitor, KU55933 could block adipocyte differentiation in 3T3-L1 
cells. This was due to defective expression of the transcriptional factors, C/EBP1 and PPARγ. 
No differences in IGF-1 receptor levels were found. The authors conclude that ATM plays a 
role in the key adipocyte transcription factors, which contribute to glucose homeostasis in 
vivo (Takagi et al. 2015). 
Moreover, the heterozygous ATM+/- ApoE-/- mouse model exhibits hyperlipidaemia on both 
normal chow-fed and high fat diets (Mercer et al. 2010) which can be reduced with the oral 
administration of MitoQ which prevents the increased adiposity, hypercholesterolaemia, 
and hypertriglyceridaemia associated with metabolic syndrome development in fat-fed 
heterozygous ATM mice (Mercer et al. 2012). Cells that are ATM deficient, exhibit decreased 
anti-oxidant capacity and increased sensitivity to ROS. The oxidation of low-density 
lipoprotein (oxLDL) and its uptake by macrophages, activates both ATM and p21 in 
fibroblasts and endothelial cell, and can act as a trigger in the development of 
atherosclerosis (Semlitsch et al. 2011). However, in the absence of ATM, oxLDL induces DNA 
double-strand breaks and chromosome breaks, as well as decreasing cell viability and colony 
formation of A-T fibroblasts, whilst significantly increasing oxLDL-induced reactive oxygen 
species which can be rescued with anti-oxidant pretreatment (Semlitsch et al. 2011). It was 
concluded in this study that ATM maintains antioxidant defence against oxLDL-mediated 
cytotoxicity (Semlitsch et al. 2011), which implies a potential role for ATM in lipid 
peroxidation as oxidized phospholipids have a high affinity for oxLDL which is increased in 
cardiovascular disease (Anderson et al. 2012). 
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Collectively, an important role for ATM in glucose homeostasis, adipocyte differentiation, as 
well as redox homeostasis is suggested, all of which can contribute towards the 
development of metabolic syndrome, Type 2 diabetes and cardiovascular disease when 
disrupted. This highlights the need to further elucidate the role of ATM within cellular 
metabolism and potentially within a more tissue specific manner.  
2.6 ATM and drug efficacy: 
 
Lastly, ATM also potentially plays a role in drug efficacy, which gives it clinical relevance. 
Metformin, the most commonly used first line treatment for T2D, is potentially associated 
with ATM. The drug increases cellular glucose uptake through activation of the AMPK 
pathway (Zhou et al. 2001) by increasing cellular AMP through the inhibition of the 
mitochondrial respiratory chain (Owen et al. 2000).  The considerable variability in 
glycaemic response to metformin treatment among patients led to a genome wide 
association study (GWAS) that associated a single nucleotide polymorphism (SNP), located 
at the locus containing the ATM gene,  with metformin treatment success (Zhou et al. 2011). 
It was found in the same study that inhibition of ATM with KU55933 decreased AMPK-
activation by metformin, and concluded that ATM acts upstream of AMPK and is required 
for a full response. Although the presence and association of metformin treatment success 
with this SNP have both been confirmed and refuted independently (Van Leeuwen et al. 
2012; Florez et al. 2012), it is also argued that AMPK-activation, in response to metformin, is 
independent of ATM, and rather acts through the organic cation transporter, OCT1, which is 
also inhibited by KU55933 (Yee et al. 2012). However, long-term metformin treatment 
stimulates cardiomyocyte glucose uptake through an AMPK-dependent decrease in GLUT-4 
endocytosis (Yang & Holman 2006) and improved glucose intolerance in ATM knockout mice 
(Takagi et al. 2015), and highlights the need for further research in this regard. Although 
little research has been done with regards to the effect of metformin or KU55933 on the rat 
cardiomyoblast cell line, H9c2, it was shown that KU55933 effectively inhibits ATM 
phosphorylation in post-mitotic myotubes (Fortini et al. 2012). Furthermore, inhibition of 
ATM with KU60019, which is 10-fold more effective and has half the IC50 value of KU55399, 
blocked AMPK activation by metformin in small-cell lung cancer cells (Storozhuk et al. 2013). 
It is, however, also known that metformin is cardioprotective (Kobashigawa et al. 2014) and 
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has been found to delay the development of diabetes and cardiovascular dysfunction in 
Goto-Kakizaki rats (non-obese model of T2D) by inhibiting the generation of superoxide in 
mitochondria (Rösen & Wiernsperger 2006). It has been suggested that ATM could be 
activated by ROS prior to metformin treatment with consequent mitochondrial inhibition 
(Ditch & Paull 2012), which implicates a possible role for ATM in response to 
hyperglycaemia-induced oxidative stress within the AMPK-pathway.  
ATM has also been implicated in doxorubicin-induced (Dox) cardiotoxicity (Zhan et al. 2016). 
Dox is a potent and widely used anti-cancer drug, but its usage is limited by cumulative dose 
dependent cardiotoxicity due to underlying mechanisms such as free radical formation, lipid 
peroxidation, p53 accumulation and activation of pro-apoptotic signalling cascades (Deavall 
et al. 2012). Dox, which is a topoisomerase II-stabilizing drug, results in ATM-dependent 
accumulation and phosphorylation of p53 and promotes the phosphorylation of ATM-
dependent DDR proteins, which can be attenuated by NAC treatment (Kurz et al. 2004). This 
suggests that hydroxyl-radicals contribute to Dox-induced activation of ATM-dependent 
pathways. Interestingly, ATM-KO mice show attenuated Dox-induced cardiotoxic effects 
(Zhan et al. 2016). The study showed that ATM is primarily expressed and activated in 
cardiac fibroblasts, where it activated the Fas-ligand, which when activated, can mediate 
apoptosis in cardiomyocytes. Systemic inhibition of ATM with KU55933 prevented Dox-
induced cardiotoxicity, and suggests that the antagonism of ATM may have potential 
therapeutic implications (Zhan et al. 2016).  
2.6 Purpose of research: 
 
Taken together, ATM seems to play a central role in cellular metabolism. Oxidative stress 
has been identified as a contributing factor in insulin resistance and coronary artery disease 
(Ceriello & Motz 2004). ATM can mediate autophagy via the AMPK-pathway in response to 
ROS (Shiloh & Ziv 2013) as well as hypoxia (Cam et al. 2010).  Even though hypoxic 
conditions, such as ischaemia, can activate AMPK independently of the AMP/ATP ratio of 
the cell (as is the case with metformin), it still requires mitochondrial DNA and ROS 
generation to activate ATM (Emerling et al. 2009).  This also holds true for ATM’s role in the 
regulation of mitochondrial homeostasis and oxidative stress that allows the protein to be 
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activated in order to prevent apoptosis is response to non-genotoxic p53 activation (Sullivan 
et al. 2015). Nevertheless, further studies are required to elucidate the relationship 
between the metformin-glycaemic response and ATM-dependent glucose metabolism and 
its activation in response to oxidative stress (Takagi et al. 2015).  
ATM is a key regulator of adipocyte transcription factors (CEBP1 and PPARγ) and adipocyte 
differentiation via  the DDR pathway (Takagi et al. 2015). On the other hand, cardiomyocyte 
differentiation is directed by mitochondrial fusion which is mediated by the proteins, 
Mitofusin-1 and -2 (Kasahara et al. 2013). Mitofusin-2 is involved in the rearrangement of 
the outer mitochondrial membrane, and cardiac myocytes lacking this protein tend to be 
pleiomorphic and contain enlarged mitochondria (Papanicolaou et al. 2011). This 
observation corresponds to the increased mitochondrial numbers and structural 
abnormalities that were observed in lymphoblastoid cells obtained from A-T patients 
(Ambrose et al. 2007). In a study with thymocytes where a fraction of ATM was localised to 
the mitochondria, defects in mitophagy (mediated by the autophagy protein, Beclin-1) as 
well as a reduction in respiration rates in cell culture lacking ATM, was shown (Valentin-
Vega et al. 2012). Furthermore, ATM can induce pexophagy (autophagy of peroxisomes) 
independently of genotoxic shock and in response to ROS (Zhang  et al., 2015), which 
implies a vital role for ATM in cellular and organelle cell fate.  
More than 30% of cardiac cell volume is occupied by mitochondria and is essential for 
normal functioning of the cardiovascular system (Westermeier et al. 2015).  In light of the 
decreased mitochondrial respiration and the intrinsic mitochondrial DNA repair defects 
associated with the absence of ATM protein kinase (Sharma et al. 2014), it is possible that A-
T and its associated conditions might very well be a mitochondrial disease (Valentin-Vega et 
al. 2012).  
In summary, mitochondrial dynamics such as fusion, fission and mitophagy are essential for 
sustained mitochondrial function in a healthy heart. In the milieu of obesity and Type 2 
diabetes, altered insulin signalling could contribute directly towards mitochondrial 
dysfunction (Boudina et al. 2009). Moreover, mitochondrial dysfunction has  been linked to 
the onset of diabetic cardiac myopathy due to hyperglycaemia induced oxidative stress 
(Westermeier et al. 2015).  ATM protein kinase plays a definitive role in adipocyte 
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differentiation, mitochondrial function and integrity as well as in glucose, redox and 
peroxisome homeostasis, but many of the underlying molecular mechanisms with regards 
to ATM’s function, especially in the mitochondria, still need to be elucidated.  
In light of the importance of mitochondrial dysfunction associated with the development of 
cardiovascular disease and ATM protein kinase’s potential underlying role, this study 
proposes to investigate the role of ATM within a well-characterised high fat diet (DIO) rat 
model with known myocardial dysfunction as well as H9c2 cardiomyoblasts in vitro by 
determining whether (1) ATM expression is influenced in cardiac mitochondria or high fat 
exposure and (2) ATM expression or regulation influences mitochondrial function by 
investigating: i) oxidative phosphorylation, ii) mitofusion and mitophagy as well as iii) redox 
status in the mitochondria. 
Aims of investigation: 
1.  To determine the effects of lipid-induced insulin resistance on ATM expression using 
a H9c2 cardiomyoblast cell line. 
2. To determine whether ATM expression or regulation influences mitochondrial 
function (oxidative phosphorylation): We will measure oxidative phosphorylation 
capacity of myocardial mitochondria from both control and HFD rats in response to 
either activation or inhibition of ATM respectively with insulin, chloroquine and a 
specific ATM inhibitor, KU60019. 
3. To determine whether ATM expression or regulation correlates with mitochondrial 
dynamics: The association between ATM and the autophagy protein, Beclin-1, as 
well as the involvement of ATM protein kinase in the autophagic pathways such as 
AMPK- activation by oxidative stress or hypoxia, suggests a potential role for ATM in 
mitophagy (i.e PINK/Parkin) and mitofission/fusion (i.e Drp1). Mitochondrial 
dysfunction is often associated with a decrease in mitophagy and an increase in 
mitochondrial fusion, which in turn could lead to increased oxidative stress, and 
decreased respiration. This study will determine whether chemical inhibition of ATM 
will inhibit mitophagy by investigating PINK, Parkin, LC3 and p62 protein levels, as 
well as the fission protein, Drp1 in an aim to possibly elucidate a direct correlation 
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between the absence of ATM and cardiac dysfunction due to dysregulation of the 
mitophagy, fission and –fusion pathways. 
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Chapter 3 : ATM is downregulated in vitro by high free fatty acid 
concentrations in the rat cardiomyoblast cell line, H9c2. 
 
Obesity, unhealthy diets and decreased physical activity contribute to non-communicable 
diseases (NCDs) such as cardiovascular disease, diabetes and cancer (Vorster 2002). The 
incidence of these diseases is increasing worldwide and more so in developing countries. In 
South Africa, the heaviest NCD burden is found in poor urban communities (Mayosi et al. 
2009) and is a common phenomenon observed in low- and middle income countries (Alwan 
et al. 2010), suggesting a link with socio-economic conditions (Mayosi et al. 2009). This 
increase in NCD prevalence is, amongst others,  driven by the rapid migration of ethnic black 
Africans to urban centres which has led to an increase in conventional cardiovascular risk 
factors (obesity, hypertension and increased cholesterol) and coronary heart disease (Yusuf 
et al. 2001).  The obesity epidemic in South Africa mainly reflects a nutritional transition, 
which is defined as a shift away from traditional diets and decreased physical activity due to 
urbanisation (Kruger et al. 2005).  A nutritional shift is also associated with increased dietary 
fat and energy intake as well as over-nutrition, and it has been suggested that SA is further 
along the nutrition transition than other Sub-Saharan countries (Micklesfield et al. 2013).  
Obesity is one of the hallmarks of metabolic syndrome, which in turn, is characterised by 
increased LDL cholesterol and decreased HDL cholesterol, hypertension and insulin 
resistance. Cellular oxidative stress underlies metabolic syndrome and has been associated 
with obesity due to low-grade inflammation, insulin resistance and consequently, cardiac 
dysfunction (Hopps et al. 2010). Obesity-associated insulin resistance is also a major risk 
factor for T2D and cardiovascular disease, and an increase in abdominal obesity predisposes 
a person to systemic insulin resistance (Qatanani & Lazar 2007).   
The absence of ATM has been associated with increased visceral fat accumulation in ATM-/- 
mice that are fed a high fat diet in an ApoE-/- background (Schneider et al. 2006).  These 
animals also exhibited pathologies similar to that of metabolic syndrome observed in 
humans. The absence of ATM results in decreased subcutaneous fat, whilst increasing 
visceral fat, which contribute to the development of T2D, and suggests a role for ATM in 
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adipocyte differentiation as well as glucose homeostasis (Takagi et al. 2015). ATM is known 
to play a role in glucose metabolism (Armata et al. 2010) and is activated by insulin (Halaby 
et al. 2008). Likewise, mutations in the Atm gene have been associated with an increased 
risk of ischaemic heart disease (Su & Swift 2000), as well as elevated glycaemia (blood 
glucose) and low insulin sensitivity in patients without diagnosed diabetes (Connelly et al. 
2016). Collectively, this results in a high incidence of insulin resistance in A-T patients (Bar et 
al. 1978).  
The finding that a high caloric diet can decrease ATM expression in cardiac rat mitochondria 
and heart tissue which was shown in our laboratory, as well as the finding that ATM is 
significantly decreased in rat muscle tissue in a high fat diet (Halaby et al. 2008), suggests a 
potential link between obesity and ATM. This study aimed to establish a high fat 
cardiomyoblast cell-culture model using H9c2 rat cardiomyoblast cells. The model is a pilot 
study intended to develop a rat cardiomyoblast model that can easily be manipulated in 
order to determine which pathways are involved in ATM-signalling under high-fat and 
insulin resistant conditions. 
3.1 Brief introduction to H9c2 (2-1) rat cardiomyoblast cells and applications in 
literature 
 
 The clonal cell-line, H9c2, was originally derived from ventricular BDIX rat heart tissue 
(Kimes & Brandt 1976) and exhibits skeletal muscle characteristics. The mononucleated 
myoblast cells retain some cardiac specific characteristics such as voltage dependent Ca2+ 
channels (Hescheler et al. 1991), and can be differentiated into multinucleated myotubes 
that are capable of producing and controlling action potentials in response to chemical or 
electropotential stimulation (Kimes & Brandt 1976). The cells originate from a 13 day old 
embryonic rat heart, and propagate as mononucleated myoblasts that present as flat, 
spindle shaped cells with two to four prominent nucleoli in their nuclei.  
The cardiomyoblasts only form multinucleated tubular structures upon reaching confluency, 
and can be stimulated to maintain a cardio-phenotype with trans-retinoic acid treatment 
which stimulates Ca2+ channel expression (Menard et al. 1999). However, differentiation of 
H9c2 cells with trans-retinoic acid can also result in a heterogeneous cell population, since 
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some cells show resistance to differentiation (Patten et al. 2017). Interestingly, the authors 
noted increased oxidative phosphorylation upon differentiation. Even in the absence of 
differentiation, H9c2 cells exhibit a higher respiration rate, mitochondrial biogenesis and 
ATP production when compared to the mouse atrial heart cell line, HL-1 (Kuznetsov et al. 
2015). These characteristics suggest that H9c2 cells are energetically more similar to primary 
cardiomyocytes and thus render them a valuable in vitro model for ischaemia-reperfusion 
experiments (Kuznetsov et al. 2015). It should be noted though, that undifferentiated H9c2 
cells prefer glycolysis as a main energy source. However, the cell line is often used for the 
analysis of cardiotoxic effects of anti-cancer drugs such as doxorubicin, and mechanisms of 
myocyte damage (Witek et al. 2016). H9c2 cells proliferate well in in vitro conditions 
(Watkins et al. 2011), but can age with the number of passages which changes the cells’ 
sensitivity to cardiotoxicity effects (Witek et al. 2016). This cell line also mimics cardiac 
hypertrophy and supports its use as a cardiac in vitro model (Watkins et al. 2011).  
An in vitro model of differentiated H9c2 cells were used to investigate the role of metformin 
in cardioprotection (Hu et al. 2016), as well as the role of apoptosis in hyperglycaemia and 
its contribution to diabetic cardiomyopathy (Cai et al. 2002). Cardiomyocytes undergo 
apoptosis in the presence of high free fatty acids, such as palmitate, which has been 
implicated in lipotoxic cardiomyopathy. Palmitate was found to induce apoptosis in 
undifferentiated H9c2 cells by increasing ROS generation and activation of the ERK1/2  
(extracellular signal-regulated kinases) pathway (Wei et al. 2013).  
Free fatty acids are associated with several cardiovascular factors and mortality in patients 
with angiographic coronary artery disease (Pilz et al. 2006). The replacement of saturated 
fatty acids with polyunsaturated fats can prevent the development of coronary heart 
disease (Jakobsen et al. 2009). Saturated palmitic acid (palmitate) is the most abundant 
circulating saturated fatty acid (Ubhayasekera et al. 2013), and can induce myocardial 
inflammatory injury through the Toll-like receptor 4 (TLR4) accessory protein MD2 in both 
mouse and undifferentiated H9c2 cell-culture models (Wang et al. 2017). However, a recent 
study found that a high fat diet (HFD) in obese-prone Sprague-Dawly rats increases the 
proportion of circulating polyunsaturated fatty acids whilst decreasing the 
monounsaturated and saturated fatty acids in serum (Liu et al. 2015). This led to the 
suggestion that fatty acid mixtures should be enriched with poly- and monounsaturated 
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fatty acids in in vitro studies when attempting to model lipid exposures during in vivo HFD 
conditions (Liu et al. 2015). 
The current high fat diet that is used in our laboratory contains 11.5 g/100g fat of which 7.6 
g/100g consist of saturated fats and 2.9 g/100g consists of monounsaturated fats (Salie et 
al. 2014). Oleate (oleic acid) is a monounsaturated fat that protects neuronal cells against 
palmitate induced mitochondrial dysfunction, insulin resistance and inflammatory signalling 
(Kwon et al. 2014).  In hyperlipidaemic conditions induced by high levels of archinodonic, 
stearic and oleic acids in differentiated H9c2 cells, the fatty acids suppressed GLUT4 and 
PPARγ transcription (Armoni et al. 2005). Oleate is accumulated in undifferentiated H9c2 
cells by the TLR4, and silencing of this receptor can ameliorate lipid accumulation in these 
cells (Dong et al. 2012).  Oleic acid alleviates palmitate-induced cardiotoxicity in neuronal 
cells, and does so in the presence and absence of bovine serum albumin (BSA) (Kwon et al. 
2014).  It has been suggested that the addition of BSA to FFAs such as oleate could partially 
mediate its protective effects in L6-muscle cells with regards to mitochondrial activity (Gao 
et al. 2009), although Kwon et al. (2014) found oleate-mediated cytoprotection irrespective 
of the presence of BSA. Lastly, undifferentiated H9c2 cells show palmitate uptake rate 
similar to that of cardiac myocytes (Van Nieuwenhoven et al. 1998). 
Taken together, and in view of a study that established an in vitro insulin resistant myocyte 
model with differentiated H9c2 cells and palmitate (Nobuhara et al. 2013), this study aimed 
to establish an undifferentiated, insulin resistant in vitro H9c2 model induced with palmitate 
and oleic acid. This pilot study aimed to determine whether ATM can be downregulated in 
such a model, and investigate the effect of high FFAs on 1) Akt in the phosphatidylinositol 3-
kinase/protein kinase B (Akt) pathway which is a crucial in the cellular insulin response 
(Bertrand et al. 2008) and 2) the insulin insensitive protein, AMPK. 
3.2 Materials and methods: 
 
The effect of insulin resistance mediated by saturated and monounsaturated free fatty acid 
was determined in undifferentiated H9c2 cardiomyoblast cells treated with five different 
conditions: 1) 0.1% of 100% ethanol stock vehicle control; 2) 0.1 mM palmitic and 0.1 mM 
oleic acid (henceforth referred to as 0.2 mM FFA), 3) 0.2 mM FFA and 5.5 mM glucose, 4) 
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100 nM insulin and 5) 100 nM insulin + 0.2 mM FFA. It should be noted that H9c2 cells are 
grown in DMEM that contains 25 mM glucose which is the basal glucose level present in all 
of the conditions listed. Protein expression levels were determined with western blotting. 
The cellular uptake of radiolabelled 2-deoxy-glucose was used to determine glucose uptake 
by the treated cells. 
3.2.1 Reagents: 
 
The H9c2 cardiomyoblast cells were a kind gift from Dr Danzil Joseph, Dept. of Physiology, 
SU (originally obtained from American Type Culture Collection (ATCC)) and were used at 
passages ranging from 10-16. Dulbecco’s Modified medium (DMEM) with 4.5 g glucose/l  
(25 mM) and L-glutamine (Biowhitaker Lonza, BE12-604F, distributed by Whitehead 
Scientific), Fetal Bovine serum (FBS, Capricorn Scientific, FBS-12A, distributed by Biocom 
Biotec), penicillin-streptomycin (Pen-strep, P4333, Sigma-Aldrich Merck) and 10X trypsin 
(59427C , Sigma-Aldrich) were purchased from the distributors indicated. Radiolabelled 2-
deoxy glucose (2-DG-[3H] NET549005MC) was purchased from Perkin-Elmer, and HumulinR 
(100 U/ml, Eli Lilly and Company) was purchased on prescription, commercially. Palmitic 
acid (P0500) and oleic acid (O1008) were purchased from Sigma-Aldrich Merck. The FFAs 
were prepared in 100% ethanol and dissolved by heating to 37°C and intermittent mixing 
with a Vortex mixer. Western blot reagents were purchased from BioRad (Lasec, South 
Africa), except for SignalBoost™Immunoreaction Enhancer Kit (EMD Millipore-Merck), and 
the Immobilon®-P PVDF membrane (EMD Millipore-Merck). The stain used for total-protein 
membrane imaging was 2,2,2 Trichloroethanol and was purchased from Sigma-Aldrich 
(T54801-500g). The antibody details are listed under materials and methods (Table 3.1).   
3.2.2 Cell culture: 
 
H9c2 cells were maintained in DMEM with 10% FBS and 1% penicillin/streptomycin (growth 
medium. Cells were maintained at 37°C and 5% CO2 in a humidified incubator, and media 
was changed every 2 to 3 days. Cells were grown to a confluency of 70-80% in 100 mm 
culture plates, where after cells were harvested with the addition of 0.25% trypsin, and after 
2 gentle washes with warm sterile PBS (phosphate buffered saline, 137 mM NaCl, 10 mM 
Phosphate, 2.7 mM KCl). The cells were centrifuged at 92 x g and resuspended in growth 
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medium. Cells were replated in a ratio of 1:3, and treated with either (i) 0.1% ethanol, (ii) 
0.1 mM palmitic acid and 0.1 mM oleic acid (0.2 mM FFA), (iii) 0.2 mM FFA + 5.5 mM D-
glucose, (iv) 100 nM insulin and (v) 100 nM insulin + 0.2 mM FFA for 24 hours. The cells 
were not starved prior to treatment as insulin was added to the assay, and treatment was 
stopped with two 1 x PBS washes, where after the cells were scraped and collected in PBS, 
and harvested with centrifugation at 92 x g for 4 minutes. The PBS was removed with 
aspiration. Each of the treatments were performed in triplicate (n=3/condition), and each 
complete experiment was repeated three times. The treatment volume made up 0.3% of 
the total media volume per plate, and was assumed not to contribute towards dilution of 
the media (0.03 ml in a 10 ml volume.) 
Cell growth and integrity were monitored during growth phase as well as before and after 
the addition of the treatments described above with an Oxion Inverso inverted microscope 
and CMEX USB camera (Euromex Microscopes Holland), and size markers were added to the 
images in Euromex ImageFocus 4.0 (Euromex).  
3.2.3 Western blotting: 
 
The collected cells were lysed in 500 μl cell lysis buffer (20 mM TRIS-HCl (pH 7.5), 1 mM 
EGTA, 1 mM EDTA, 150 mM NaCl, 1 mM β-glycerophospate, 2.5 mM tetra sodium 
pyrophosphate, 10 mM sodium orthovanadate, 1% Triton X-100, 10 μg / mL leupeptin, 10 
μg / mL aprotinin and 50 μg / mL PMSF). Zirconium oxide beads (0.5 mm, Next Advance, 
Biocom Biotech) were added to the  cell lysates, where after the cells were further lysed in a 
Bullet blender (Next Advance laboratory equipment) at 4 000 revolutions per minute (rpm) 
making use of three cycles at 4°C for 1 minute with a 5 minute resting period in between. 
The lysates were rested on ice for 20 minutes prior to centrifugation at 12074 x g for 10 min 
at 4°C. The supernatants were carefully removed and placed in a new set of 1.5 ml 
Eppendorf tubes. Protein concentration was determined with a Bradford protein assay 
(Bradford 1976).  
Cell lysates were prepared to a total volume of 15 μl containing 20 μg protein in lysis buffer 
and one volume 3X Laemmli sample buffer (2.5 M glycerol, 0.189 M TRIS-HCl (pH 6.8), 10% 
SDS, 1.275 mM bromophenol blue, 15% β- mercaptoethanol). The samples were boiled for 
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four minutes and stored at -80° Celsius until use. Samples were boiled again for 4 minutes 
prior to being loaded on 7.5% resolving denaturing SDS-PAGE gels (7.5% acrylamide/bis-
acrylamide (Sigma-Aldrich Merck), 0.375 M TRIS-HCl (pH 8.8), 1% SDS, 0.5% APS, 0.05% 
TEMED,  50 µl 2,2,2 Trichloroethanol (Stainfree), Sigma-Aldrich), and 4% stacking gels (0.126 
M TRIS-HCl, 1% SDS, 0.5% APS and 0.05% TEMED) which were subjected to electrophoresis 
for 1 hour at 200 V and 200 mA. The proteins that were investigated in these experiments 
are summarised in Table 3.1. 
A modified transfer buffer was used (25 mM TRIS, 190 mM glycine and 10% methanol v/v), 
and the gels were allowed to rest for 30 minutes in the buffer prior to activation in the 
ChemiDoc MP system (Bio-Rad Laboratories), where after it was transferred. An image of 
the gel was stored by the ChemiDoc MP system. Transfer was performed at 200 V and 200 
mA for 1 hour 30 minutes at 4° Celsius onto an Immobilon®-P PVDF membrane (EMD 
Millipore). An image of the transferred proteins on the membrane was again stored for 
normalization purposes. The membranes were briefly placed in methanol, and allowed to 
dry before blocking in a 5% liquid fat-free milk solution. After blocking, the membranes were 
washed three times in TBS-T (20 mM TRIS-HCl (pH 7.6), 137 mM NaCl, 0.1% Tween-20), for 5 
minutes at a time. The membranes were then cut above and below the protein of interest in 
order to investigate several proteins on the same membrane. The membrane was incubated 
in primary antibody (Table 3.1) overnight (maximum 16 hours) at 4°C and washed three 
times (as described previously) after incubation. The membrane was placed in secondary 
antibody (1:4000 dilution of HRP-linked secondary antibody #7074, CST in TBS-T) for one 
hour at room temperature.  
The membrane was washed three times (as described previously) prior to being imaged 
with Clarity™Western ECL Blotting Substrate and visualised on the Chemidoc MP system on 
the Chemi Hi sensitivity setting, which was stopped prior to overexposure (which appears 
red on program settings). Membranes from the same experiment were analysed in parallel. 
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Table 3.1: Summary of antibodies used to investigate the insulin-resistant H9c2 cell culture model: 
Protein 
antibody 
Size Dilution and dilutant Species 
origin 
Supplier Product 
code 
ATM 350 kDa 1:1000 TBS-T Rabbit Abcam ab199726 
Phospho-ATM 
(Ser1981) 
350 kDa 1: 1000 Primary 
SignalBoost™Immuno-
reaction Enhancer Kit 
Rabbit CST (D25E5) 
#13050 
Akt (PKB) 60 kDa 1: 1000 TBS-T Rabbit CST (C67E7) 
#4691 
Phospho-Akt 
(Ser473) 
60 kDa 1: 1000 TBS-T Rabbit CST (193H12) 
#4058 
AMPK 62 kDa 1:1000 TBS-T Rabbit CST (D63G4) 
#5832 
Phospho-AMPK 
Thr172 
62 kDa 1:1000 TBS-T Rabbit CST (D4D6D) 
#50081 
mTOR 289 kDa 1:1000 TBS-T Rabbit CST (7C10) 
#2983 
Phospho-mTOR 
Ser 2448 
289 kDa 1:1000 TBS-T Rabbit CST #2971 
*CST: Cell Signaling Technology 
3.2.5 Western blot analysis and normalization: 
 
Protein levels were normalised to total protein loaded on the gel and transferred to the 
membrane, in ImageLab 5.0. The software calculates the total pixel intensity per lane across 
the surface area of the lane, and accordingly normalises the pixel intensity of the protein 
band in question to that of its total protein lane (Gilda & Gomes 2014; Rivero-gutiérrez et al. 
2014). Consequently, each lane was adjusted manually to include as much of the visible lane 
surface area in ImageLab 5.0, and analysed using the software function for normalisation to 
total protein. The normalised pixel intensities for each protein band of interest were 
exported to Excel (Microsoft Office 2010) and the fold-change compared to the control-
treated cells (0.1% EtOH) were determined by calculating the average pixel intensity of 
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normalised band values for the control group, and dividing the average normalised pixel 
intensities of each treatment by that of the control group. Once analysed, the data were 
exported to Graphpad Prism 6.0 for statistical analysis. This method negates the use of a 
loading control to normalize for equal loading. 
3.2.4 Glucose uptake: 
 
Radiolabelled 2-deoxy glucose (2-DG) uptake by H9c2 cells was performed as described 
previously (Fischer et al. 1991; Huisamen et al. 2001) with modifications. Similarly to 
cardiomyocytes the cells were washed twice with PBS, and serum starved for 3 hours in 
DMEM without FBS or Pen/Strep, followed by a period of 30 minutes where the cells were 
deprived of all substrates using Solution E (6 mM KCl, 1 mM Na2HPO4, 0.2 mM NaH2PO4, 1.4 
mM MgSO4, 128 mM NaCl, 10 mM HEPES, 1.25 mM CaCl2 and 2% fatty acid free BSA fraction 
V, pH 7.4). The cells were pre-incubated for 5 min in a shaking benchtop incubator (37°C) 
with or without phloretin (400 μM) for measurement of non-carrier mediated glucose 
uptake. Phloretin was dissolved in DMSO and stored as 6.4 mM stock solution and diluted 
with medium immediately before use.  Each experimental treatment (n=3/ condition, five 
conditions) was incubated with or without 10 nM insulin under the same conditions for 15 
min, after which glucose uptake was initiated by addition of 2-deoxy-D-[3H]glucose (1.5 
μCi/ml; final concentration 1.8 μM) (2-DG).  Glucose uptake was allowed to progress for a 
further 30 min before the reaction was stopped by adding 100 μl phloretin to give a final 
concentration of 400 μM. The cells were washed twice in HEPES buffer to remove 
extracellular 2-DG, and dissolved in 1M NaOH. The assay is represented graphically in Figure 
3.1. 
Afterwards, samples were diluted with dH2O to 0.5 M NaOH. A small aliquot of this was 
used to assay the protein content of every aliquot in triplicate by the method of Lowry et al. 
(1951), whilst the rest was counted in duplicate for radioactivity in a Beckman LS 6500 
multi-purpose scintillation counter.  The specific activity of the radiolabelled solution was 
determined and the 2-DG uptake calculated as pmol 2-DG/mg prot/30 min. 
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Figure 3.1: Schematic representation of the glucose uptake assay. Two sets of experiments (5 
treatment conditions, n=3/condition)  were prepared in parallel and were either stimulated with 
insulin (top protocol) or only treated with phloretin (bottom protocol), respectively. The cells were 
serum starved for three hours, prior to being substrate starved (start of protocol) for 30 min in 
Solution E. Phloretin was added to the cells that were not stimulated with insulin and incubated 
for 5 minutes (bottom), before insulin was added to the cell cultures that were stimulated with 
insulin (15 min). 2-DG was added to both sets of experiments and incubated for 30 minutes, and 
stopped with the addition of phloretin to the insulin-stimulated experiment. Both sets of 
experiments were aspirated, washed and aspirated twice with HEPES buffer, and incubated with 
1N NaOH at 37°C for 1 hour. One volume of distilled H2O was added for a final concentration of 
0.5N NaOH. A volume of cell lysate was incubated overnight in scintillation fluid prior to being 
counted in duplicate, and the remaining cell lysate was used for a Lowry assay protein 
concentration determination (protocol adapted from (Fischer et al. 1991; Huisamen et al. 2001)). 
3.2.5 Statistical analysis: 
 
The data was analysed using GraphPad Prism 6.0 software (GraphPad Software, Inc., La 
Jolla, CA). Statistical comparisons were made using a two-tailed Student’s t-test or 1-way 
analysis of variance (ANOVA) followed by a Bonferroni post-hoc test where applicable. All 
values and error bars are presented as mean ± s.d., and the level of significance was set at p 
< 0.05. 
3.3 Results and discussion: 
 
The H9c2 cells used during this experiment conformed to the description by Kimes & Brandt 
(1976), and showed 2-4 distinct nucleoli in the nuclei of the cells (Fig 3.2). No differences 
were noticed visually between the different passages, and the cells maintained their 
structural integrity. The cells were not differentiated in light of a previous report that 
showed that some cells within a H9c2 cell population can be resistant to differentiation 
(Patten et al. 2017), that can result in a heterogenous population. 
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Figure 3.2: H9c2 cell structure between different passages.  Images of cells were taken on a regular 
basis during proliferation to monitor confluency, integrity and general cell health. Panel a shows 
cells at passage 9 and panel b at passage 13. The arrows indicate a typical H9c2 cell with its 
nucleus and nucleoli. The scale bar is 100 µm, at 40x magnification. 
The experimental design was initially  optimised with a 0.1 mM palmitic acid, which is widely 
reported to induce inflammation (Wang et al. 2017), insulin resistance (Nobuhara et al. 
2013) and mitochondrial dysfunction (Wei et al. 2013) in H9c2 cells. The protein expression 
levels of ATM, Akt and mTOR were investigated to gauge the sensitivity of the cells to 0.1 
mM palmitic acid in line with studies that have shown that ATM can be activated by insulin 
(Halaby et al. 2008).  
No differences were observed in total mTOR protein levels after 24 hours of 100 nM 
palmitic acid or 100 nM insulin incubation of H9c2 cells. The downregulation of ATM in HFD 
conditions and obesity in rats led to suggestion that ATM is required for the full activation of 
Akt in response to insulin stimulation in mouse fibroblasts (Halaby et al. 2008). Similarly, this 
study shows that ATM protein levels are decreased with 0.1 mM palmitic acid treatment, 
albeit not significantly (Figure 3.3).  The addition of 0.1 mM palmitic acid together with 
insulin significantly decreased Akt protein levels (p<0.005, 1-way ANOVA, Bonferroni post-
hoc test) compared to insulin treatment alone as well as compared to the control H9c2 cells. 
The same trend was observed for ATM, where the combination of 100 nM insulin together 
with 0.1 mM palmitic acid significantly decreased (p<0.05 ,1-way ANOVA,  Bonferroni post-
hoc test) total ATM protein levels. This corresponds well with the suggestion that ATM is 
required for the full activation of Akt in response to insulin stimulation (Halaby et al. 2008), 
and suggests that the combination of palmitic acid and high insulin concentrations influence  
the protein levels of both Akt and ATM in a similar manner. 
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Figure 3.3: Western blot analysis of total ATM, total Akt and mTOR protein levels in H9c2 cells 
treated with 0.1 mM palmitate. Undifferentiated H9c2 cells were treated respectively with either 
0.1% EtOH (vehicle control indicated as ‘Control” on the graph), 0.1 mM palmitic acid (FFA), 0.1 
mM FFA and 5.5 mM glucose, 100 nM insulin or 100 nM insulin + 0.1 mM FFA (n=3/condition). The 
cells were lysed and analysed with western blotting. Protein expression levels for mTOR was 
normalised to membrane 1 (left) and ATM and Akt was normalised to membrane 2 (right). The 
samples were loaded as shown on the membrane and a high molecular weight marker (mm) was 
loaded in the first lane. Lane 1 from the Ins+FFA was excluded from analysis due to less protein 
loaded initially. The fold-change in protein levels for each of the proteins are shown relative to the 
mean pixel intensity of the control group. A one-way ANOVA was performed for each protein of 
interest and all values and error bars are presented as mean ± s.d., and the level of significance 
was set at p < 0.05.* p<0.05, **p<0.005. 
The aim of this experiment was to determine whether a similar model can be established in 
H9c2 cells with the addition of oleate and palmitate in order to establish a model closer to 
that of an in vivo HFD-induced obesity model, as was suggested by Liu et al. (2015). 
Consequently, this study investigated the effect of a saturated and monounsaturated free 
fatty acids on H9c2 cells. Oleic acid protects neuronal cells against palmitate induced insulin 
resistance and inflammatory signalling (Kwon et al. 2014) as well as mitochondrial 
dysfunction, which was also observed in L6-muscle cells (Gao et al. 2009). High 
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concentrations of palmitate in undifferentiated H9c2 cells have been associated with 
apoptosis and ROS generation (Wei et al. 2013) as well as insulin resistance and 
mitochondrial dysfunction (Nobuhara et al. 2013). A previous study within our laboratory 
stimulated neonatal cardiomyocytes a with 0.25 mM oleate and palmitate and found that 
this concentration of FFA had no effect on cell viability assessed with trypan blue or 
propidium iodide (Ms S Pêrel, MSc thesis, 2009). Cell viability was not assessed during this 
study, and is a major shortcoming. 
H9c2 cardiomyoblasts were treated with final concentrations of either 0.1% EtOH (vehicle), 
0.2 mM FFA (0.1 mM palmitic and 0.1 mM oleic acid dissolved in EtOH), 0.2 mM FFA+5.5 
mM glucose, 100 nM HumulinR insulin and 100 nM insulin+0.2 mM FFA. The use of 0.2 mM 
palmitate has previously been shown to induce insulin resistance in differentiated H9c2 cells 
(Nobuhara et al. 2013), whilst apoptosis was observed in response to 0.1 mM palmitate 
treatment of undifferentiated H9c2 cells (Wei et al. 2013).  Mitochondrial dysfunction has 
also been reported in C2C12 cells treated with 0.2 mM palmitate (Jheng et al. 2012). This 
study observed no difference in cellular morphology between untreated H9c2 
cardiomyoblasts, or cells treated with 0.1% EtOH after 24 hours (Fig 3.4 a and b). However, 
treatment with 0.2 mM FFA resulted in shorter, rounder cells (insert, Fig 3.4 d) after 24 
hours similar to that observed in palmitic acid treated H9c2 cells (Wang et al. 2017).  
Rounded cells was also observed in cells treated with 0.2 mM FFA and 5.5 mM glucose.   
It should be noted that this is merely an observation and was not quantified.  Quantification 
of hypertrophy should be interesting in this case, together with an assessment of lipid 
accumulation, based on previous observations that H9c2 cardiomyoblasts mimics 
hypertrophy in a manner similar to that of primary cardiomyocytes (Watkins et al. 2011).  
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Figure 3.4: H9c2 cardiomyoblast prior to and after 24 hours of FFA treatment.  H9c2 
cardiomyoblasts were imaged directly prior to treatment (panels a, c and e) and after 24 hours of 
either 0.1% EtOH (panel b), 0.2 mM FFA (panel d) where cells started to exhibit a rounded 
compard to an elongated shape(insert), or 0.2 mM FFA + 5.5 mM glucose treatment (panel f). H9c2 
cells are maintained in high glucose medium (25 mM) under normoxic conditions, and 5.5 mM 
glucose was added to increase the glucose concentration. The scale bar represents 100 µm.  
Insulin also seemed to result in rounding of cells compared to elongated cells in the H9c2 
cardiomyoblasts after 24 hours of treatment, whilst dark aggregates could be observed in 
a b 
c d 
e f 
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cells treated with insulin and FFA (Fig 3.5). Again, this was not quantified, but can be 
suggestive of increased cytoplasm vacuolization similar to that observed in H9c2 
cardiomyoblasts treated with supra-therapeutic doses of doxorubicin (Sardão et al. 2009). 
Although lacking in this study, this suggests that further investigation into the formation of 
vacuoles and autophagy as well as the quantification of hypertrophy, could extend this 
model to provide a better understanding of lipotoxicity and hyperinsulinaemia in the heart. 
 
 
Figure 3.5: H9c2 cardiomyoblast prior to and after 24 hours of insulin and insulin plus FFA 
treatment. H9c2 cardiomyoblasts were imaged prior to (panel a and c) and directly after 
treatment with 100 nM insulin (panel b) and 100 nM insulin plus 0.2 mM FFA (panel d). The scale 
bar represents 100 µm. 
Contrary to Nobuhara et al. (2013) who did not observe any glucose uptake in 
undifferentiated H9c2 cardiomyoblasts compared to differentiated myoblasts with 10 nM 
insulin stimulation, this study shows insulin-stimulated 2-DG  uptake in the presence of 10 
nM insulin alone, albeit not significantly because of the wide scatter in the small sample 
size.  All the treatments used in this study suppressed glucose uptake when stimulated in 
the presence of 10 nM insulin. The 24 hour treatment of 0.2 mM FFA alone and the 
a b 
c d 
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combination of 0.2 mM FFA + 100 nM insulin treatment suppressed 2-DG-uptake glucose 
uptake in the presence of 10 nM insulin and the readings were well grouped. Although no 
significant difference was observed.  
 
Figure 3.6: 2-[3H]-deoxy glucose uptake in undifferentiated H9c2 cardiomyoblast cells.  Glucose 
uptake was measured in undifferentiated H9c2 cells under either basal conditions, with the 
stimulation of 10 nM insulin in untreated cells, or with 10 nM insulin stimulation in cells treated 
with 1) 0.2 mM FFA, 2) 0.2 mM FFA + 5 mM glucose, 3) 100 nM HumulinR insulin or 4) 100 nM 
HumulinR insulin + 0. 2 mM FFA, respectively after 24 hours of treatment. No significant 
differences were observed (one way ANOVA with Bonferroni-post hoc analysis (n=2-3)). 
In line with a previous study that showed that the addition of 100 nM insulin to H9c2 cells 
elicits an insulin resistant response (Ha & Pak 2005),  the current study found a similar result 
when stimulating glucose uptake with 10 nM insulin in cells that have been treated with 100 
nM of insulin over 24 hours. Insulin stimulated uptake in cells that were treated with a 
combination of 5 mM glucose and 0.2 mM FFA gave no significant results (n=2, Fig. 3.6). 
However, none of these results were significant compared with either basal uptake or 10 
nM insulin stimulated uptake in control vehicle cells. 
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Figure 3.7: Western blot analysis of total ATM and phosphorylated ATM, as well as AMPK and 
phosphorylated AMPK protein levels in H9c2 cells treated with 0.2 mM palmitate and oleic acid. 
Undifferentiated H9c2 cells were treated respectively with either 0.1% EtOH (vehicle control), 0.2 
mM palmitic and oleic acid (FFA), 0.2 mM FFA and 5.5 mM glucose, 100 nM insulin or 100 nM 
insulin + 0.2 mM FFA (n=3/condition). Protein expression levels for total ATM and total AMPK was 
normalised to membrane 1 (left) and phospho-ATM and phospho-AMPK was normalised to 
membrane 2 (right). The samples were loaded as shown on the membrane and a high molecular 
weight marker (mm) was loaded in the first lane. The fold-change in protein levels for each of the 
proteins are shown relative to the mean pixel intensity of the control group.  
The insulin-sensitive protein, Akt and phospho-Akt, as well as the insulin-insensitive protein, 
AMPK and phosphorylated AMPK (at Thr172) were investigated. The latter were included 
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because of the increased autophagy that was previously reported in response to lipotoxicity 
in H9c2 cells (Cai et al. 2002).   
Both total ATM as well as phosphorylated ATM increased significantly in the presence of 0.2 
mM FFA and 100 nM insulin, whilst phosphorylated AMPK increased significantly, although 
total AMPK levels did not when compared to the control treated cells (p<0.05, one-way 
ANOVA) (Fig. 3.7). This however, did not translate to a significant increase in the phospho-
ATM/total ATM ratio or phospho-AMPK/total AMPK ratio (Fig 3.8) in this model. It does 
suggest that the addition of the monounsaturated fatty acid, oleate, can be protective via an 
ATM-mediated mechanism in hyperinsulinaemia-induced insulin resistance in the presence 
of high free fatty acids (0.2 mM FFA+100 nM insulin), but not in the presence of free fatty 
acids alone (0.2 mM FFA).  
 
Figure 3.8: Phospho-ATM/total ATM, phospho-AMPK/total AMPK and phospho-Akt/total Akt 
ratios. The arbitrary units calculated after normalisation to the total protein for each lane was 
used to determine the ratio for each corresponding lane by division of the phospho-protein value 
by the total protein.  
An increase in AMPK Thr172 phosphorylation in response to palmitate was reported 
previously, where it was shown that increased AMPK activity resulted in increased fatty acid 
oxidation, independently of changes in the AMP/ATP ratio in L6 cells (Watt et al. 2006). 
Oleate treatment inhibits palmitate-induced activation of AMPK, and this has been 
suggested to be one of the mechanisms through which oleate mediates its protective effects 
(Palomer et al. 2018). 
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Kwon & Querfurth (2015) also showed that the addition of oleate improved pAMPK, and 
found that palmitate alone inhibits the phosphorylation of AMPK, decreases 
phosphorylation of Raptor and 4E-BP1 and activates p70S6K, without changing the 
phosphorylation levels of mTOR or Rictor. This was completely prevented by the addition of 
oleate, in a similar fashion to that of metformin-mediated activation of AMPK (Kwon & 
Querfurth 2015).  
 
Figure 3.9: Western blot analysis of total mTOR and phosphorylated mTOR (Ser2448) in H9c2 cells 
treated with 0.2 mM palmitate and oleic acid. Undifferentiated H9c2 cells were treated 
respectively with either 0.1% EtOH (vehicle control), 0.2 mM palmitic and oleic acid (FFA), 0.2 mM 
FFA and 5.5 mM glucose, 100 nM insulin or 100 nM insulin + 0.2 mM FFA. The cells were lysed and 
analysed with western blotting. Protein expression levels for mTOR was normalised to membrane 
1 (left) while p-mTOR was normalised to membrane 2 (right).  
AMPK is also located upstream of mTOR, and ATM activates AMPK either via LKB1 in 
response to oxidative stress (Alexander et al. 2010), or independently of LKB1 in response to 
growth factors in an IGF-1 mediated manner (Suzuki et al. 2004). Moreover, there might 
also exist a negative feedback loop between ATM and mTOR (Shen & Houghton 2013), and 
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mTOR was thus included in the study. The inhibition of AMPK phosphorylation by palmitate 
has also been implicated in the pathogenesis of obesity due to increased mTOR activity 
(Kwon & Querfurth 2015; Palomer et al. 2018). 
Our study could not find any significant effects on mTOR protein levels or phospho-mTOR 
with the addition of 0.2 mM FFA, 0.2 mM FFA+5.5 mM glucose, or insulin to H9c2 
cardiomyoblasts. Although decreased mTOR expression was observed in the presence of 
FFA and a combination of FFA and glucose, no significant differences were observed (Fig 
3.9). A reduction was observed in mTOR phosphorylation at Ser2448 with the addition of 5 
mM glucose to the FFA, which was restored to basal levels in the presence of 100 nM insulin 
and 100 nM insulin together with 0.2 mM FFA (Fig 3.9). These membranes represent lysates 
from two repeated experiments that were electrophoresed on different days, and 
consequently a ratio could not be determined between phospho-mTOR and total mTOR.  
The decrease observed in mTOR Ser2448 phosphorylation, could potentially suggest an 
increase in autophagy as a manner to cope with hyperglycaemic and hyperlipidaemic 
conditions. A study found that H9c2 cells that are treated with angiotensin II show increased 
expression of hypertrophy marker genes as well as decreased TSC2 phosphorylation which 
concomitantly decreased AMPK activation, increased glucose uptake and mTOR activation 
(Stuck et al. 2008), which potentially implicates the activation of the insulin sensitive Akt-
pathway. Moreover, both mTOR and Rictor (mTORC2)  are required for the phosphorylation 
of Akt at Ser473, and a reduction in either mTOR or Rictor can inhibit the activation of Akt 
(Sarbassov et al. 2005).  
A recent study that characterised insulin resistance in vascular smooth muscle cells found 
that oleate and insulin induced phosphorylation of Akt at Thr308, whilst oleate alone caused 
phosphorylation of AMPK (Perdomo et al. 2015). The study also found that palmitate 
treatment over a period of 18 hours induced insulin resistance that was characterised by a 
decrease in phosphorylated Akt as well as phosphorylated p70S6K. Similarly, the present 
study found that phosphorylated Akt was decreased compared to insulin alone in the 
presence of 100 nM insulin and 0.2 mM FFA, whilst being significantly increased in the 
presence of a 100 nM insulin when compared to 0.2 mM FFA treatment alone (p<0.05, one-
way ANOVA) (Fig. 3.10). Phosphorylated mTOR levels remained at basal levels. These results 
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are summarized in Table 3.2, which shows the relative protein expression of each of the 
proteins investigated in response to the different treatments relative to the vehicle control 
cells. 
 
 
Figure 3.10: Western blot analysis of total tAkt and phosphorylated Akt (Ser473) in H9c2 cells 
treated with 0.2 mM palmitate and oleic acid. Undifferentiated H9c2 cells were treated 
respectively with 0.1% EtOH (vehicle control), 0.2 mM palmitic and oleic acid (FFA), 0.2 mM FFA 
and 5.5 mM glucose, 100 nM insulin and 100 nM insulin + 0.2 mM FFA. The cells were lysed and 
analysed with western blotting. Protein expression levels for Akt was normalised to membrane 1 
(left) and p-Akt was normalised to membrane 2 (right).  
In summary, the use of 0.2 mM palmitate and oleic acid, both in the presence and absence 
of 100 nM insulin is sufficient to induce insulin resistance in undifferentiated H9c2 cells (Fig 
3.6) although this was not significant and needs to be repeated. 
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Table 3.2: Protein expression levels compared to vehicle control cells after 24 hours of treatment 
where the FFA is listed in the first row and the combination of treatments in the next row. The 
first block represents 0.1 mM palmitic acid and the second block 0.2 mM FFA (0.1 mM palmitate + 
0.1 mM oleate): 
Condition t-ATM p-ATM t-Akt p-Akt t-AMPK pAMPK mTOR p-
mTOR 
0.1 mM 
palmitate 
↓  ↓    - 
 
+ 5.5 mM 
glucose 
↓  ↓    - 
 
+100 nM 
insulin 
↓*  ↓**    - 
 
100 nM 
insulin 
alone 
-  -    ↑ 
 
         
0.2 mM 
FFA 
- ↑ - ↓ ↑ - ↓ ↓ 
+ 5.5 mM 
glucose 
- ↑ - - - - ↓ ↓ 
+100 nM 
insulin 
↑* ↑* ↑ ↑ - ↑* - - 
100 nM 
insulin 
alone 
↑* ↑ ↑ ↑ ↑  - - 
*p<0.05; **p<0.005 fold change relative to control, 2-way ANOVA, Bonferroni post-hoc 
test↑ 
The phospho Akt/total Akt protein levels were also decreased by FFA compared to the 
vehicle control. It should be noted that these changes were not significant, but lays the 
ground work for a potential model that can be used to examine insulin resistance.  The 
underlying mechanisms and role of ATM remains to be elucidated. The co-treatment with 
both oleic and palmitic acid in combination with insulin significantly increased both total 
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and phosphorylated ATM levels, which could suggest that oleate might act in a similar 
manner on ATM as AMPK (Kwon & Querfurth 2015; Palomer et al. 2018) . The decrease 
observed in the phospho-Akt/total Akt ratio is accompanied with a concomitant increase in 
the AMPK ratio when cells are treated with palmitic and oleic acid as well as insulin.  No 
difference was noted in the phospho-ATM/ATM ratio. In agreement with Kwon et al. (2014) 
this study also only noted phosphorylation of Akt in the presence of insulin, and not with 
FFA alone. The study by Ussher & Jaswal (2009) also failed to induce AMPK phosphorylation 
with either 0.1 mM or 0.2 mM palmitate or oleate, respectively. This could potentially 
suggest different underlying mechanisms for insulin resistance induced with either 
hyperlipidaemia or a combination of hyperlipidaemia and hyperglycaemia as well as 
hyperlipidaemea and hyperinsulinaemia. Unlike Halaby et al. (2008) this study did not 
observe phosphorylation of ATM in response to insulin treatment alone, however ATM 
phosphorylation was significantly increased compared to control treated cells in response to 
the combination of insulin and FFA treatment. Moreover, total ATM levels increased 
significantly in the presence of palmitic and oleic acid together with insulin, compared to 
palmitate and insulin alone in Fig 3.7. However, this increase was not observed in Fig 3.3, 
and highlights the need for more experiments with 0.1 mM palmitate alone compared to a 
combination of 0.1 mM palmitate and 0.1 mM oleate. These results are summarised in 
Table 3.2. 
Taken together, this pilot study provides an initial dissemination of a hyperlipidaemic insulin 
resistant H9c2 model that is sensitive to glucose and insulin addition. Moreover, similar 
models have been used to investigate the role of mitochondrial dysfunction in H9c2 cells 
(Kwon et al. 2014; Wang et al. 2017; Gao et al. 2009). The model described in the current 
study can thus potentially be used to study mitochondrial dysfunction in response to 
induced insulin resistance; moreover, the model can be easily manipulated which would 
suggest that the ATM specific inhibitor can be used to inhibit ATM.  
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Chapter 4 : Ataxia-Telangiectasia Mutated protein kinase is located on 
the inner mitochondrial membrane of rat cardiac mitochondria 
 
ATM is activated by endogenous mitochondrial oxidative stress (Zhang et al. 2018) and acts 
as an important sensor of reactive oxygen species (ROS), independently of the DNA damage 
response pathways (Guo et al. 2010). Studies have shown that ATM is located in the 
mitochondrial fraction of fibroblasts (Valentin-Vega et al. 2012), and is activated more 
specifically within the mitochondria rather than the peroxisomes (Morita et al. 2014). 
Following on this finding and a study that showed that ATM co-localize with peroxisomes 
(Watters et al. 1999), it was demonstrated that ATM is recruited to peroxisomes in response 
to oxidative stress (Zhang et al. 2015). The question thus arises whether ATM is located 
within the mitochondria, or recruited as is the case with peroxisomes.  
ATM has been implicated in the regulation of mitochondrial function, specifically with 
regards to mitochondrial respiration (Ambrose et al. 2007). In this regard, Complex I of the 
ETC was found to be down-regulated in the absence of ATM in ATM-/- fibroblasts (Valentin-
Vega et al. 2012).  Elucidation of the protein’s location can thus contribute towards a better 
understanding of its role within mitochondria. This chapter describes the development of a 
digitonin-based mitoplast isolation technique in order to determine whether ATM is 
associated with the outer or inner mitochondrial membrane (OMM and IMM) or matrix of 
the mitochondria.  The role of ATM as both an oxygen- and redox sensor suggests that the 
protein might be associated with the IMM or matrix of cardiac mitochondria, and could 
potentially play a role in oxidative phosphorylation. 
4.1 Development of a mitoplast isolation protocol: 
 
Mitochondria are often described as the powerhouses of cells, and supply the necessary 
energy for normal cell functioning and contraction of the heart. This and other essential 
functions, as well as the implication of mitochondrial dysfunction in many diseases such as 
Alzheimer’s disease, Parkinson’s disease and diabetes (Scheffler 2001), have led to the 
description of several applications and techniques for the isolation of mitochondria.  The 
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IMM and matrix, when isolated together is known as a mitoplast, whilst the OMM can be 
removed without damaging the mitoplast. Each of these compartments is essential for the 
proper functioning of mitochondria as a whole.  
Several protocols have been described for the isolation of mitoplasts from mitochondria. 
Many protocol optimizations led Bachmann et al. (1966) to suggest that the most effective 
procedure to obtain a well-resolved outer membranous fraction involves the disruption and 
consequent separation of the inner and outer membrane by sonication. In order to obtain 
the IMM, it was suggested that the best approach is to strip the outer membrane away from 
the IMM with phospholipase (Allmann et al. 1966). Today, the most commonly used 
techniques include digitonin and osmotic shock (Tzagoloff 1982).  Although the French press 
is also sometimes used, its use is limited by the availability of the necessary equipment. 
Digitonin, a mild non-ionic detergent, preferentially degrades the OMM, as measured by the 
release of monoamine oxidase, an enzyme only found on the outer membrane and 
accordingly, a suitable biochemical marker (Schnaitman et al. 1967). The seminal work of 
Greenawalt (1974) gives a detailed description of the isolation of mitoplasts from rat liver 
with a digitonin-based protocol. Even though Greenawalt (1974) reported that this method 
did not seem to be as effective for the isolation of mitoplasts from rat and bovine heart 
mitochondria, Javadov et al. (2011) successfully used this technique without any 
modification to isolate mitoplasts from Sprague-Dawley rat hearts. The latter study 
investigated the effect of NHE-I inhibition on mitochondrial fission and fusion proteins 
during post-infarction remodelling on mitoplasts isolated from the rat heart ventricles. 
Mitochondria were isolated from myocytes, and purified on a Percoll gradient, before being 
subjected to digitonin treatment. At a concentration of 1 % digitonin the mitoplasts tested 
positive for both adenine nucleotide translocase (ANT) and NHE-I, but not for the voltage-
dependent anion channel (VDAC), which suggests that NHE-I is associated with the 
mitochondrial inner membrane. The VDAC proteins are found at contact sites between the 
inner and outer membrane (Doran & Halestrap 2000), and allows communication, together 
with ANT, between these membranes, although VDAC is typically associated with outer 
membrane whilst ANT is associated with the inner membrane. 
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A common issue associated with most mitoplast isolation techniques, is the release of the 
matrix components, which Burnette & Batra (1985) overcame by combining several 
techniques, including varying concentrations of Na-EDTA in the mitoplast isolation buffer. 
The intactness of the isolated mitochondria was based on NADH oxidation activity before 
and after sonication, and before being used for fractionation.  This study’s novel approach 
was to include EDTA in the sucrose buffer, suggesting that this would contribute towards 
the destabilization of the outer membrane by forming complexes with the polar head 
groups associated with membrane lipids. In conclusion, the authors suggest that gentle 
predigestion of the outer membrane with phospholipase will weaken the membrane 
without disruption, which can then be removed through hypotonic swelling and exposure to 
EDTA and digitonin, without rupturing the matrix.  
Several studies since have also made use of sucrose gradient centrifugation. Sucrose 
gradient centrifugation was described for the isolation of mitochondria and mitochondrial 
fractions from rat liver (Ohlendieck et al. 1986). This study highlighted the fact that 
osmotically lysed mitochondria revealed a membrane fraction containing both outer and 
inner membranes, bound by membrane contacts. These membranes could not be separated 
through further centrifugation, and outer membrane contact with the inner membrane had 
to be removed through uncoupling with dinitrophenol, before the membranes could 
subsequently be separated on a density gradient (Ohlendieck et al. 1986).  
The presence of outer membrane remnants, attached by contact sites to the inner 
membrane, has especially been noted in studies using microscopy to investigate mitoplasts 
prior to “patch-clamp” experiments. An example of such a study was reported by Ryu et al. 
(2011) that investigated and characterized a ryanodine-sensitive channel in heart mitoplasts 
that were isolated from Sprague-Dawley rat heart mitochondria. Mitoplasts were obtained 
through differential gradient centrifugation in a mannitol/sucrose buffer (M/S buffer), and 
were investigated visually using a phase contrast microscope. The mitoplasts appeared as 
transparent vesicles (2-5 μm in diameter) with “cap” regions that are remnants of the OMM, 
and were avoided in the patch-clamp experiments.  
Osmotic shock was also used to obtain mitoplasts in a study that characterised a Ca2+ 
sensitive ion-channel on the IMM (Kirichok et al. 2004). In this study, mitochondria were 
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isolated from lysed Cos-7 cells. The mitochondria were subjected to osmotic shock in a 
hypotonic solution, whereafter the mitoplasts were sedimented from solution by 
centrifugation. The mitoplasts were resuspended in a hypertonic solution, and also 
investigated prior to patch-clamping. Several mitoplasts showed black spots on the inner 
membrane, which the authors suggested to be remnants of the outer membrane at several 
contact sites between the membranes.  
A study by Beutner et al. (2001) used the protocol described by Ohlendieck et al. (1986) in 
order to identify a ryanodine receptor in rat heart mitochondria, and included a more 
rigorous centrifugation protocol to remove any OMM remnants from the isolated 
mitoplasts. Briefly, isolated mitochondria from two rat hearts was purified on a Percoll 
gradient and osmotically shocked. The membranes were disrupted by sonication, and intact 
mitochondria were removed through centrifugation. The supernatant was transferred as a 
final layer onto a continuous sucrose gradient and centrifuged for at least 8 hours to 
separate the membrane vesicles (Beutner et al. 2001). Similarly to Ohlendieck et al. (1986), 
Beutner et al. (2001) used succinate dehydrogenase (SDH) as a marker for the IMM, and 
tested for the presence of contact sites (CS) as well as the OMM with the VDAC antibody. 
The western blotting results showed clear bands for VDAC in all of the fractions that were 
probed including the cytosol, whole mitochondria, OMM and contact site fractions. 
However, no VDAC could be detected in the IMM fraction, which suggests that the IMM and 
thus the mitoplast, did not have any OMM remnants. 
Unlike Beutner et al. (2001), a study that investigated cardiac mitochondrial thyroid 
receptor isoforms, used VDAC as a marker for both the IMM and OMM, COXIV for the inner 
membrane and mtHSP70 as a matrix marker (Morrish et al. 2006). The results showed that 
the VDAC marker was present in the whole, purified, mitochondrial, mitoplast, and 
mitochondrial membrane fractions. It was not present in the matrix fraction, which was also 
the only fraction to test positive for the HSP70 marker. Briefly, the mitochondria were 
isolated with a mitochondrial isolation kit, and used to produce mitoplasts with digitonin 
(Schnaitman & Greenawalt 1968), which were further sub-fractionated through swelling in a 
hypotonic solution. The inner membrane and matrix fractions were collected after several 
cycles of freeze-thawing and ultra-centrifugation (100 000 x g at 4°C for 1 hour).  Morrish et 
al. (2006) also tested for Hexokinase-2 as a marker, which is associated with the OMM, but 
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not with the mitoplast, IMM or matrix, and showed no OMM contamination in the latter 
fractions. It is thus possible that the study detected VDAC in the mitoplast fraction due to 
contact sites between the inner and outer membranes which the hexokinase-marker could 
not detect.  
However, in a different study, a time specific demonstration of the degradation of the outer 
membrane (and thus a decrease in VDAC) through digitonin fractionation (0.3 mg digitonin) 
of rat heart mitochondria, revealed no VDAC marker present after 30 minutes of 
fractionation, whilst the ANT marker stayed relatively consistent throughout (Srisakuldee et 
al. 2014). The latter study aimed to demonstrate that fibroblast growth factor 2 (FGF2) 
protects heart cells from ischeamic and reperfusion–induced death through a mechanism 
linked to PKC-mediated connexin43 phosphorylation. Connexin43 has previously been 
reported to be associated with the inner mitochondrial membrane (obtained with 0.6% 
digitonin fractionation; Rodriguez-Sinovas et al. 2006) through Western blotting that used 
VDAC and ANT respectively as the outer and inner membrane markers. Similar to the study 
of Morrish et al. (2006), the VDAC marker was present in both the outer membrane and 
mitoplast (inner membrane and matrix) fractions, but not in the matrix fraction alone. Both 
Srisakuldee et al. (2014) and Rodriguez-Sinovas et al. (2006) used Cyphilin D (CypD, a 
mitochondrial matrix protein), to investigate the purity of the matrix fraction. These studies 
also made use of Percoll gradient centrifugation in order to isolate clean, intact 
mitochondria prior to digitonin fractionation. 
The studies discussed here represent but a few of the many studies that have investigated 
either the location or presence of certain proteins within mitochondria. A common theme 
throughout all of the above mentioned studies are the use of either sucrose or Percoll 
gradients to further purify mitochondria after isolation. Hypotonic disruption is sufficient 
when using the mitochondria for patchclamping experiments, but outer membrane 
contamination as well as disruption of the inner membrane seems to be problematic. Once 
intact, purified mitochondria are obtained, the lack of plasma membranes as well as nuclear 
contamination can be confirmed with the use of the plasma markers such as Na+K+ATPase 
and either PCNA (proliferating cell nuclear antigen) or GAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) as a nuclear marker. The mitochondria can then be sub-fractionated with 
digitonin at varying concentrations.  
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The optimal concentration of digitonin used for fractionation is determined by the ratio of 
digitonin to mitochondrial protein, but can be influenced by other contaminating proteins 
(Greenawalt 1974).  Once the mitochondria are sub-fractionated with digitonin, the 
different mitochondrial fractions can be identified with the markers previously mentioned 
(VDAC, outer membrane, but due to contact sites, potentially found on the inner membrane 
as well; ANT, inner membrane and either HSP70 or CypD as a matrix marker). The above 
mentioned studies commonly made use of western blotting, although several studies used 
either gold-labelling or fluorescent confocal microscopy for initial identification of the 
location of certain proteins prior to western blotting experiments.   
Collectively, these studies were used to design a digitonin permeabilisation protocol for the 
isolation of OMM, IMM and matrix fractions from cardiac mitochondria obtained from male, 
Wistar rats.  Isolation of intact mitoplasts was confirmed with transmission electron 
microscopy. The location of ATM was determined with western blotting and confirmed with 
super-resolution structured illumination microscopy (SR-SIM)  
4.2 Materials and methods: 
 
In order to identify the location of ATM within cardiac mitochondria, subsarcolemmal 
mitochondria were isolated from male Wistar rat hearts, subjected to digitonin- and Lubrol 
WX-based permeabilisation, and prepared for western blotting. Mitoplast isolation was 
confirmed with transmission electron microscopy (TEM), and ATM was detected with SR-
SIM microscopy and western blotting.  
4.2.1 Reagents: 
 
All chemicals were purchased from Sigma-Aldrich-Merck, except where indicated otherwise. 
Sodium pentobarbitone (Eutha-naze) was obtained from Bayer. Proteinase K (recombinant, 
PCR grade) was purchased from Roche Diagnostics GmbH, Germany). Western blot reagents 
were purchased from BioRad (Lasec, South Africa), except for SignalBoost™Immunoreaction 
Enhancer Kit (EMD Millipore-Merck), and the Immobilon®-P PVDF membrane (EMD 
Millipore-Merck). The following antibodies were purchased from Cell Signaling Technologies 
(USA): ATM (D2E2) Rabbit mAb #2873 and VDAC rabbit polyclonal Ab #4866. The ANT 
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1/2/3/4 (#H-188), 34 kDa was purchased from Santa Cruz Biotechnology. For the SR-SIM 
experiments, rabbit mAB Anti-ATM antibody [EPR17059] (ab199726) was purchased from 
Abcam. TOM20 and VDAC anti-mouse antibodies were a kind gift from the Division of 
Molecular Biology and Human Genetics, Parkinson’s Research group, Stellenbosch 
University. The goat Anti-Rabbit IgG H&L (Alexa Fluor® 488, ab150077) and goat Anti-Mouse 
IgG H&L (Alexa Fluor® 594, ab150116) secondary antibodies were a kind gift from the Dept 
of Physiology, SU (Prof Ben Loos).  
4.2.2 Animals: 
 
All the procedures involving animals were in compliance with the South African National 
Standard for the care and use of animals for scientific purposes (SANS 10386:2008); the 
Medical Research Council Guidelines on Ethics for Medical Research; Book 3: Use of Animals 
in Research and Training and the National Institutes of Health Office of Laboratory Welfare: 
The Guide for the Care and Use of Laboratory Animals, 8th Edition; USA, and was approved 
by the Research Ethics Committee: Animal care and Use, Stellenbosch University, South 
Africa (approval numbers SU-ACUM12-0040; SU-ACUD16-00179). 
Male Wistar rats (weighing approximately 250 grams) were housed at the Central Research 
Facility (Stellenbosch University) in a temperature controlled (~23°C) environment with a 
12-hour light/dark cycle and fed normal rat chow. The animals were injected with Eutha-
naze (Bayer, 200 mg/ml at an overdose of 200 mg/kg via intraperitoneal injection 
performed by a registered animal laboratory technologist, South African Veterinary Council, 
SAVC number: AL16/15486), and euthanised through exsanguination after rapid excision of 
the heart. Two animals were used per experiment, and the experiments were repeated five 
times for protocol optimisation and confirmation, once for TEM and once for SR-SIM 
experiments (total number of animals used: 14 animals) 
4.2.3 Mitochondrial isolation: 
 
The mitochondrial isolation protocol is based on the method described by Sordahl et al. 
(1972) and Venter et al. (1991). Briefly, after excision of the heart, the atria were removed 
and the ventricular tissue was placed in ice-cold KE isolation buffer (0.18 M KCl, 0.01 M 
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EDTA, pH 7.4) and finely diced with scissors. The tissue was washed in isolation buffer to 
remove all traces of blood, and briefly homogenised (2 X 5 seconds at speed 13 000 rpm) 
with a Heidolph SilentCrusher M. This was followed by a slow centrifugation step in a Sorvall 
RC6-PLUS centrifuge (755 x g for 10 minutes at 4° Celsius) in order to obtain a pellet 
containing the nuclei, cell membranes and any remaining tissue. The supernatant was 
transferred to a clean centrifuge tube and centrifuged at 18 800 x g for 10 minutes at 4°C to 
obtain a mitochondrial pellet.  The pellet was re-suspended in ice-cold mitochondrial 
isolation buffer with a 2 cm3 Potter-Elvehjem glass-teflon homogenizer, and stored on ice 
until use.  
4.2.4 Mitochondrial subfractionation with digitonin and Lubrol WX: 
 
For subfractionation, the atria were removed directly after excision of the heart, and the 
remaining ventricular tissue of two hearts were placed in ice-cold D-mannitol/sucrose buffer 
adapted from  Greenawalt (1974) and Beutner et al. (2005) (M/S buffer; 70 mM sucrose, 
220 mM D-mannitol, 10 mM HEPES, 0.5 M EGTA, pH to 7.2 with KOH). The tissue was finely 
diced as described previously, and subjected to homogenization (Heidolph SilentCrusher M). 
Mitochondria were isolated as described above and resuspended in ice cold M/S buffer. The 
mitochondrial fraction was washed with centrifugation at 5366 x g for 10 min at 4°C, and 
resuspended in ice-cold M/S buffer. Protein concentration was determined with a Bradford 
protein assay (Bradford 1976) prior to 1.2% digitonin treatment (Sigma, D141). A 1.2 % 
digitonin solution was prepared freshly before each fractionation experiment by boiling 12 
mg digitonin (D141, Sigma-Aldrich) in 1 ml of M/S buffer for 1 minute, and allowed to cool 
to room temperature before use. Mitochondrial protein concentration was determined with 
a Bradford assay (Bradford 1976). A volume equal to 100 μg mitochondria was aliquoted 
into a clean Eppendorf tube, and an equal volume of 1.2% digitonin was added, to give a 
total amount of 50 µg mitochondria:1.2% digitonin. This reaction served as the master 
reaction from which aliquots were taken. An aliquot was taken at the moment of addition (0 
minute time point), and the reaction was quenched and diluted 10 X with ice-cold M/S 
buffer containing bovine serum albumin (BSA, 25 μg/ml). The master digitonin-
permeabilisation reaction was allowed to continue for 30 min whilst gently stirring at 0° 
Celsius, and aliquots were taken at 15 min, 20 min and 30 min time points, and quenched as 
Stellenbosch University  https://scholar.sun.ac.za
 
 
87 
 
previously described. Aliquots were taken at different time points to determine the time 
point at which most of the OMM has been removed without rupturing the mitoplast. The 
quenched 10 X dilution time-point reactions were subsequently centrifuged at 5366 x g for 
10 min at 4°C (Sigma 1-14K) to obtain the mitoplasts (sediment), and the supernatant was 
carefully aspirated.  The supernatant was centrifuged at 100 000 x g for 1 hour at 4°C to 
obtain the outer mitochondrial membrane (OMM) fraction.  
The mitoplast fraction was further subfractionated into a matrix and IMM fraction. The 
matrix fraction was obtained by resuspending the mitoplast fraction in ½ the original 
volume of M/S buffer, followed by centrifugation at 5 633 x g for 10 min at 4° C. The 
supernatant was carefully aspirated and added to OMM fraction, whilst the mitoplast 
fraction was resuspended in 0.16 mg/ml Lubrol WX (Sigma; Greenawalt 1974; Schnaitman & 
Greenawalt 1968), and rested in an ice bath for 15 min. The nonionic detergent, Lubrol WX 
is a solubilising agent for membrane bound proteins, and is capable of solubilising most of 
the matrix proteins whilst the IMM is impervious to solubilisation  (Chan et al. 1970). The 
suspension was centrifuged at 100 000 x g for 1 hour. The supernatant contained the matrix 
proteins and the pellet contained the IMM fraction. A schematic diagram of the protocol is 
shown in Figure 4.1. 
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Figure 4.1: Schematic diagram of mitochondrial fractionation to obtain mitoplasts. Isotonically 
swollen mitochondria were prepared from the hearts of male Wistar rats in a modified M/S buffer 
with differential centrifugation (left panel). A ratio of 50 μg mitochondria: 1.2% digitonin was 
digested at 0°C and was either quenched immediately (0 min) with the addition of a 9 volumes of 
M/S buffer containing 25 mg/ml BSA or allowed to continue for 15, 20 or 30 minutes. The 
reactions were centrifuged to obtain mitolasts at each time point and the supernatant was further 
centrifuged to obtain the OMM fraction. The mitoplasts were subfractionated into the IMM and 
matrix with Lubrol WX and ultracentrifugation (right panel).  
All fractions were resuspended in a small volume of M/S buffer and an equal volume of 1 X 
SDS buffer (10% glycerol, 50 mM TRIS-HCl pH 6.8, 30 mM β-glycerophosphate, 2.5 mM 
EGTA, 1 mM NaVO4, 0.5 mM NaF, 10% SDS) was added for Western blotting purposes. 
4.2.5 Proteinase K digestion: 
 
Proteinase K is a stable serine protease that hydrolyzes a variety of peptide bonds and is 
commonly used to degrade nucleases in nucleic acid extractions preparations. However, the 
protease can also degrade many proteins in their native conformation and has been shown 
to degrade ATM in the presence and absence of Triton-X, as described by Zhang et al. 
(2015). Briefly, a total of 25 μg M/S-isolated mitochondria were subjected to Proteinase K 
digestion (0.1 μg/ml, Roche) in the presence of 0.1 % Triton-X (which disrupts membranes) 
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for 1 minute, 3 minutes, 5 minutes and 10 minutes at 37°C. The reactions were quenched 
with 5 mM phenylmethyl sulphonyl fluoride (PMSF) on ice, and centrifuged at 10 000 x g for 
10 min at 4°C. The pellets were resuspended in M/S buffer and an equal volume of 1x SDS 
buffer for Western blotting purposes for western blotting purposes. 
4.2.6 Western blotting: 
 
Briefly, the cell membrane and nuclei (CN), cytosol(C), mitochondrial (M), OMM, IMM and 
matrix fraction lysates (indicated in Figure 4.1) were prepared for western blotting  with the 
addition of one volume M/S buffer, one volume 1 X SDS buffer (10% Glycerol, 50 mM TRIS-
HCl, pH 6.8, 30 mM β-glycerophosphate, 1 mM Na3VO4, 0.5 mM NaF, 2% SDS) and one 
volume 3 X Laemmli sample buffer (2.5 M glycerol, 0.189 M TRIS-HCl (pH 6.8), 10% SDS, 
1.275 mM bromophenol blue, 15% β- mercaptoethanol). The samples were boiled for four 
minutes and stored at -80°C until use. Samples were boiled again for 4 minutes prior to 
being loaded on 4–15% Mini-PROTEAN® TGX™ Stain free Precast Protein Gels (Bio-Rad 
Laboratories), and subjected to electrophoresis for 1 hour at 200 Volt and 200 mAmp. Due 
to major size differences in the proteins investigated (ATM protein kinase, 350 kDa, #2873, 
Cell Signaling Technology (CST); VDAC #4866, 32 kDa, CST; and ANT 1/2/3/4 #H-188, 34 kDa 
Santa Cruz Biotechnology), a modified transfer buffer was used (25 mM TRIS, 190 mM 
glycine and 10% methanol v/v), and the gels were allowed to rest for 30 minutes in the 
buffer prior to activation in the ChemiDoc MP system (Bio-Rad Laboratories), and transfer. 
Transfer was performed at 200 V and 200 mA for 1 hour 30 minutes at 4°C onto an 
Immobilon®-P PVDF membrane (EMD Millipore). The membranes were briefly placed in 
methanol, and allowed to dry before blocking in a 5% liquid fat-free milk solution. The 
antibodies were diluted  1:1000 as follows: SignalBoost™Immunoreaction Enhancer Kit 
(EMD Millipore) for ATM protein kinase antibody (CST) and secondary antibody; TBS-T for 
VDAC antibody and secondary antibody, and TBS-T with 2.5% fat free milk solution for ANT 
1/2/3/4 (SCBT) and its secondary antibody. After primary (overnight at 4° Celsius) and 
secondary antibody (1h at room temperature [~ 23° Celsius]) incubation the membranes 
were treated with Clarity™Western ECL Blotting Substrate and visualised on the Chemidoc 
MP system.  
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4.2.7 Transmission electron microscopy: 
 
In brief, samples were processed with a Leica EM tissue processer, fixed in glutaraldehyde 
and scoped with a JEOL 10-11 transmission microscope (JEOL, Japan) and a SIS imaging 
according to standard protocol (National Health Laboratories Services, Tygerberg Hospital, 
Cape Town, South Africa). The microscopy was done by Mrs. N Muller at the NHLS. 
4.2.8 Super –resolution Structured Illumination Microscopy (SR-SIM): 
 
Super-Resolution Structured Illumination Microscopy (SR-SIM) was performed at the 
Stellenbosch University Central Analytical facility (CAF) Fluorescence Microscopy unit.  
Mitochondria and mitoplasts were prepared as described previously and fixed with 2.5% 
glutaraldehyde.  The samples were incubated overnight at 4° Celsuis with either ATM 
(Abcam, anti-rabbit, mAb, ab199726)  and VDAC (CST, anti-mouse), or ATM and Tom20 
(Abcam, anti-mouse), washed and probed with the appropriate fluorescent Goat Anti-Rabbit 
IgG H&L (Alexa Fluor® 488, ab150077) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594, 
ab150116) secondary antibody. TOM 20 is an OMM import protein, whilst VDAC is 
associated with the contact points between the inner and outer mitochondrial membrane. 
Samples were acquired with a Zeiss LSM 780 ELYRA PS.1 microscope. Thin (0.1 mm) z- stacks 
of high-resolution image frames were collected with 5 rotations by using an alpha Plan-
Apochromat 1006/1.46 oil DIC M27 ELYRA objective and an ELYRA PS.1 (Carl Zeiss 
Microimaging) microscope equipped with a 488 nm laser (100 mW), 561 nm laser (100 mW) 
and Andor EM-CCD camera (iXon DU 885). Micrographs were reconstructed with ZEN 
software (black edition, 2011, version 7.04.287) using a structured illumination algorithm 
(Heintzmann & Cremer 1999). The sample fixation, as well as the majority of imaging, was 
performed by Prof B Loos at the Central Analytical facility (CAF), Department of Physiology, 
Stellenbosch University. 
4.3 Results and discussion: 
 
In order to evaluate whether mitochondria can be successfully isolated with the modified 
M/S buffer, and if the protocol enabled mitochondrial swelling in order to aid the removal of 
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the OMM with digitonin, samples of 1) mitochondria isolated with KE buffer (Fig 4.2 a and 
b), 2) freshly isolated M/S mitochondria prior to digitonin permeabilisation (0 min time 
point) (Fig 4.2 c and d) 3)  20 minutes after digitonin permeabilisation (Fig 4.2 e and f) and 4) 
30 minutes after digitonin permeabilisation (Fig 4.2 g and h) were submitted for 
transmission electron microscopy at the NHLS, Tygerberg hospital, South Africa, for imaging 
(Figure 4.2). 
Mitochondria that were isolated in M/S buffer were swollen (Fig 4.2, panel c , 2 µm, panel d, 
0.5 μm) compared to mitochondria isolated in isotonic mitochondrial isolation buffer (KE 
buffer, Fig 4.2, panel a, 2 µm and panel b, 0.5 μm) exhibiting loosened outer membranes, 
which are shown in the enlargement in Fig 4.2, panel b and d.  Hypotonically swollen 
mitochondria with M/S buffer (Fig 4.2, Panel d) also exhibited cristae rearrangement which 
appeared more rounded compared to well-structured cristae of mitochondria isolated in KE 
buffer (Figure 4.2, panel c and d compared to panel a and b). This suggests that the M/S 
buffer was sufficient to promote mitochondrial swelling and to loosen the OMMs to aid 
digitonin treatment. After 20 minutes of 1.2% digitonin treatment, dark, rounded structures 
could be observed that ranged in size, as well as OMM remnants in Figure 4.2, panel e (2 
μm) and f (1 μm). 
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Figure 4.2: Transmission electron micrographs of mitochondria and mitoplasts after 20 and 30 
minutes of 1.2% digitonin permeabilisation.  Panel a represents functional mitochondria isolated 
with KE buffer (2 μm), where panel b is an enlargement of two mitochondria with well-coupled 
a b 
c d 
e f 
g h 
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IMM and OMM (insert), as well as structured cristae (white arrow; 0.5 μm). Panel c and d show 
M/S buffer isolated mitochondria that present as swollen, with disrupted cristae structure and 
exhibit loose OMM. Panel e and f respectively show mitoplasts (Panel e, 2 μm) that are 
highlighted in Panel f (1 μm, black arrows) as well as remnants of OMM (highlighted by the black 
box). Mitoplasts are identifiable through electron-opaque granules found in the mitochondrial 
matrix (insert) and can be observed in mitoplasts of all sizes. Panel g (2 μm) and panel h (0.5 μm) 
represents a mitoplast preparation after 30 min of digitonin treatment, where as the insert shows 
pinched cristea.  
The mitoplast structures observed in Fig 4.2 panel f (black arrows) were also seen by 
Sileikyte et al. (2011) after 20 minutes of 1.2% digitonin treatment. The outer membrane 
(Fig 4.3, panel f, black block) resembles the same structures observed by Hoppel et al. 
(1998) and confirmed the successful removal of the outer membrane from the mitoplasts. 
Electron-opaque particles, which are associated with the matrix (Hackenbrock 1972), were 
also observed (enlargement, Fig 4.2, panel f) and used as an identifying marker of 
mitoplasts. Interestingly, fewer and smaller mitoplast structures were observed, whilst 
some of the OMM were retained after 30 minutes of digitonin permeabilisation (Figure 4.2, 
panel g, 2 μm). However, in Figure 4.2, panel h (0.5 μm) and the insert a broken 
mitochondrial structure can be observed with rod-like structures that resemble pinched 
cristea. Whether this is the case is unclear, however, it confirmed that 20 min digitonin 
treatment is sufficient to obtain rounded, swollen mitoplasts that resembles mitoplast 
structures reported in literature obtained with digitonin and sonication (Hovius et al. 1990) 
or digitonin alone (Sileikyte et al. 2011). This suggests that 20 minutes of 1.2% digitonin 
treatment is optimal to obtain intact mitoplasts from M/S isolated mitochondria, whilst 
removing the majority of OMM.  
Taken together, the modified MS buffer aided mitochondrial swelling that loosened the 
OMM and contributed to the formation of mitoplasts after the addition of 1.2% digitonin. 
The optimal time point for permeabilisation is 20 minutes as fewer and smaller mitoplast 
structures are observed after 30 minutes.  
The fractions obtained from the different time points were centrifuged (Fig 4.1) to obtain 
separated OMM and mitoplast fractions (indicated as IMM for western blot purposes) and 
probed for ATM, VDAC and ANT1/2/3/4 with western blotting (Fig 4.3). The fractions probed 
with western blotting were taken from each of the isolation steps, where CN represents the 
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cell membrane and nuclei obtained in the initial pellet and C, the cytosolic fraction after 
pelleting the mitochondrial fraction (M).  
ATM was observed in the CN and mitochondrial fractions as well as at the 0 min time point 
in the OMM and IMM fractions. This time point served as a control prior to the removal the 
OMM from the mitoplast with digitonin, where it is expected that the OMM is still largely 
attached to the mitochondria, and was confirmed with TEM (Fig 4.2, panel d). ATM could 
not be observed at any other time point within the isolated OMM fractions after digitonin-
based removal from the mitoplasts, but was present in the IMM fraction (mitoplast plus 
IMM) at each time point. This correlated well with the presence of the IMM marker, ANT 
1/2/3/4 in each of the mitoplast time point fractions, which was absent in the OMM time-
point fractions.  The OMM marker, VDAC was predominantly present in the CN, M and 
OMM time-point fractions, although VDAC protein could be detected in the cytosolic, and 
IMM time-point fractions.  This might be due to contact point contamination (also observed 
by Ryu et al. 2011; Kirichok et al. 2004; Srisakuldee et al. 2014), but did not result in any 
association between ATM and the OMM. 
These observations suggest that ATM is associated with the mitoplast fraction (IMM and 
matrix), whilst the presence of ATM within the CN and M fractions served as a positive 
control, because of its well-known association with the nucleus as well as prior association 
with the mitochondria (Morita et al. 2014).  
ATM has previously been associated with mitochondria (Valentin-Vega et al. 2012), and was 
further investigated with a differential centrifugation isolation (Morita et al. 2014), similar to 
the protocol used in our study. The resultant fractions were referred to as the heavy and 
light membrane fractions, and the heavy fraction, which consisted mainly out of 
mitochondria, was found to contain ATM and phosphorylated ATM (Morita et al. 2014). The 
current study expands on these results, and shows that ATM is associated with the 
mitoplast fraction of isolated cardiac mitochondria. It should also be noted that the work 
presented by Valentin-Vega et al. (2012) and Morita et al. (2014) was performed 
respectively in immortalized human fibroblast and Hep2G cells, which makes this the first 
report to show that ATM is located in cardiac mitoplasts under normoxic conditions. 
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Figure 4.3: Western blot analysis after the subcellular fractionation of the mitochondrial, outer 
mitochondrial (OMM) and mitoplast (inner mitochondrial membrane {IMMI} and matrix) 
fractions.  The first lane (mm) indicates the HiMark pre-stained protein standard (ThermoFischer 
Scientific), the second lane was loaded with the cellular membrane and nuclear (CN) fraction and 
served as a positive control for ATM, whilst C indicates the cytosolic fraction. The mitochondrial 
fraction (M) was digested over time (0 min, 15 min, 20 min and 30 min) and separated into OMM 
and IMM fractions with differential centrifugation prior to Western blotting with antibodies for 
ATM (350 kDa), Voltage Dependant Anion Channel (VDAC, 32 kDa) and Adenine Nucleotide 
Transproter 1/2/3/4 (ANT1/2/3/4, 34 kDa). The images were cropped and full-length blots as well 
as total protein membrane images are presented in Addendum A (Fig A1).  
Mitoplasts can be separated into the IMM and matrix, the latter containing the 
mitochondrial DNA, enzymes and ribosomes.  In light of the observed association between 
ATM and the mitoplast fraction, the mitoplast fractions at 0 min and 20 min were further 
separated into the IMM and matrix fractions with Lubrol-WX permeabilisation (Figure 4.4). 
ATM was again found to be mainly associated with the IMM at 0 and 20 min, whilst a light 
band can be observed in the OMM fraction at 20 min. This could suggest incomplete 
digitonin disruption and separation, because ANT1/2/3/4 was also seen in these fractions. 
ATM was observed in the nuclear (CN) and mitochondrial (M) fractions which served as a 
positive control, whilst VDAC was observed in all the fractions except at IMM 20 min and in 
the matrix. Neither ANT1/2/3/4 nor ATM were observed in the matrix fraction, and although 
it is tempting to suggest that ATM is not found in the matrix, a robust matrix marker should 
have been included to confirm the purity of the fraction.  
The association of ATM with the outer membrane of the peroxisome was confirmed with 
Proteinase K digestion in the presence and absence of Triton-X (Zhang et al. 2015). In the 
study by (Zhang et al. 2015), the authors used proteinase K digestion in the presence and 
absence of Triton-X to show that ATM is present in the peroxisome, together with the 
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peroxisome membrane protein, PMP70 at 0 min, but is rapidly digested both in the 
presence and absence of Triton-X, and is not present after 5 minutes of proteinase K 
digestion. Conversely, ATM was not present after M/S -isolated mitochondria were digested 
for 1 minute with Proteinase K and Triton-X membrane disruption, but were observed after 
3 and 5 minutes of digestion, and not after 10 minutes. Both the IMM marker, ANT1/2/3/4 
as well as  the OMM marker, VDAC are resistant to proteinase K digestion (Diokmetzidou et 
al. 2016) and was present at all time points (Fig 4.4). This confirms that ATM is located on 
the inner and not outer mitochondrial membrane, and supports the notion that it is not 
associated with the matrix.  
 
Figure 4.4: Subfractionation of the mitoplast fraction into the IMM and matrix and proteinase K 
digestion of the mitochondrial fraction. Mitoplasts were prepared from M/S isolated 
mitochondrial fractions and further digested with Lubrol WX to obtain the IMM and matrix 
fractions. Proteinase K digestion in the presence of Triton-X was performed on M/S isolated 
mitochondria to confirm the presence of ATM on the inner mitochondrial membrane. ATM was 
observed after 3 and 5 minutes whilst VDAC and ANT1/2/3/4 could be observed at all time points. 
The images were cropped and full-length blots as well as total protein membrane images are 
presented in Appendix 1 (Fig 2). The first lane (left, mm) indicates the HiMark pre-stained protein 
standard (ThermoFischer Scientific), and the 5th last lane (mm) represents the PageRuler 
Prestained Protein Ruler (ThermoFischer Scientific). 
The association of ATM with the IMM (ANT), and not OMM (VDAC), which was observed in 
the IMM western blot fraction, was further investigated with SR-SIM. The  different 
fractions of KE-isolated mitochondria, and M/S isolated mitochondria at 0 min and 20 min of 
digitonin treatment were imaged with either ATM (anti-rabbit) and VDAC (anti-mouse, Fig 
4.5) or ATM (anti-rabbit) and TOM20 (anti-mouse, Fig 4.6) fluorescently labelled antibodies.  
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Figure 4.5: Super resolution structured illumination microscopy (SR-SIM) micrographs of isolated 
mitochondria and mitoplast preparations probed with VDAC (OMM, red) and ATM (IMM, green). 
Mitochondria were isolated with either KE buffer (panel a, overlay), or M/S buffer (panel b, 
overlay, 1 μm) at 0 min digitonin treatment and after 20 min digitonin treatment (panel c, overlay, 
0.5 μm). Panels d-f show VDAC (red) respectively in KE-isolated mitochondria, M/S buffer isolated 
mitochondria at 0 min and after 20 min digitonin permeabilisation. Panels g-i show ATM (green) in 
KE isolated mitochondria and M/S-isolated mitochondria after 0 and 20 min of digitonin 
treatment, respectively. 
As expected from the Western blot results, ATM (green) could be clearly observed in the 
fixed KE-buffer isolated mitochondria, and overlayed very well with VDAC, which suggests 
tightly coupled and intact mitochondria (Fig 4.5 a). The two fluorescently labelled proteins 
were sufficient to visualise the isolated mitochondria, and compared well to TOM20 in Fig 
4.6 (panel d, 1 μm). Although ATM appeared more clustered (Fig 4.6, panel g, 1μm), the 
protein is still seen across the mitochondrial structure. The addition of digitonin (0 min) to 
M/S buffer isolated mitochondria, resulted in the clustering, or punctate formation of ATM, 
whilst both the OMM proteins (Fig 4.5, panel b, and fig 4.6 panel b, 1 μm) still indicate 
rounded mitochondrial structures. The structure corresponds with the swollen 
mitochondrial structure observed with TEM (Fig 4.2 panel d), whilst the punctate formation 
of ATM, might correspond with the structural rearrangement of the cristae or it might be 
facing towards the intermitochondrial space, which would make it vulnerable to surface 
disruption by digitonin. 
VDAC ATM 
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Figure 4.6: Super resolution structured illumination microscopy (SR-SIM) micrographs of isolated 
mitochondria and mitoplast preparations probed with TOM20 (OMM, red) and ATM (IMM, green). 
Mitochondria were isolated with either KE buffer (panel a, overlay), or M/S buffer (panel b, 
overlay, 1 μm) at 0 min digitonin treatment and after 20 min digitonin treatment (panel c, overlay, 
0.5 μm). Panels d-f show TOM20 (red) respectively in KE-isolated mitochondria, M/S buffer 
isolated mitochondria at 0 min and after 20 min digitonin treatment. Panels g-i show ATM (green) 
in KE isolated mitochondria and M/S-isolated mitochondria after 0 and 20 min of digitonin 
treatment, respectively. 
After 20 minutes of digitonin treatment, no association could be observed between ATM 
and VDAC (Fig 4.5, panel c, 0.5 μm), nor TOM20 (Fig 4.6, panel c, 0.5 μm), which supports 
the notion that ATM is associated with the IMM and not the OMM of cardiac mitochondria. 
It also suggests that ATM is not associated with contact points between the OMM and IMM; 
if this was the case, the expectation would be that ATM would be associated with VDAC 
after 20 min of digitonin permeabilisation, but not with TOM20, which was not the case. 
Whereas VDAC was previously observed in the mitoplast fraction, TOM20 is an import 
protein located on the OMM. Thus, in order to determine whether there is any association 
between ATM and the contact points, or between ATM and the OMM, a marker was chosen 
that is not associated with the IMM at all. 
In conclusion, these results show that ATM is associated with the IMM of rat cardiac 
mitochondria. The protein was not be associated with VDAC, and was predominantly 
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present within the cellular and nuclear fractions, mitochondrial fraction, and the mitoplast 
fraction. Further subfractionation confirmed that ATM was associated with the IMM and not 
the matrix. The formation of punctates by ATM suggest that the protein could be facing 
towards the intermitochondrial space between the inner and outer membrane which would 
expose it to partial digitonin treatment. It is clear that greater resolution and more sensitive 
microscopy techniques, such as super resolution correlative light and electron microscopy 
(CLEM) are required to resolve the inversion of the mitoplast with sonication.  
The association of ATM with the IMM suggests a potential role for ATM in oxidative 
phosphorylation, and is discussed in the next chapter. 
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Chapter 5 : ATM plays a role in mitochondrial oxidative phosphorylation 
and mitophagy 
 
Mitochondria are essential for energy production in the heart, and dysfunction thereof has 
been linked with heart failure (Rosca et al. 2008; Rosca & Hoppel 2010), diabetic 
cardiomyopathy (Boudina et al. 2007; Boudina et al. 2009; Boudina & Abel 2010), as well as 
metabolic and inflammatory pathophysiology (reviewed by Forrester et al. 2018).  
Under physiological conditions the heart produces approximately 95% of its required ATP 
through oxidative phosphorylation of free fatty acids (Opie 2004). Mitochondrial function is 
impaired in obesity, insulin resistance and T2D (reviewed by Bugger & Abel 2008), and can 
result in mitochondrial substrate oxidation and decreased ATP production. Inefficient 
nutrient oxidation decreases ATP production and oxygen consumption, and in turn, increase 
ROS production and stimulate inflammation as well as contributing to mitochondrial 
dysfunction and insulin resistance (Kim et al. 2008). Collectively, this can lead to the 
development of heart failure and cardiac hypertrophy (reviewed by Doenst et al. 2013). 
Moreover, increasing evidence suggests that changes in glucose homeostasis in cardiac 
hypertrophy includes altered glucose transport and increased glycolysis which is associated 
with the loss of metabolic flexibility as well as an increased dependence on glucose 
utilization (Shao & Tian 2016). 
In the presence of increased glucose and insulin, the heart favours glucose as its preferred 
substrate, whereas metabolism of the diabetic heart is characterised by a decrease in 
glucose uptake and oxidation (Bertrand et al. 2008). Long chain fatty acid uptake and 
oxidation is enhanced, albeit not sufficiently, to prevent the accumulation of lipids and 
consequent lipotoxicity. It has been suggested that this can lead to the development of 
myocardial insulin resistance, although the underlying mechanisms are still poorly 
understood (Bertrand et al. 2008). Concomitant with the above, insulin resistance is 
characterised by alterations of the insulin-induced activation of PI-3K/Akt signalling pathway 
(Ouwens et al. 2007; Huisamen 2003) whereas the translocation of insulin-activated Akt to 
mitochondria in cardiac muscle may have important implications on myocardial 
bioenergetics (Yang et al. 2009). Biguanides, such as metformin, activate AMPK that can 
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stimulate glucose uptake in insulin-resistant cardiomyocytes through the stimulation of Akt 
phosphorylation in a PI-3K dependent manner (Bertrand et al. 2006). Furthermore, 
metformin is known to delay the development of diabetes and cardiovascular dysfunction in 
Goto-Kakizaki rats by inhibiting the generation of superoxide in the mitochondria (Rösen & 
Wiernsperger 2006). The combined effect of decreased myocardial insulin signalling, which 
promotes oxidative stress and mitochondrial uncoupling, as well as reduced flux through the 
TCA cycle and decreased fatty acid oxidation, all impairs mitochondrial energetics (Boudina 
et al. 2009).  
Under physiological conditions, mitochondrial oxygen consumption is tightly coupled with 
ATP synthesis (Bugger & Abel 2008). Briefly, substrate oxidation produces the reducing 
equivalents, NADH and FADH2 that donate electrons to the ETC. The electron transfer to 
oxygen atoms results in energy that generates an electrochemical gradient by pumping 
protons across the IMM into the intermitochondrial membrane space. These protons re-
enter the matrix through Complex V (F1F0 ATPase) which uses energy to regenerate ATP 
from ADP, and is known as coupling of oxidative phosphorylation. A small proportion of the 
protons can bypass the F1F0 ATPase, which results in increased oxygen usage without 
concomitant ATP production and is known as mitochondrial uncoupling. In mice hearts 
lacking the uncoupling protein, UCP3, mitochondria are more coupled, although ROS 
production is increased which suggests that mitochondrial uncoupling can facilitate a 
reduction in oxidative stress (Vidal-Puig et al. 2000). UCP3 does not seem to be required for 
fatty acid oxidation (Vidal-Puig et al. 2000), but rather stimulates glucose transport and 
GLUT4 translocation to the cell surface in cardiac cells by activating the PI-3K/Akt dependent 
pathway (Huppertz et al. 2001). The protective role of UCP3 with regards to oxidative stress 
is especially relevant in a high fat diet, and seems to protect mitochondria against lipid 
induced mitochondrial dysfunction, although only after long-term exposure to high fat 
conditions (Nabben et al. 2011).  
Insulin can also affect mitochondrial dynamics in cardiomyocytes, and was shown to 
increase Opa1 (mitochondrial dynamin like GTPase) protein levels which increased 
mitochondrial fusion as well as membrane potential whilst elevating both oxygen 
consumption and ATP production (Parra et al. 2014). Mitochondrial fusion is also crucial for 
the maintenance of mitochondrial morphology as well as for cardiac respiration (Chen et al. 
Stellenbosch University  https://scholar.sun.ac.za
 
 
102 
 
2011). Interestingly, a recent study showed that mice lacking the mitophagy mediating 
protein, FUNDC1, were protected against high fat diet induced obesity, had improved insulin 
sensitivity and glucose tolerance, but presented with decreased mitochondrial energetics 
(Fu et al. 2018). The authors suggest that FUNDC1 plays a crucial role in maintaining 
mitochondrial quality control that is required for the regulation of cellular metabolism. 
Moreover, the autophagic protein BNIP3 reduces oxidative phosphorylation and ATP 
synthesis, possibly through the promotion of ETC protein degradation in the mitochondria, 
without triggering apoptosis (Thomas et al. 2011).  In a study in humans and mice, it was 
found that a HFD alone is sufficient to downregulate the genes required for the oxidative 
phosphorylation ETC proteins as well as mitochondrial biogenesis (Sparks et al. 2005). 
Collectively, this suggests that insulin and mitochondrial dynamics are important for 
myocardial energy metabolism (Westermeier  et al. 2015).  
ATM has been implicated in mitophagy (Qi et al. 2016), is required for insulin-mediated 
activation of Akt (Halaby et al. 2008), and has been implicated in the pathogenesis of 
metabolic syndrome that can be alleviated through chloroquine-mediated activation of ATM 
(Halaby et al. 2013; Razani et al. 2010; Schneider et al. 2006). The silencing or absence of 
ATM also results in decreased mitochondrial respiration (Ambrose et al. 2007; Zakikhani et 
al. 2012), decreased mitochondrial membrane potential and ATP synthesis (Ambrose et al. 
2007; Valentin-Vega et al. 2012) as well as in a down regulation of Complex I (Valentin-Vega 
et al. 2012). This suggests a potential role for ATM in oxidative phosphorylation and 
mitochondrial energetics in obesity and insulin resistance. 
In view of this study’s finding that ATM is located on the inner mitochondrial membrane of 
cardiac mitochondria (Chapter 4), this study  further aimed to determine whether acute ex 
vivo inhibition of ATM with the ATM specific inhibitor, KU60019, influences mitochondrial 
oxidative phosphorylation in a high fat diet induced obese model of male Wistar rats in 
either the presence or absence of the ATM activators, insulin and chloroquine. 
5.1 Materials and Methods: 
 
Hearts were isolated from young, control male Wistar rats and perfused ex vivo with either 
0.03% DMSO (vehicle, n=5) or 3 µM KU60019 (n=5). Isolated subsarcolemmal mitochondria 
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from the perfused hearts were used to determine mitochondrial oxygen consumption with a 
Clarke-type oxygraph in either a glutamate-malate buffer that assesses the malate-aspartate 
shuttle and NADH oxidation by Complex I, or a palmitoyl-L-carnitine-malate buffer that 
assesses β-oxidation. This study was extended to include 45 high fat fed diet induced obese 
(DIO) male Wistar rats and their chow fed age matched counterparts (AMC, n=42). Hearts 
from these animals were perfused with 0.3 IU/l insulin or 30 µM chloroquine in the 
presence of absence of 3µM KU60019. Each perfused heart was divided in two; one half was 
used for the isolation of mitochondria, and the other heart half was prepared for western 
blotting purposes (Fig 5.1). 
5.1.2 Reagents: 
 
Chloroquine diphosphate salt (C6628) and KU60019 (SML1416) was purchased from Sigma-
Aldrich Merck. HumulinR (100 U/ml, Eli Lilly and Company) was purchased commercially on 
prescription. Sodium pentobarbitone (Eutha-naze) was obtained from Bayer. Western blot 
reagents were purchased from BioRad (Lasec, South Africa), except for 
SignalBoost™Immunoreaction Enhancer Kit (EMD Millipore-Merck), and the Immobilon®-P 
PVDF membrane (EMD Millipore-Merck). The antibodies were purchased from Cell Signaling 
Technologies (USA) and Abcam as indicated in Table 5.2. All other reagents were purchased 
as indicated previously.  
5.1.3 Animals: 
 
All the procedures involving animals were in compliance with the South African National 
Standard for the care and use of animals for scientific purposes (SANS 10386:2008); the 
Medical Research Council Guidelines on Ethics for Medical Research; Book 3: Use of Animals 
in Research and Training and the National Institutes of Health Office of Laboratory Welfare: 
The Guide for the Care and Use of Laboratory Animals, 8th Edition; USA, and was approved 
by the Research Ethics Committee: Animal care and Use, Stellenbosch University, South 
Africa (approval numbers SU-ACUM12-0040; SU-ACUD16-00179). 
Male Wistar rats (weighing approximately 250 grams and 12 weeks of age) were housed at 
the Central Research Facility (Stellenbosch University) in a temperature controlled (~23°C) 
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environment with a 12-hour light/dark cycle and fed normal rat chow (n=10). For the DIO 
rats, the animals at 8 weeks of age were either continued on normal rat chow (n=50), or 
placed on a hyperphagic diet (Salie et al. 2014) (n=50) for a period of 16 weeks (Table 5.1). 
The animals were injected with Eutha-naze (200 mg/kg via intraperitoneal injection) 
performed by a registered animal laboratory technologist, South African Veterinary  Council, 
SAVC number: AL16/15486), and euthanised through exsanguination after rapid excision of 
the heart. The hearts were arrested in Krebs-Henseleit buffer (KHB; 119 NaCl mM, 24.9 mM 
NaHCO3, 4.7mM  KCl, 1.2 mM KH2PO4, 0.6 mM MgSO4·7H2O, 0.59 mM Na2SO4, 1.25 mM 
CaCl2·12H2O and 10 mM glucose; pH 7.4). 
After anaesthetizing the animals, they were weighed and non-fasting blood glucose was 
measured by means of a tail prick and glucometer. Visceral (perirenal and perigonadal) fat 
deposits were removed and weighed post-exsanguination. The adiposity index was 
calculated as the ratio of visceral fat mass to total body mass (visceral fat/total bodymass) 
and expressed as percentage (Leopoldo et al. 2016; Jeyakumar et al. 2009; Pawlak et al. 
2004). 
Table 5.1: Compositions of the control chow diet compared to the diet induced obesity (DIO) diet: 
 Fat 
(g/100 
g) 
Protein 
(%) 
CHO 
(%) 
Sugar 
(g/100 
g) 
Energy 
(kJ/100g) 
Rat chow 4.8 17.1 34.6 6.6 1272 
DIO 11.5 8.3 42.0 24.4 1354 
CHO: carbohydrates; DIO: diet induced obesity 
5.1.4 Langendorff perfusions (for mitochondrial analysis): 
 
Excised hearts (n=10  young controls  {12 weeks old}, n=50 for chow fed AMC DIO, n=50 
DIO) were cannulated via the aorta and perfused with retrogradely in Langendorff mode 
with Krebs-Henseleit buffer at a constant pressure of 100 cm H2O. Hearts were stabilized for 
20 minutes, after which they were perfused in a recirculating manner with KHB containing 3 
μM KU60019 (n=5) or an equal volume DMSO (0.03 %; n=5) for the 12-week old control rats. 
The chow fed age matched controls and DIO rat hearts were perfused in the same manner, 
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and the experimental protocols are shown schematically in Fig. 5.1. Protein determination 
for the mitochondrial data was performed with a Lowry assay (Lowry et al. 1951). 
 
Figure 5.1: Experimental design layout for oxidative phosphorylation analysis in the presence and 
absence of the ATM activators, insulin and chloroquine with or without the ATM inhibitor, 
KU60019. Male Wistar rat hearts were perfused with the treatments indicated for both the 
chow-fed and DIO diets. After perfusion, the hearts were cut in half, of which one half was 
used for mitochondrial preparation in an isotonic solution for oxidative phosphorylation 
analysis with glutamate+malate or palmitoyl-L-carnitine+malate substrate. Mitochondria 
were prepared form the other half in precisely the same manner with the exception that 
the final mitochondrial pellet was lysed in a lysis buffer for western blotting purposes. 
5.1.5 Oxygen consumption in isolated mitochondria: 
 
Mitochondrial oxygen consumption was analysed with a Clarke-type oxygraph (Oxytherm 
system, Hansatech Instruments) immediately following isolation. Briefly, two chambers 
containing a glutamate or palmitoyl-L-carnitine assay buffer (250 mM sucrose, 10 mM TRIS-
HCl (pH 7.4), 8.5 mM K2HPO4-3H2O, 2 mM malate and 5 mM glutamate or 0.45 mM 
palmitoyl-L-carnitine; pH 7.4), equilibrated to ambient oxygen levels at 25°C, were analysed 
in parallel.  Data were captured with HansaTechPlus software.  Oxygen consumption prior to 
the addition of ADP (State 2), oxygen consumption in the presence of ADP (State 3), oxygen 
consumption after complete utilization of ADP (State 4) and State 3 oxygen consumption 
after 20 minutes anoxia followed by reoxygenation were noted. These values were used to 
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calculate the oxygen consumption (nano atoms O/min/mg mitochondrial protein), oxidative 
phosphorylation rate (nmol ATP/min/mg mitochondrial protein), respiratory control index 
(RCR, State 3/state 4), and the ADP/O ratio (number of ADP molecules for each oxygen atom 
consumed and is an index of the efficiency of oxidative phosphorylation) . 
The rate of oxygen consumption over time as a function of substrate oxidation in the 
presence of saturating ADP concentrations was interpreted as the oxidative phosphorylation 
capacity of mitochondria and is widely used as a measure of mitochondrial function. It 
should be noted that many studies are performed in isolated mitochondria which in itself 
has the advantage of well-established protocols and easy-to interpret results that can be 
normalised to protein content or Cytochrome c, but has the disadvantage of lacking cellular 
context, is prone to damage and often requires large amounts of tissues (Brand & Nicholls 
2011). Intact cells offer cell-specific context but cannot easily be manipulated chemically 
and are often not quantitative (Brand & Nicholls 2011). That being said, isolated 
mitochondria are widely used to assess mitochondrial dysfunction in heart failure, ischaemia 
and reperfusion (Chen et al. 2008; Lesnefsky et al. 2001), as well as in obesity and diabetes, 
which also give insight into oxidative stress   
5.1.6 Western blotting:  
 
Briefly, the mitochondrial lysates were prepared for western blotting with the addition of 
one volume 1 X lysis buffer (20 mM TRIS-HCl (pH 7.5), 1 mM EGTA, 1 mM EDTA, 150 mM 
NaCl, 1 mM β-glycerophospate, 2.5 mM tetra sodium pyrophosphate, 10 mM sodium 
orthovanadate, 1% Triton X-100, 10 μg / mL leupeptin, 10 μg / mL aprotinin and 50 μg / mL 
PMSF). Zirconium oxide beads (0.5 mm, Next Advance, Biocom Biotech) were added to the  
mitochondrial lysates, where after the mitochondria were further lysed in a Bullet blender 
(Next Advance laboratory equipment) at 4 000 revolutions per minute (rpm) making use of 
three cycles at 4°C for 1 minute with a 5 minute resting period in between. The lysates were 
rested on ice for 20 minutes prior to centrifugation at 12074 x g for 10 min at 4°C. The 
supernatants were carefully removed and placed in a new set of 1.5 ml Eppendorf tubes. 
Protein concentration was determined with a Bradford protein assay (Bradford 1976).  
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Mitochondrial lysates were prepared to a total volume of 15 μl containing up to 50 μg 
protein in lysis buffer (2 volumes) to one volume 3 X Laemmli sample buffer (2.5 M glycerol, 
0.189 M TRIS-HCl (pH 6.8), 10% SDS, 1.275 mM bromophenol blue, 15% β- 
mercaptoethanol).The samples were boiled for four minutes and stored at -80° Celsius until 
use, with the exception of the samples used for the mitochondrial oxphos antibody kit 
(Abcam) that were not boiled at all. Samples were boiled again for 4 minutes prior to being 
loaded on 4–20% Criterion® TGX™ Stain free Precast Protein Gels (Bio-Rad Laboratories), 
and subjected to electrophoresis for 1 hour at 200 V and 200 mA. Due to major size 
differences in the proteins investigated, a modified transfer buffer was used (25 mM TRIS, 
190 mM glycine and 10% methanol v/v), and the gels were allowed to rest for 30 minutes in 
the buffer prior to activation in the ChemiDoc MP system (Bio-Rad Laboratories), whereafter 
proteins were transferred. Transfer was performed at 200 V and 200 mA for 1 hour 30 
minutes at 4° C onto an Immobilon®-P PVDF membrane (EMD Millipore). The membranes 
were briefly placed in methanol, and allowed to dry before blocking in a 5% liquid fat-free 
milk solution. Membranes were washed in TBS-T (20 mM TRIS-HCl (pH 7.6), 137 mM NaCl, 
0.1% Tween-20) for 3 x 5 minutes. The antibodies used during this experiment are listed in 
Table 5.1. After primary and secondary antibody (donkey anti-rabbit secondary antibody; 
HRP-linked secondary antibody #7074, CST) incubation, the membranes were treated with 
Clarity™Western ECL Blotting Substrate and visualised on the Chemidoc MP system on the 
Chemi Hi sensitivity setting, which was stopped prior to overexposure (which appears red 
on program settings). The secondary antibody that was used against the Total oxphos 
rodent antibody cocktail was Anti-mouse IgG, HRP-linked Antibody #7076 (1:4000 dilution). 
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Table 5.2: : Summary of antibodies used to investigate ATM protein levels, oxidative 
phosphorylation, mitophagy and autophagy: 
Protein 
antibody 
Size Dilution and 
dilutant 
Species 
origin 
Supplier Product 
code 
Total 
OXPHOS 
Rodent WB 
Antibody 
Cocktail 
CI subunit NDUFB8-
20 kDa 
CII-30kDa 
CIII-Core protein 2-
48 kDA 
CIV subunit I-40 kDa 
CV alpha subunit-55 
kDa 
1:1000 TBS-T Mouse Abcam (ab110413) 
ATM 350 kDa 1:1000 in Primary 
SignalBoost™Immu
no-reaction 
Enhancer Kit 
Rabbit CST (D2E2) 
#2873 
Phospho-
ATM 
(Ser1981) 
350 kDa 1: 1000 Primary 
SignalBoost™Immu
no-reaction 
Enhancer Kit 
Rabbit CST (D25E5) 
#13050 
PINK 50, 60 kDa 1: 1000 in TBS:T Rabbit CST (D8G3) 
#6946 
Parkin 52 kDa 1:1000 in TBS-
T+2.5% milk 
Rabbit Abcam (ab233434) 
Drp1 78-82 kDa 1:1000 in TBS-T Rabbit CST (D6C7) 
#8570 
LC3 14, 16 kDa 1:1000 TBS-T Rabbit CST #4108 
UCP3 30 kDa 1:1000 in TBS-T Rabbit CST (D6J8K) 
#97000 
TOM70 70 kDa 1:1000 in TBS-T Rabbit Abcam (ab83841) 
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5.1.7 Statistical analysis: 
 
The data was analysed using GraphPad Prism 6.0 software (GraphPad Software, Inc., La 
Jolla, CA). Statistical comparisons were made using a two-tailed Student’s t-test or 2-way 
analysis of variance (ANOVA) followed by a Bonferroni post-hoc test where applicable. All 
values and error bars are presented as mean ± s.d., and the level of significance was set at p 
< 0.05. 
5.2 Results and discussion: 
 
5.2.1 Inhibition of ATM decreases Complex I-mediated oxidative phosphorylation  
 
A small but significant reduction in mitochondrial respiration rates has previously been 
reported in ATM-deficient lymphoblastoid cells with a rezasurin assay (Ambrose et al. 2007). 
In view of the observed consistent association between ATM and the IMM of cardiac 
mitochondria (Chapter 4), this study investigated the effect of acute ATM inhibition on 
oxidative phosphorylation in isolated hearts obtained from 12-week old male Wistar rats 
(n=10; 295.7 ± 17.45 g). The hearts were stabilised and subjected to retrograde Langendorff 
perfusion with either DMSO (0.03%, dimethyl sulphoxide, n=5) or 3 µM KU60019 (ATM-
specific inhibitor dissolved in DMSO, n=5) for 20 minutes prior to mitochondrial isolation in 
KE buffer.  
The RCR did not differ significantly between mitochondria from DMSO and KU60019 
perfused hearts (Figure 5.2). The substrates glutamate and malate, are utilised to 
investigate the mitochondrial aspartate shuttle that produces NADH which is oxidized by 
complex I (NADH dehydrogenase) of the electron transfer chain (ETC) to NAD+ (Rosca et al. 
2008). Oxidation of NADH donates an electron to complex I, which is used for ATP 
production.  
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Figure 5.2: Inhibition of ATM decreases Complex I mediated oxidative phosphorylation rate.  Male 
Wistar rat hearts were perfused with either DMSO (n=5) or KU60019 (n=5) and oxidative 
phosphorylation was determined polarographically. Panel a) shows the RCR values and panel b) 
ADP/O values. Both the active respiratory rate (State 3, panel c) and resting respiratory rate (State 
2 and 4, panel c and d) were measured, and used to determine the oxidative phosphorylation rate 
(normalised to total protein) as shown in panel e. Values correspond to 10 individual experiments 
(0.03% DMSO control, n=5; KU60019, n=5), and error bars are presented as mean ± standard 
deviation.* p<0.05, **p<0.005. 
The ADP/O ratio indicates the number of ADP molecules for each oxygen atom consumed 
and is an index of the efficiency of oxidative phosphorylation (Fig 5.2, panel b). This ratio 
differed significantly (p= 0.0298, Bonferroni post-hoc test) for the complex I-mediated 
reduction of the NADH-linked substrates, GM, in KU60019-perfused hearts compared to 
controls. This resulted in a significant reduction (p=0.0024, Bonferroni post-hoc test) in the 
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oxidative phosphorylation rate (ATP/min/mg mitochondrial protein) in GM, but not in the 
PCM respiratory buffer (Fig 5.2, panel e). 
Interestingly, the changes observed with GM as substrate were not seen in PCM as 
substrate. Interestingly, western blot showed that ATM protein levels were decreased in the 
mitochondria isolated from hearts perfused with 3 µM KU60019 compared to hearts 
perfused with DMSO alone, albeit not significantly (p=0.2859, two-tailed Student’s t-test, Fig 
5.3), which agrees with the suggestion by (Patel et al. 2011) that acute incubation results in 
post-transcriptional changes induced by inhibition rather than transcriptional changes. The 
ATM inhibitor, KU60019 will decrease the kinase activity of the protein without necessarily 
changing its expression levels. 
 
Figure 5.3: Western blot analysis of total ATM in hearts perfused retrogradely with either 0.03% 
DMSO or 3 µM KU60019.  The total ATM protein level in mitochondrial lysates obtained from 
hearts perfused with either DMSO or KU60019 is shown and was normalised to the total protein 
membrane shown.  
Palmitoyl-L-carnitine is imported into the mitochondrial matrix where it undergoes β-
oxidation and produces Co-enzyme A (CoA), NADH and FADH2 (flavin adenine dinucleotide).  
NADH  transfers electrons to the ETC at complex I, whilst FADH2 transfers electrons to the 
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ETC at complex II, which are the main source of ATP production in a healthy heart (Rosca & 
Hoppel 2010). As the glutamate-malate substrate assesses the aspartate-malate shuttle that 
produces NADH that provides electrons to complex I, our results suggest that the inhibition 
of ATM has a larger effect on complex I mediated NADH oxidation than FADH2 oxidation at 
Complex II. Concomitantly, Atm-deficient murine thymocytes also exhibited a decrease in 
complex I enzyme activity and reduced ATP synthesis, but an increase in oxygen respiration 
was detected, which has been suggested to be context specific with regards to the cell-type 
(Valentin-Vega et al. 2012).  For example, heterozygous ATM+/- mice hearts do not show any 
reduction in Complex I activity (Mercer et al. 2010). However, when investigating the effect 
of KU60019 on the subunits of the mitochondrial oxidative phosphorylation complex listed 
in Table 5.2, the present study found that all of the complexes were reduced after 20 
minutes of acute ex vivo perfusion with significant effect of the inhibitor between 
mitochondria prepared from DMSO-perfused and KU60019 perfused hearts (p=0.0136, 2-
Way ANOVA) but no significant differences were found between the individual complexes 
with a Bonferroni post-hoc test (Fig 5.4). Of the five subunits investigated all but one, are 
nuclear encoded, which supports the notion of a post-transcriptional rather than 
transcriptional response. 
The underlying mechanism for ATM in this context, still remains unknown. Patel et al. (2011) 
showed that Complex IV is significantly decreased in the extensor digitorum longus muscles 
of mice after 1 hour of incubation with KU55933, and suggests a post-transcriptional role for 
ATM in oxidative phosphorylation. Moreover, the inhibition of Complex IV is known to 
increase ROS production and electron leak at Complex I or III by reducing the redox centres 
of these complexes (Chen et al. 2003). 
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Figure 5.4: OXPHOS complex analysis of cardiac mitochondria.  Mitochondria, obtained from male, 
Wistar rat hearts that were perfused ex vivo with either 0.03% DMSO (n=4) or 3 µM KU60019 
(n=4), exhibited decreased electron transfer chain complexes. The positive control (+) was 
supplied with the Abcam Total OXPHOS Rodent WB Antibody Cocktail. The KU60019 complexes 
were normalised to their controls. 
Whether KU60019 inhibits complex IV, which then decreases the redox centre of Complex I 
of the ETC, or whether the loss of ATM reduces all of the complexes, thereby exacerbating 
oxidative stress, is still unknown. It should be noted that the differences in complex 
reduction was small, and the role of ATM in this regard requires further investigation. 
5.2.2 The role of ATM in obesity and cardiac oxidative phosphorylation in isolated 
mitochondria 
 
Previous studies have shown that oxygen usage increases in high fat fed mice whilst 
decreasing cardiac efficiency, and was associated with increased mitochondrial uncoupling 
due to elevated UCP3 expression (Cole et al. 2011). Moreover, the Complex I-linked 
substrates, glutamate and malate, but not Complex II-linked substrates 
(succinate/rotenone) reduced respiration significantly in the muscle fibres of mice fed a high 
fat high sugar diet compared to mice fed standard chow (Bonnard et al. 2008). On the other 
hand, mitochondrial uncoupling was mediated by the activation UCPs in db/db mice, which 
was suggested to be due to increased delivery of reducing equivalents from β-oxidation to 
the ETC, and coupled with decreased oxidative phosphorylation capacity, increases ROS 
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production and lipid peroxidation and consequently drives uncoupling (Boudina et al. 2007). 
In view of the association between obesity and mitochondrial dysfunction (reviewed by 
Bhatti et al. 2017), as well as the potential role of ATM in obesity and insulin signalling, the 
current study evaluated the role of ATM in cardiac oxidative phosphorylation in DIO and 
their age-matched control chow fed male Wistar rats.  
 
Figure 5.5 Weight, adiposity index and non-fasting blood glucose of diet-induced obese (DIO) male 
Wistar rats and their age-matched counterparts (AMC).  Total body weight (left panel), adiposity 
index (middle panel) and non-fasting blood glucose (right panel) was determined for each of the 
AMC (n=50) and DIO rats (n=50) Significance was determined with a Student’s t-test, mean ± s.d.).  
This study investigated the role of ATM in oxidative phosphorylation of cardiac 
mitochondria obtained from a diet induced obese Wistar rat model. After 6 weeks of being 
fed a hyperphagic obesity inducing diet, the DIO-fed rats gained significantly more weight 
than their chow fed AMC (389.6 ± 38.75 g compared to 348.2 ± 42.33 g, p<0.0001, two-
tailed Student’s t-test). The adiposity index was significantly higher (p<0.0001) in DIO (5.479 
± 1.128%) than the chow-fed AMC group (3.255 ± 1.296%), whereas no difference 
(p=0.1534) was observed for non-fasting glucose values (nmol/l) between the DIO (8.088 ± 
1.083) and chow fed AMC (8.461 ± 1.472) groups (Figure 5.5). These rats represent a much 
larger cohort of male, Wistar rats that were fed with  normal rat chow or a DIO diet for 66 
weeks from the age of 8 weeks, and were tested for insulin resistance with an oral glucose 
tolerance test, as well as homeostatic model assessment (HOMA) for insulin resistance (IR). 
These results were not generated within this study, and are thus not reported here but it is 
accepted that the rats used during this study were insulin resistant (Addendum C). 
Unlike Boudina et al. (2007), the present study showed that ADP-stimulated oxygen 
consumption (State 3) as well as in the oxidative phosphorylation rate of mitochondria in 
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DIO hearts did not reduce significantly when compared with mitochondria from chow-fed 
AMC hearts regardless of the substrate present (Table 5.3). The model used by Boudina et 
al. (2007) is a well characterised mouse model of obesity and severe T2D (db/db mice), 
whereas the present study used a diet-induced, pre-diabetic obese rat model. Moreover, a 
study that investigated mitochondrial dysfunction in T2D patients compared to non-diabetic 
obese controls showed a significant reduction in subsarcolemmal mitochondrial ETC activity 
of T2D patients compared to obese controls (Ritov et al. 2005). They did however also 
notice a significant reduction in ETC activity in obese patients compared to lean controls. It 
is possible that the diet-induced obesity model used in the present study was not sufficient 
to mediate mitochondrial dysfunction, or it might merely be that the n-values used were too 
small to detect significant differences. 
Table 5.3: Comparison of State 3 and State 4 (nano atoms O/min/mg protein) and oxidative 
phosphorylation rate (nmols ATP/mg mitochondrial protein/min) between chow-fed age-matched 
control and DIO animals: 
 Glutamate + malate Palmitoyl-L-carnitine + malate 
 Control (n=4) DIO (n=7) Control (n=4) DIO (n=7) 
State 3 219.70 ± 88.21 168.05 ± 50.41 246.05 ± 112.89 176.20 ± 33.35 
State 4 33.54 ± 15.24 35.56 ± 16.92 36.74 ± 18.58 29.70 ± 3.94 
Oxphos rate 525.68 ± 154.55 416.83 ± 143.45 634.39 ± 156.54 430.63 ± 130.76 
 
Irrespective of diet, when evaluating the effects of inhibition of ATM in these hearts, a 
significant effect (p=0.0351) was detected with a 2-way ANOVA in State 3 respiration 
between KU60019-treated hearts and DMSO-perfused hearts (Fig 5.6). Likewise, KU60019 
had a significant effect on the oxidative phosphorylation rate (p=0.0014) using a 2-way 
ANOVA analysis, but no specific differences were observed with a Bonferroni post-hoc test 
(Fig 5.6). This implies that the inhibition of ATM has a direct effect on oxygen consumption 
and ATP synthesis in rat heart mitochondria from both diet groups, and agrees with the 
observation in the young control cardiac mitochondria (Fig 5.2), although no differences 
were noted in the ADP/O ratio in GM substrate as was seen previously in mitochondria 
obtained from young, control rats with the chemical inhibition of ATM. 
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This could imply that the decrease in ATP synthesis (oxidative phosphorylation rate) were 
not due to uncoupling which is typically associated with increased oxygen consumption 
(reviewed by Bugger & Abel 2008), but rather decreased ETC efficiency. Interestingly, 
coupling efficiency (ADP/O) ratio is suggested to be a poor reporter of mitochondrial 
dysfunction (Brand & Nicholls 2011). It should be noted that ADP/O values (Fig 5.6a) were 
decreased in isolated mitochondria from KU60019-perfused hearts in AMC (2.03 ± 0.13, 
n=5, compared to 2.46 ± 0.23 DMSO-perfused, n=5) and DIO (2.03 ± 0.26 compared to 2.26 
± 0.47 DMSO perfused) in the GM substrate. Using PCM as substrate, the ADP/O ratio was 
decreased in mitochondria from AMC rat hearts perfused with KU60019 (1.93 ± 0.35) 
compared to DMSO-perfused mitochondria (2.12 ± 0.22), but was increased in DIO perfused 
with KU60019 (2.34 ± 0.35) compared to DMSO-perfused mitochondria. None of these 
differences were significant, and could again reflect the low n-values, or possibly reflect a 
change in substrate oxidation rather than a change to the ETC machinery, although the 
latter is probably unlikely in light of the finding that the ETC complexes were reduced overall 
(Fig. 5.4). 
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Figure 5.6: Inhibition of ATM decreased basal levels of State 3 oxygen consumption and oxidative 
phosphorylation rate. Male Wistar rat hearts from the AMC and DIO rats were perfused with 
either DMSO (n=4/group; green) or KU60019 (n=5/group; blue) and oxidative phosphorylation was 
determined polarographically in GM and PCM substrates. Panel a shows the RCR values and panel 
b) ADP/O values. Both the active respiratory rate (State 3, panel c) and resting respiratory rate 
(State 4, panel d) were measured, and used to determine the oxidative phosphorylation rate 
(normalised to total protein) as shown in panel e. Recovery of State 3 respiration after 20 minutes 
of anoxia is shown in panel f.  
 
The respiratory control index (Fig 5.6b) was similar for both KU60019 and DMSO-perfused 
AMC and DIO hearts, which suggests that KU60019 did not influence mitochondrial capacity 
for oxidative efficiency, nor exhibit excessive proton leak. No difference was observed after 
20 minutes of anoxia in either substrate or diet, and was not influenced by KU60019 
perfusion (Fig 5.6f). 
In summary, the inhibition of ATM in hearts from young control rats resulted in a significant 
decrease in ADP/O and oxidative phosphorylation rate in GM, but not PCM substrates. The 
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inhibition of ATM did not alter the total ATM levels (and activity of ATM was not 
determined), and had a small effect on the mitochondrial ETC complexes. Significant 
increases were observed in both weight and adiposity index in the DIO-fed rats compared to 
the chow-fed AMC rats, but no differences were observed with regards to State 3, State 4 
respiration or the oxidative phosphorylation between these two groups. Inhibition of ATM 
decreased State 3 respiration overall, as well as oxidative phosphorylation, but no 
differences were observed between the chow-fed AMC group or DIO group, irrespective of 
the substrate used. 
5.2.3 Insulin improves oxidative phosphorylation and protects against anoxia 
 
Insulin is an important regulator of mitochondrial oxidative phosphorylation; it increases 
mitochondrial protein transcription in vastus lateralis muscle biopsies from healthy controls, 
whilst T2D patients have a reduced capacity to improve ATP production in response to high 
insulin levels (Stump et al. 2003). As early as 1960, Hall et al. (1960) showed that insulin 
improves oxygen consumption and ATP production in isolated liver mitochondria obtained 
from diabetic rats similar to levels found in normal control animals, and suggested that a 
small amount of endogenous insulin is sufficient to maintain mitochondria. It has been 
suggested that insulin specifically affects the succinate carbons that are metabolised in the 
mitochondrial TCA cycle (Bessman et al. 1986). Moreover, ATM is activated by insulin and is 
required for the activation of Akt in response to insulin treatment (Halaby et al. 2008). Thus, 
we aimed to determine whether (i) insulin improves oxidative phosphorylation in the DIO 
model used in this study and (ii) inhibition of ATM interferes with the action of insulin, by 
evaluating mitochondrial oxidative phosphorylation after ex vivo perfusion with 100 nM 
insulin (HumulinR) or 100 nM insulin + 3 µM KU60019 with both GM and PCM substrates.  
Mitochondria from the insulin perfused chow-fed AMC and DIO hearts were first compared 
to mitochondria from DMSO-perfused chow-fed and DIO hearts.  Insulin perfusion improved 
State 3 respiration (p=0.0028) and ATP synthesis (p=0.01) overall, irrespective of chow-fed 
(n=9) or DIO (n=9) diet, or substrate used (2-way ANOVA, Bonferroni post-hoc test, bars 
presented as mean ± s.d.) when compared to mitochondria from DMSO-perfused hearts, as 
shown in Fig. 5.7. Interestingly, the RCR was improved significantly in cardiac mitochondria 
from both control and DIO insulin-perfused hearts (p<0.001) in a GM, but not so in the PCM 
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substrate, when compared to mitochondria from DMSO perfused AMC and DIO hearts. This 
was reflected by the significant increase in State 4 respiration (p<0.0036) in Fig 5.7, which 
indicates a proton leak in the PCM substrate in cardiac mitochondria from both AMC and 
DIO animals.  
 
Figure 5.7: Insulin significantly improves basal levels of State 3 oxygen consumption, oxidative 
phosphorylation rate in both a carbohydrate and fatty acid substrate. Hearts from both the chow-
fed AMC and DIO group were perfused with either DMSO or 100 nM insulin, and ADP/O (panel a), 
RCR (panel b), State 3 (panel c) and State 4 (panel d) respiration, as well as the ATP synthesis rate 
(panel e) and percentage recovery of State 3 respiration after 20 minutes of anoxia determined 
(panel f). * p<0.05; ** p<0.005, **** p<0.0001. 
These observations suggest that the positive effects of insulin on oxidative phosphorylation 
are mediated via the malate-aspartate shuttle and TCA cycle, and agree with the finding that 
insulin mediates its effects via succinate in the TCA  cycle (Bessman et al. 1986). The positive 
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effect with regards to RCR and recovery after anoxia is decreased when investigated in a 
PCM substrate. 
Palmitoyl-L-carnitine enters the mitochondria independently of CPT1 (carnitine 
palmitoyltransferase I) via CACT (carnitine acylcarnitine translocase) where it undergoes 
sequential β-oxidation to produce reducing equivalents (Rosca et al. 2012). Fatty acids are 
known to cause mitochondrial uncoupling but the mechanism is still controversial. It has 
been suggested that there might be two potential mechanisms,  the first being either in 
response to a high mitochondrial membrane potential that drives the negatively charged 
FFAs outwards (reviewed by Kadenbach 2003), and the second via the ADP/ATP antiporter 
(Goglia & Skulachev 2003). 
Kadenbach (2003) suggested that ROS can activate the uncoupling proteins, UCP1-3, in the 
presence of excess FFA, consequently increasing proton leak  and decreasing mitochondrial 
membrane potential in order to prevent further ROS production. On the other hand, 
Boudina et al. (2007) suggested that increased reducing equivalents often present in 
obesity, and coupled with a reduced ability to oxidise these equivalents, can drive 
mitochondrial ROS production, which will lead to uncoupling. Furthermore, mild uncoupling 
can be protective in the heart by lowering the oxidative phosphorylation and consequently 
reducing ROS production (Cadenas 2018). Mild uncoupling with the mitochondrial 
uncoupler arbonilcyanide p-triflouromethoxyphenylhydrazone (FCCP) improves post-
ischaemic recovery via a ROS-dependent pathway that does not result in a decrease of 
cellular ATP or potassium channel activation (Brennan et al. 2006).  
In view of the results that indicate that KU60019 decreases oxidative phosphorylation whilst 
insulin improves it when compared to controls, the present study compared mitochondria 
from chow-fed AMC and DIO hearts that were perfused with a combination of insulin and 
KU60019, to the groups previously discussed.  
When comparing isolated mitochondria from chow-fed AMC (n=8) and DIO hearts perfused 
with a combination of KU60019 and insulin (n=9), (Fig. 5.8) to the KU60019 and insulin 
perfused groups discussed previously, all the measured parameters were influenced. The 
combination of KU60019 and insulin significantly decreased the ADP/O ratio in mitochondria 
from perfused DIO hearts in the GM-substrate (p<0.05,) and the PCM substrate when 
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compared to KU60019 alone (p<0.05) as well as compared to insulin alone (p<0.005). The 
treatments contributed to an overall effect of p<0.0001 (all statistical analysis performed by 
2-way ANOVA, Bonferroni post-hoc test).  
 
Figure 5.8: The combination of KU60019 and insulin perfusion significantly influenced ADP/O, RCR, 
and recovery after anoxia in isolated mitochondria. Isolated mitochondria from chow-fed AMC 
and DIO hearts were compared with the groups perfused with either KU60019 or insulin alone. 
ADP/O values (panel a), RCR values (panel b), and State 3 respiration recovery after 20 minutes of 
anoxia (panel f) was significantly influenced. The combination of insulin and KU60019 did not 
influence State 3 (panel c) or State 4 (panel d) respiration or ATP synthesis. p<0.05. * p<0.05; ** 
p<0.005, **** p<0.0001. 
Interestingly, the combination treatment also resulted in a significant decrease (p<0.0001) 
in the RCI of mitochondria from chow-fed AMC hearts perfused with insulin alone in GM 
substrate. This suggests that any positive effects exerted by insulin through the malate–
aspartate shuttle is decreased by the addition of KU60019, and supports the hypothesis that 
ATM might mediate an effect on substrate utilisation through Complex I. No effect was seen 
with the combination treatment in either chow-fed or DIO cardiac mitochondria in the PCM 
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substrate, and again supports the hypothesis that the effect of ATM is mediated through 
carbohydrate metabolism rather than β-oxidation. Drug intervention had an overall effect 
(p<0.0001, 2-way ANOVA) however the only significance detected with the Bonferroni post-
hoc test was within the chow-fed controls in the GM-substrate, as mentioned already.  
Both State 3 (p=0.008) and State 4 (p=0.0148) respiration was increased with insulin and the 
combination of insulin and KU60019 (2-way ANOVA) when compared hearts perfused with 
KU60019 alone, but no specific differences could be detected with a Bonferroni post-hoc 
test. A slight decrease was observed in State 3 oxygen consumption and ATP synthesis with 
the combination treatment compared to insulin alone for mitochondria from chow-fed 
animals in the GM-substrate, and can potentially be due to the observed decrease in RCR, 
which seems to be mainly driven by the increase in state 4 respiration.  
Interestingly, the combination of insulin and KU60019 significantly improved recovery after 
anoxia for mitochondria from perfused hearts of chow-fed rats in GM substrate (p<0.005), 
as well as for DIO in a GM substrate (p<0.05) and PCM-substrate (p<0.05), whereas 
treatment contributed significantly to the effect observed (p<0.0001, 2-way ANOVA, 
Bonferroni post-hoc test). This would suggest that the positive effect observed in recovery 
after anoxia is mediated by insulin and not by inhibition of ATM. Furthermore, the inhibition 
of ATM improved recovery after anoxia in the PCM substrate both for mitochondria from 
chow-fed and DIO rats, which was not observed in mitochondria from hearts treated with 
insulin alone. However, the underlying mechanism for this is still unknown.  
A possible hypothesis for the significant increase in recovery observed after 20 minutes of 
anoxia in a PCM buffer could potentially be the partial inhibition of Complex I by KU60019 
that is improved by insulin. The inhibition of mitochondrial respiration is cardioprotective 
during ischaemia and reperfusion, and more specifically the inhibition of Complex I by either 
rotenone (Lesnefsky et al. 2004) or amobarbital (Chen et al. 2006). A previous study in our 
laboratory found that ATM inhibition improved cardiac function in control and high caloric 
fed rat hearts during early reperfusion but had no effect on cardiac function during later 
reperfusion (Espach 2017).  
However, the mechanism of the observed improvement by perfusion with insulin followed 
by mitochondria incubation in a PCM substrate is unknown. The inhibition of ATM alone is 
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insufficient to obtain increased recovery after anoxia. It might be that insulin provides 
protection against oxidative stress which is improved by the inhibition of ATM potentially 
through a Complex I mediated effect. Alternatively, activation of the PI-3K/Akt pathway 
might inhibit the translocation of Bax (a pro-apoptotic protein which is mainly localised in 
the cytosol), to the mitochondria, and can promote cell survival (Tsuruta et al. 2002). 
However, this will have to be investigated further in the context of ATM. 
Taken together, the mitochondrial ADP/O values of DIO rat hearts decreased significantly 
when perfused with a combination of insulin and KU60019 when compared to insulin-
perfused hearts, irrespective of the substrate used. Moreover, perfusion with this 
combination significantly decreased the RCI when compared with hearts perfused with 
insulin alone in a GM but not PCM substrate. However, this did not influence the improved 
State 3 recovery after anoxia that was previously observed with insulin perfusion; as a 
matter of fact the combination of insulin and KU60019 significantly improved recovery after 
anoxia in both diets and substrates used. 
5.2.4 Chloroquine improves recovery after anoxia that is further improved with the 
inhibition of ATM: 
 
Chloroquine modulates chromatin conformation changes without causing DNA damage 
(Bakkenist & Kastan 2003), and can thus act as a non-canonical activator of ATM (Cremona 
& Behrens 2014). ATM is consequently phosphorylated at Ser1981, allowing it to dissociate 
into monomers that bind with ATMIN (ATM interactor protein) and can phosphorylate, for 
example, p53. In the context of metabolic syndrome, low-dose chloroquine treatment 
improves glucose tolerance in an ATM dependent manner in an ATM+/+ ApoE-/-, db/db and 
ob/ob mouse models (Schneider et al. 2006). Chloroquine treatment also reduces the 
development of atherosclerosis in western diet fed (high fat) mice in a p53-mediated 
manner, but can improve glucose tolerance, insulin sensitivity and hepatic Akt signalling 
irrespective of p53 (Razani et al. 2010). Similarly, in a L6-muscle cell model, chloroquine 
improved insulin-stimulated Akt-phosphorylation and glucose uptake, as well as Akt activity 
in insulin resistant rats (Halaby et al. 2013).  
The metabolic effects of chloroquine also have clinical relevance as it increases insulin 
secretion, decreases insulin clearance, improves peripheral glucose uptake and decreases 
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dyslipidaemia in patients (Asamoah et al. 1990; Powrie et al. 1991; Powrie et al. 1993).  
Chloroquine is an acidotrophic, lysosomotropic agent that prevents endosomal acidification 
and consequently inhibits lysosome-autophagosome fusion and degradation (Shintani & 
Klionsky 2004), effectively protecting insulin against endosomal degradation (Bevan et al. 
1997). The drug increases cellular glucose uptake through the promotion of GLUT4 
trafficking to, and fusion with, the cellular plasma membrane by increasing cellular Ca2+ 
uptake (Zhou et al. 2016). However, on a cellular level, chloroquine treatment increase 
mitochondrial fragmentation and cristae destruction which is associated with increased 
oxidative stress and mitochondrial dysfunction (Chaanine et al. 2015). Similar results were 
noted in cortical neurons where chloroquine treatment significantly increased mitochondrial 
DNA damage, inhibited key mitochondrial functions and consequently, resulted in significant 
alterations in cellular metabolism (Redmann et al. 2017).  
Chloroquine is commonly used as an autophagy inhibitor in vivo and in vitro (Klionsky et al. 
2016). Chloroquine treatment worsened cardiac performance in Type 1 Diabetes, whilst 
hearts from db/db mice exhibited poorer diastolic function when compared to hearts 
obtained from either control or heterozygous db/+ mice (Kanamori et al. 2015). The latter 
study concluded that chloroquine decreased diastolic function in Type 2 Diabetes (T2D), and 
noted that this could be due to suppressed autophagy in the diabetic heart. 
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Figure 5.9: Mitochondria from chloroquine-perfused rat hearts show improved recovery after 
anoxia but also increased State 4 respiration.  Mitochondria from chloroquine perfused chow-fed 
AMC and DIO hearts were compared to DMSO-perfused chow-fed  and DIO hearts with regards to 
a) ADP/O ratio, b) RCR, c) Sate 3 respiration, d) State 4 respiration, e) ATP synthesis and f) 
Recovery after anoxia. p<0.05. ** p<0.005. 
The present study observed significantly improved recovery after anoxia (p=0.0004) in 
response to chloroquine treatment, and specifically in mitochondria from DIO chloroquine 
perfused hearts (n=8) in a GM substrate (Fig 5.9; p<0.005, 2-way ANOVA, Bonferroni post-
hoc test). However, State 4 respiration increased significantly overall upon treatment 
compared to control DMSO perfused cardiac mitochondria (p=0.0096, 2-way ANOVA, 
Bonferroni post-hoc test), and although not reflected in the ADP/O values, would suggest 
uncoupling (Fig 5.9).  
In primary neurons, chloroquine has been shown to decrease mitochondrial enzymes both 
within the ETC and TCA cycle as a secondary effect of autophagy, which consequently 
resulted in decreased mitochondrial quality (Redmann et al. 2017). In this study, 
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chloroquine did not affect either the ADP/O ratios or RCR as a measure of mitochondrial 
quality (Fig 5.9). The combination of KU60019 and chloroquine likewise did not affect either 
ADP/O ratios or RCR, but notably increased state 3 respiration in DIO-perfused mitochondria 
in both GM and PCM substrates (Fig 5.10). 
The current study also compared mitochondria from hearts perfused with a combination of 
chloroquine and KU60019, to the groups perfused with chloroquine alone (Fig 5.9) as well as 
the groups perfused with KU60019 alone (which is also shown in Fig. 5.6 compared to DMSO 
perfused hearts).  
 
Figure 5.10: Mitochondria from hearts perfused with a combination of chloroquine and KU60019 
did not show significant effects on influence oxidative phosphorylation. Both chow-fed AMC and 
DIO hearts perfused with a combination of chloroquine and KU60019 did not show any significant 
changes when compared to hearts perfused with either chloroquine or KU60019 alone for panel a) 
ADP/O ratios, or panel b, respiratory control index. State 3 (panel c) and State 4 (panel d) 
respiration, as well as ATP synthesis (panel e) and recovery after anoxia. 
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Overall, the combination treatment with both chloroquine and KU60019 (Fig 5.10) 
contributed significantly to the effect on State 3 respiration (p=0.0146, 2-way ANOVA), 
although no significant differences could be identified with Bonferroni post-hoc test. The 
notable but not significant decrease in chloroquine + KU60019 State 3 respiration compared 
to basal KU60019 levels in mitochondria from perfused chow-fed rat hearts in both GM and 
PCM substrates, suggests that the effect observed might be diet based. State 4 respiration 
increased in a similar fashion, with an overall significant contribution to the effect of drug 
treatment (p=0.0191, 2-way ANOVA) with the most marked increase in mitochondria from 
the DIO rats, irrespective of the substrate used (not significant, Bonferroni post-hoc test). 
The comparison of mitochondria from hearts perfused with KU60019 alone to hearts 
perfused with a combination of chloroquine and KU60019 is shown in Addendum D and 
shows that most of the changes observed are due to the addition of chloroquine. 
Interestingly, the inhibition of ATM in the presence of chloroquine improved ATP synthesis 
compared to the inhibition of ATM alone in mitochondria from both control and DIO rats in 
PCM substrate, and DIO in a GM substrate (overall effect was p=0.0067, 2-Way ANOVA).  
This would suggest that mitochondria that derive from a high free fatty acid environment 
(DIO fed rats) or mitochondria primarily utilising free fatty acids through β-oxidation (PCM 
substrate), might be protected against any detrimental effects of acute ex vivo chloroquine 
treatment. Chloroquine reversibly inhibits transmembrane electron transport (Crane et al. 
1994), and was previously shown to be toxic to pig aortic cells (Crane et al. 1994). The 
addition of LDL protected the cells against chloroquine induced toxicity, although it did 
result in the accumulation of both lipid droplets and autophagic vacuoles (Crane et al. 1994). 
Likewise, isolated mitochondria in PCM substrate performed better, which indicates that the 
addition of palmitoyl-L-carnitine might protect the mitochondria against chloroquine 
toxicity. 
The effect of chloroquine is most notable on the key components of glutaminolysis in the 
TCA cycle, which includes α-ketoglutarate, glutamate and glutamine, whilst succinate levels 
remain at basal levels in primary rat neurons treated with chloroquine (Redmann et al. 
2017). This would potentially suggest that the inhibition of ATM together with chloroquine, 
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could exacerbate this effect on glutaminolysis, and supports the notion that ATM might play 
a role in Complex I mediated substrate oxidation.  
Alternatively, the absence of ATM can result in a decrease in autophagy. ATM initiates 
autophagy via LKB1-mediated AMPK phosphorylation and mTOR suppression in response to 
ROS and RNS in the cytoplasm (Zhang et al. 2013; Tripathi et al. 2013). It can also promote 
autophagy by signalling AMPK in response to DNA damage (Li et al. 2017). Thus, the 
inhibition of ATM would result in an increase in mTOR, and decreased autophagy due to the 
inability to initiate the formation of autophagosomes. This would lead to the accumulation 
of damaged mitochondria. The main effect of chloroquine would thus become secondary if 
there are fewer autophagosomes formed, and would mean that the effect observed in 
mitochondria treated with both chloroquine and KU60019 would mainly be due to a 
decrease in mitochondrial oxidative phosphorylation and TCA cycle enzymes mediated by 
chloroquine, as was observed previously in neurons (Redmann et al. 2017). However, the 
last alternative is unlikely because chloroquine itself did not affect cardiac mitochondria in a 
similar fashion. It is very difficult to dissociate these two alternatives from each other and 
would require microscopy where the formation of autophagosomes are monitored, or a 
stepwise metabolomic analysis of liquid chromatography mass spectroscopy (LC-MS) similar 
to that performed by Redmann et al. (2017). 
Taken together, chloroquine perfusion of chow-fed AMC and DIO hearts had little effect on 
oxidative phosphorylation compared to DMSO-perfused chow-fed AMC and DIO hearts, 
with the exception of mitochondria from chloroquine-perfused DIO hearts in GM substrate 
that exhibited significantly improved recovery after anoxia. The overall effect of drug 
treatment changed significantly in State 3 and 4 respiration, as well as ATP synthesis when 
hearts were perfused with a combination of chloroquine and KU60019 compared to either 
chloroquine or KU60019 alone. This was mainly driven by increased State 3 and 4 
respiration rate in DIO-hearts perfused with a combination of chloroquine and KU60019 
compared to KU60019 alone. Combined, it improved ATP synthesis in DIO hearts in both GM 
and PCM substrates, as well as recovery after anoxia. 
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5.2.5 Chemical inhibition of ATM  with KU60019 influences mitophagy in cardiac 
mitochondria: 
 
Cytosolic ATM is responsible for macroautophagy of peroxisomes (pexophagy, (Zhang et al. 
2015) in response to ROS, and has been implicated in mitochondrial maintenance through 
mitophagy  (Valentin-Vega et al. 2012). Recently, ATM was also shown to co-localise with 
PINK on the mitochondrial membrane in spermidine-induced mitophagy (Qi et al. 2016).   
A high oxidative rate is linked to increased mitophagy and mitochondrial renewal, although 
the link between mitophagy and energy metabolism is still poorly understood (Melser et al. 
2015). High oxidative rates have been linked with increased mitophagy through the 
recruitment of Rheb to the OMM which interacts with Nix and LC-3II to improve autophagy, 
and maintain oxidative phosphorylation efficiency (Melser et al. 2015). Conversely, BNIP3-
mediated impairment of mitochondrial oxidative phosphorylation drives mitochondrial 
turnover through autophagy (Thomas et al. 2011).  ATM deficiency in ATM-/- fibroblasts has 
been associated with a decrease in oxidative phosphorylation as well as decreased 
mitophagy (Valentin-Vega et al. 2012). Moreover, it has been shown that spermidine 
mediates mitophagy through the PINK-Parkin pathway in an ATM dependent manner (Qi et 
al. 2016). Whilst it is known that ATM is a positive regulator of autophagy and that its 
inhibitor, KU55933 markedly decreases autophagy, no studies in this regard have yet been 
done with the ATM inhibitor, KU60019. In light of the decreased oxidative phosphorylation 
observed in this study with KU60019, it raises the question whether this might be due to a 
reduction in either mitophagy or autophagy. 
The inhibitor, KU60019, decreased both total ATM levels in chow-fed KU60019 perfused 
hearts, albeit not significantly (Fig 5.11). This was expected, as the inhibitor should not 
affect its expression levels, after 20 minutes of ex vivo perfusion (post-translational rather 
than a transcrptional response, Patel et al. 2011), but rather its activity. Several attempts to 
detect phospho-ATM(Ser1981) was unsuccessful, and might suggest that if ATM, if it is 
phosphorylated in the mitochondria, it is not through the phosphorylation of Ser1981, but 
rather possibly via the phosphorylation of Cys2991, which is sensitive to oxidative stress 
(Zhang et al. 2018).  This marker was not investigated in this study, but suggests that any 
changes that are observed, and potentially mediated through ATM in this study, might 
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rather be post-transcriptional and not in response to DNA damage induced during these 
experiments.  It would thus be of great value to investigate the phosphorylation of ATM at 
Cys2991 in the future, as it may corroborate the role of ATM in mitochondrial oxidative stress. 
Unlike previous studies in our laboratory, the present study did not observe a difference in 
total-ATM levels in cardiac mitochondria between chow-fed and DIO animals. However, 
total ATM levels increased significantly in mitochondria from DIO hearts after perfusion with 
a combination of insulin and KU60019 compared to insulin alone (p<0.005, 2-way ANOVA, 
Bonferroni post-hoc test).  Interestingly this was not observed in the cardiac mitochondria 
from control chow fed rats. 
 
Figure 5.11: Total and phospho-ATM levels, as determined with western blotting, were decreased 
when perfused with KU60019, but accumulated in combination with insulin in obesity.  Western 
blot analysis of total-ATM levels are shown in the left hand panel whilst phospho-ATM levels 
(Ser1981) are shown in the right hand panel for mitochondria from chow-fed AMC and DIO hearts 
perfused with DMSO, KU60019, insulin, and a combination of insulin and KU60019. 
This indicates that insulin in combination with the inhibition of ATM, might lead to the 
accumulation of ATM in cardiac mitochondria in DIO hearts, but the underlying mechanism 
is unclear. This corresponds with a significant decrease in the ADP/O ratio, and interestingly, 
a significant increase in recovery after anoxia.  
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Figure 5.12: Chloroquine perfusion reduced the detectable levels of total ATM levels with western 
blotting, in both chow-fed and DIO cardiac mitochondria.   
Total ATM was also detected in hearts perfused with chloroquine, and decreased when both 
chow-fed and DIO hearts were perfused with KU60019, although not significantly (Fig. 5.12). 
Again, no decrease was observed in the ATM levels of DIO heart mitochondria compared to 
that of chow-fed heart mitochondria. No phosphorylated ATM could be detected. This could 
again be indicative that ATM might not be phosphorylated at Ser1981 as it would be in 
response to DNA damage, but potentially rather activated in another manner such as 
phosphorylation at Cys2991 as discussed above.  
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It is however notable that the inhibition of ATM with KU60019 decreased its total levels in 
mitochondria from both chow-fed and DIO perfused hearts. Moreover, the inhibition of 
ATM influenced PINK, Parkin and TOM70 (Fig 5.13) and LC3-I/II levels (Fig 5.15), which 
indicates a role for ATM in mitophagy (Fig 5.13). Under normoxic circumstances PINK is 
imported into the mitochondria via TOM70 (translocase of outer membrane), and the TIM 
(translocase of the inner membrane) complex on the inner membrane. The N-terminal of 
PINK’s mitochondrial targeting signal is removed, and the rest of the protein is then exposed 
to the cytosol, where it is rapidly degraded by the ubiquitin proteasome system (reviewed 
by Nguyen et al. (2016). Damaged mitochondria accumulate PINK on the OMM, where it is 
autophosphorylated when bound to the TOM-complex. This last step is required both for 
the activity of PINK as well as the recruitment of Parkin to the damaged mitochondria. 
Although no significant changes were observed for TOM70 (Fig 5.13) in mitochondria from 
DIO animals, treatment with KU60019 resulted in decreased TOM70 that can indicate that 
less PINK can be imported into the mitochondria and are consequently accumulate, thus 
driving Parkin-mediated autophagy. However, this is not the case for the combined insulin 
and KU60019 treatment, which could suggest that alternative pathways might be involved. 
The present study demonstrated that PINK decreased in mitochondria from control chow-
fed rat hearts perfused with insulin compared to DMSO-perfused mitochondria alone (Fig. 
5.13; p<0.0054, 2-way ANOVA, Bonferroni post hoc test). This insulin-induced effect was not 
observed in cardiac mitochondria from DIO rats, which might be indicative that the rats 
were indeed insulin resistant and therefore had a reduced ability to respond to insulin. 
However, Parkin increased significantly in mitochondria from DMSO-perfused DIO hearts 
(p<0.0005, 2-way ANOVA) compared to the DMSO perfused chow-fed AMC hearts, and 
suggests a role for Parkin-mediated mitophagy in obesity A recent study found that a 100 
nM insulin alone do not stimulate either the accumulation of PINK or the recruitment of 
Parkin in SHSY5Y cells, however when mitochondria become depolarised (with for example 
FCCP treatment), both PINK and Parkin are accumulated in response to insulin-stimulated 
Akt signalling (Soutar et al. 2018). Conversely, Kubli et al. (2015) found that Parkin can be 
recruited to depolarized mitochondria and activate mitophagy in the absence of PINK. It is 
also possible that insulin treatment resulted in increased ROS production, which would 
correlate with an increased oxidative phosphorylation rate, as was observed previously in 
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this study. Moreover, in vitro treatment with 100 nM insulin, as was used in this study, has 
previously been shown to significantly increase ROS production in 3T3-L1 adipocytes (Hoehn 
et al. 2009). A recent study also found that Parkin recruitment in response to ROS-mediated 
mitophagy is not dependent on increased PINK protein levels (Xiao et al. 2017).  
 
Figure 5.13: Western blot analysis of the mitophagy markers, PINK and Parkin in chow-fed and DIO 
cardiac mitochondria prepared from hearts perfused with DMSO, KU60019, insulin and a 
combination of insulin and KU60019.  PINK and TOM 70 was probed on the same membrane 
(shown above, left) and normalised to total protein. Parkin was probed on and normalised to the 
membrane shown on the right. An n=3 was used per group, and bars represent the mean value ± 
s.d. * p<0.05, ** p<0.005, ****p<0.0005. 
Briefly, insulin stimulates the accumulation of PINK and translocation of Parkin to 
depolarized mitochondria. Parkin can also be recruited to depolarized mitochondria in the 
absence of PINK. Moreover, Parkin can be recruited to mitochondria in response to ROS, 
independently of PINK. 
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KU60019 also significantly increased Parkin accumulation in mitochondria from chow-fed, 
perfused hearts (p<0.0005), which might again be associated with increased oxidative 
stress. Moreover, the effect of Parkin was significantly increased over all in response to the 
diet (p=0.0005) and with drug intervention (p=0.0001; 2-way ANOVA). In mitochondria from 
chow-fed AMC hearts, Parkin increased significantly (p<0.0005) when perfused with 
KU60019, compared to DMSO alone, as well as in insulin-perfused hearts (p<0.005) when 
compared to mitochondria from DMSO-perfused hearts. 
The effects observed with regards to diet would be consistent with a model where obesity 
increases oxidative stress, which can, in turn result in increased mitophagy. It has indeed 
been shown that adiponectin, which is mainly produced by adipose tissue, can modulate 
mitophagy and suppress apoptosis in response to oxidative stress (Ren et al. 2017). Taken 
together, the inhibition of ATM seems to modulate mitophagy in a Parkin-dependent 
manner that is independent of PINK accumulation in chow-fed AMC and DIO hearts.  
However, when autophagy is inhibited by chloroquine, which specifically targets the 
lysosomal degradation of autophagosomes, Parkin is significantly reduced in both the chow-
fed and DIO heart perfused with KU60019 (Fig 5.14, p<0.05, 2-way ANOVA, Bonferroni post-
hoc test). Previously a significant increase was observed in Parkin levels of KU60019-
perfused chow-fed AMC hearts compared to DMSO perfused chow-fed AMC hearts as well 
as DMSO DIO perfused hearts. It would validate repeating the experiment to confirm 
whether Parkin is increased (Fig. 5.13) or decreased in response to KU60019 in ex vivo 
perfusions of chow-fed AMC hearts and DIO hearts (Fig 5.14). PINK protein levels changed 
significantly with KU60019, chloroquine and the combination of chloroquine and KU60019 
treatment (p<0.0005, 2-way ANOVA, Bonferroni post-hoc test) in both mitochondria from 
chow-fed rats and DIO-rats.  
Parkin was reduced in a similar fashion to PINK (p<0.0001, 2-way ANOVA, Bonferroni post-
hoc test) in chow-fed AMC hearts perfused with chloroquine (p<0.0005, Bonferroni post-hoc 
test). Chow-fed AMC hearts perfused with a combination of chloroquine and KU60019 also 
presented with significantly decreased Parkin (p<0.0005, Bonferroni post-hoc test) when 
compared to chow-fed AMC hearts perfused with either DMSO or KU60019 alone. Parkin 
Stellenbosch University  https://scholar.sun.ac.za
 
 
135 
 
levels were also significantly decreased in mitochondria from DIO hearts perfused with a 
combination of chloroquine and KU60019 (p<0.005) compared to KU60019 alone (Fig 5.14). 
 
Figure 5.14: Western blot analysis of the mitophagy markers, PINK and Parkin in mitochondria 
from chow-fed and DIO hearts perfused with DMSO, KU60019, chloroquine and a combination of 
chloroquine and KU60019.  Pink protein expression levels were normalised to the membrane 
shown on the left whilst Parkin protein expression levels were normalised to the membrane 
shown on the right. * p<0.05, ** p<0.005, ****p<0.0005. 
This would suggest that chloroquine inhibits PINK/Parkin mitophagy, which could contribute 
towards mitochondrial dysfunction and the accumulation of damaged mitochondria. This is 
in line with the observation that chloroquine treatment in pressure overload hypertrophy 
impairs mitochondrial antioxidant capacity and increases oxidative stress (Chaanine et al. 
2015). The question however remains what the underlying mechanisms for this would be. 
The combination of chloroquine and KU60019 significantly exacerbates the decrease in both 
PINK (p<0.05) in mitochondria from chow-fed animals and Parkin in both chow-fed 
(p<0.0005) and DIO animals (p<0.005, 2-way ANOVA, Bonferroni post-hoc test), and 
suggests that PINK/Parkin mitophagy is inhibited in this scenario.  
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A recent observation by Bartolomé et al. (2017) might shed light on this observation: the 
study observed that mTORCI regulation plays a synergistic role in mitophagy, where it is first 
required to initiate general autophagy but is also required for the selective targeting of 
PINK/Parkin mediated mitophagy in uncoupled mitochondria which is exacerbated in the 
presence of chloroquine.  This was observed in TSC2-/- cells, which is a known target of ATM 
(Alexander et al. 2010). It is thus possible that the inhibition of ATM plays a similar role in 
cardiac mitophagy, leading to the upregulation of mTORC1 and consequent decreased 
PINK/Parkin localisation to damaged mitochondria that is further aggravated by the 
inhibition of lysosomal degradation. 
It is possible that macroautophagy can also play a role in the selective clearance of 
mitochondria, with regards to ATM’s cytosolic role as a positive regulator of autophagy 
(Stagni et al. 2018). The present study therefore evaluated LC3-I and II as well as p62 
mitochondrial associated levels as markers of autophagy. Parkin recruitment to the OMM 
results in the ubiquitination of mitochondrial proteins that can recruit p62 to the 
mitochondria marked for mitophagy (Kroemer et al. 2010), and allows for interaction with 
the autophagosomal membrane (Yamano et al. 2016).  
In line with the role of ATM in autophagy, a significant decrease (p<0.0001) was observed in 
LC3-II (autophagosome-bound) when mitochondria from chow-fed AMC hearts were 
perfused with a combination of insulin and KU60019 compared to mitochondria from hearts 
perfused with insulin alone (Fig 5.15; p< 0.05 2-way ANOVA, Bonferroni post-hoc test). 
Interestingly, LC3-II was also significantly decreased in mitochondria from DIO hearts 
perfused with KU60019 (p<0.005, Bonferroni post-hoc test) compared to mitochondria from 
DIO hearts perfused with DMSO. LC3-I protein levels were difficult to detect, and this could 
potentially be ascribed to the fact the LC3-I is cytosolic until it is converted to its lipidated 
form on the autophagosomal membrane to LC3-II. The fractions analysed here were 
mitochondrial, and would thus concur with the expectation that LC3-I detection would be 
limited. Consequently, no significant differences were detected in either LC3-I or the LC3-II/I 
ratio.  However, the decrease noted in the LC3-II levels indicate that there are decreased 
LC3-II bound autophagosomal membranes, and suggests a decrease in autophagy, which 
would concur with increased mTORC1 levels in the absence of ATM (Alexander et al. 2010). 
The effect observed here is thus potentially a consequence of the cytosolic role of ATM.   
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Figure 5.15: Western blot analysis of the autophagy markers, LC3 in mitochondria from chow-fed 
and DIO hearts perfused with DMSO, KU60019, insulin and a combination of insulin and KU60019.  
LC3-1 and LC3-II are both detected with the same probe and was normalised to the membrane 
shown. The normalised fold-change to control values was used to determine the ratio of LCII to 
LC3I. * p<0.05, ** p<0.005. 
Likewise, the same effect was noted on LC3-II expression in mitochondria from both chow-
fed AMC and DIO hearts perfused with KU60019, chloroquine and a combination of 
chloroquine and KU60019 when compared to mitochondria from DMSO perfused chow-fed 
AMC and DIO hearts. A significant increase in LC3-II levels were noted in mitochondria from 
chloroquine perfused chow-fed AMC hearts compared to mitochondria from DMSO 
perfused chow-fed AMC hearts (p<0.005, Bonferroni post-hoc test). However, LC3-II protein 
levels in mitochondria from KU60019 perfused chow-fed AMC hearts decreased significantly 
(p<0.05) compared to mitochondria from DMSO perfused chow-fed AMC hearts. Moreover, 
when chow-fed AMC hearts were perfused with a combination of chloroquine and 
KU60019, LC3-II levels decreased significantly to those seen in chow-fed AMC hearts 
perfused with chloroquine alone (p<0.0005, Bonferroni post-hoc test). This would suggest 
that the reduction in LC3-II levels in chow-fed AMC cardiac mitochondria is due to the 
inhibition of ATM. A similar reduction in LC3-II protein levels were seen in mitochondria 
Stellenbosch University  https://scholar.sun.ac.za
 
 
138 
 
from DIO rat hearts perfused with KU60019 compared to mitochondria from DIO hearts 
perfused with DMSO (p<0.05). This reduction was again observed in mitochondria from DIO 
hearts perfused with a combination of chloroquine and KU60019, compared to LC3-II levels 
in mitochondria perfused with chloroquine alone (p<0.0005, Bonferroni post-hoc test). This 
supports the notion that the inhibition of ATM had the largest effect on LC3-II protein levels 
in both chow-fed AMC and DIO hearts. 
 
Figure 5.16: Western blot analysis of the autophagy markers, LC3 in mitochondria from AMC and 
DIO hearts perfused with DMSO, KU60019, chloroquine and a combination of chloroquine and 
KU60019. The probe for LC3 detects both LC3-I and LC3-II and was normalised to the 
membrane shown. The normalised fold-change to control values was used to determine the 
ration of LC3-II to LC3-I. * p<0.05, ** p<0.005, ****p<0.0005. 
Taken together, these results suggest that the inhibition of cytosolic ATM rather than 
mitochondrial ATM interferes with the formation of an autophagosome, most probably 
through increased mTOR expression/activation (Alexander et al. 2010). The accumulation of 
LC3-II, which is well associated with chloroquine treatment, was significantly reduced in 
both chow fed AMC and DIO hearts treated with either a combination of insulin and 
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KU60019 or a combination of chloroquine and KU60019. This supports the hypothesis the 
inhibition of ATM contributes to a significant reduction of LC3-II levels.  
Lastly, this study investigated the selective autophagy marker p62, the mitochondrial fission 
protein, DrpI and the mitochondrial uncoupling protein, UCP3.  
 
Figure 5.17: Western blot analysis of p62, Drp1 and UCP3 in mitochondria from chow-fed and DIO 
hearts perfused with DMSO, KU60019, insulin or a combination of insulin and KU60019. The 
autophagy marker, p62 was probed on and normalised to the membrane on the left, and Drp1 as 
well as UCP3 were probed on and normalised to the same membrane shown on the right hand 
side. An n=3 was used per group, and bars represent the mean value ± s.d. * p<0.05. 
The selective autophagy marker, p62, is recruited to damaged mitochondria in response to 
ubiquitination of OMM proteins by Parkin, where it binds to the ubiquitin chain and 
interacts with LC3-II on the autophagosomal membrane. It is thus not surprising that a 
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similar decrease was noted in p62 protein levels to that seen in LC3-II (Fig 5.15), where 
chow-fed AMC hearts were perfused with either KU60019 or a combination of insulin and 
KU60019.  No change were observed for p62 in obesity which corresponds to the lack of 
differences observed in Parkin levels overall in obesity. The role of p62 in the context of 
obesity will require further investigation, but these results indicate that KU60019 had a 
similar effect on p62 levels in mitochondria from chow-fed AMC hearts but not DIO hearts. 
This would suggest that it is not influenced by the negative feedback of ATM on mTORC1, or 
that an alternative mitophagy pathway is at play. Interestingly, it has been observed that 
p62 is required for the clustering of damaged mitochondria, but is dispensable in Parkin 
mediated mitophagy (Narendra et al. 2010). 
BNIP3 mediated mitophagy, for example, entails Drp1 facilitated fission and Parkin 
recruitment in cardiac myocytes, where BNIP3 promotes the translocation of Parkin and 
Drp1 fission is correlated with increased autophagy (Lee et al. 2011). The current study 
showed both KU60019 and insulin as well as a combination of insulin and KU60010 had a 
significant effect (decrease) overall in Drp1 protien levels (p<0.0038) irrespective of diet. 
Interestingly, this correlated with a decrease in PINK levels with the exception of an increase 
in PINK levels when hearts were perfused with a combination of insulin and KU60019. In 
PINK deficient cells, increased oxidative stress as well as mitochondrial turnover is observed, 
which is mediated by an increase in fission (Dagda et al. 2009). What is of note though is 
that hyperglycaemia facilitates mitochondrial fission through Drp1, which was not observed 
in our DIO model, and concurs with the lack of difference observed in the non-fasting blood 
glucose levels of the chow-fed and DIO animals used in this study. Furthermore, insulin is 
known to stimulate mitochondrial fusion via Akt-mTOR-NFκB-Opa1 signalling pathway in 
cardiomyocytes (Parra et al. 2014). The decrease that is observed in fission (Drp1) in chow-
fed and DIO hearts perfused with insulin or a combination of insulin and KU60019 thus 
agrees with the study by Parra et al. (2014). In the study by Valentin-Vega et al. (2012), 
enlarged mitochondria with a swollen appearance was noted in ATM-/- thymocytes, and 
agrees with the present study’s observation that Drp1 is down-regulated in response to 
KU60019 perfusion in both chow-fed and DIO hearts. 
Lastly, both KU60019 and insulin perfusion decreased UCP3 expression, in chow-fed but not 
DIO perfused hearts. Overall, drug treatement significantly decreased UCP3 expression 
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(p<0.0004), whereas KU60019 perfusion significantly decreased UCP3 levels compared to 
chow-fed hearts (p<0.05) similar to the effect of insulin (p<0.05). No differences were noted 
in obesity. Likewise, Boudina et al. (2007), did not observe increased levels of UCP 3 in 
db/db mice, although they did observe increased uncoupled respiration and proton leak. 
This study did not observe any increase in UCP3 that can explain the increase observed in 
State 4 respiration in insulin perfused hearts in PCM substrate (Fig 5.7), but does not 
preclude the possibility of fatty acid induced uncoupling.  
In conclusion, the perfusion of chow-fed and DIO hearts with KU60019 resulted in a 
reduction in State 3 respiration, which translated into decreased ATP synthesis, and was 
overall, associated with decreased total ATM levels, as well as a decrease in the autophagy 
markers, LC3-II and p62, decreased fission and interestingly, decreased uncoupling in chow-
fed hearts. This corroborates with previous literature reporting decreased mitochondrial 
respiration (Ambrose et al. 2007) and ATP synthesis in the absence of ATM (Valentin-Vega et 
al. 2012). Although the underlying mechanisms regarding mitophagy could not be fully 
elucidated in this study, the results indicate that this might be due to inefficient PINK/Parkin 
mitophagy, although there are indications of PINK independent Parkin mitophagy. This 
phenotype could not be rescued with the addition of insulin to KU60019 in either chow-fed 
or obese hearts, although it did improve many of the parameters such as ATP synthesis. 
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Chapter 6 : Mitochondrial NAD+/NADH redox state and the use of 
fluorescent life-time imaging microscopy (FLIM) 
 
The redox state is the key regulator of energy production and intermediary cellular 
metabolism,  and is crucial in health and metabolic disease (Forrester et al. 2018). The redox 
pairs NAD+/NADH reflects the balance of the TCA cycle to ETC activity and can result in the 
production of ROS in the event of TCA dysfunction, whilst the NADP+/NADPH pool mediates 
the antioxidant defence (Blacker et al. 2014). NAD+ is an essential co-factor that is central to 
ATP production via the oxidation of its reduced form, NADH, in mitochondria, whilst the 
cellular NADP+/NADPH ratio governs lipid, amino acid and nucleotide synthesis in various 
metabolic pathways (Srivastava 2016). Under highly aerobic conditions, electrons are 
shuttled from cytosolic NADH to the mitochondria via glycerol-3-phosphate and the malate-
aspartate shuttle, where it is oxidized by Complex I to NAD+, and leads to the majority of 
ATP production via oxidative phosphorylation (Yu & Heikal 2009)(Fig 2.6).  
On the other hand, NADP+ is reduced to NADPH mainly through the oxidative branch of the 
PPP in the cytosol, and maintains the intracellular redox state through the synergistic action 
(Fig 2.4) of the antioxidant enzymes and thiol-containing antioxidants, such as glutathione 
(GSH) and thioredoxin (TRX) that require both ATP and NADPH for their regeneration 
(Cardaci et al. 2012). The role of ATM in the PPP and glycolysis have already been discussed 
(Chapter 2, Section 2.3.4; Zhang et al. 2018; Cosentino et al. 2011), as well as the observed 
reduction of NAD+, NADH and NADP+ in the cerebellum of ATM-/- mice (Stern et al. 2002). 
Replenishment of NAD+ improved the lifespan of ATM-/- mice and worms (C. elegans), and 
ameliorated A-T phenotypes in mice through the upregulation of mitophagy and DNA repair 
(Fang et al. 2016). An increase in the NAD+/NADH ratio, possibly through fasting, exercise or 
redox stress have also been linked with increased mitochondrial biogenesis through the 
deacetylation of PGC1α by activated Sirtuin 1 (SIRT1, Andres et al. 2015). An extensive 
review by Cheng et al. (2017) suggests that insulin signalling maintains the NAD+/NADH 
ratio; it  acts as a mediator for the PGC1α/SIRT1 pathway by maintaining the ETC and 
suppressing of FOXO1/HMOX1. This supports the hypothesis set forth by Valentin-Vega et 
al. (2012) which suggests that the accumulation of mitochondria in the absence of ATM 
could be due to ineffective mitophagy rather than increased biogenesis. A disruption in 
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insulin signalling as  well as  a decrease in the NAD+/NADH redox pairs in ATM-/- (Stern et al. 
2002; Fang et al. 2016) will decrease biogenesis rather than increase it. There is thus value 
in being able to quantify the ratio of NAD+/NADH and NADP+/NADPH. The redox pair ratios 
can give insight into the metabolic state of a cell as well as its oxidative and redox state. 
Understanding the metabolic and redox state of cells under pathological conditions can 
offer potential therapeutic value when replenished as demonstrated by Fang et al. (2016). 
Lastly, the inhibition of ATM also decrease Cytochrome C oxidase (COX, or complex IV)  
activity in permeabilised muscle tissue in a post-transcriptional manner (within an hour of 
KU55933 treatment), and is correlated with a decrease in G6PD, which suggests a shift 
towards glycolysis (Patel et al. 2011). ATM promotes glucose flux through the PPP by 
increasing both the abundance as well as activity of G6PD, consequently increasing NADPH 
production which is required for the anti-oxidant response in cells (Zhang et al. 2018). 
Moreover, the inhibition of COX increases ROS production and electron leak at Complex I or 
III by reducing the redox centres of these complexes (Chen et al. 2003). A reduction in the 
redox centre of Complex I should thus lead to decreased NADH oxidation if ATM inhibition 
impacts complex I. 
6.1 Two-photon FLIM microscopy: 
 
In 1979, Chance et al. (1979) showed that NADH, primarily of mitochondrial origin, can be 
illuminated with ultraviolet light. The nicotinamide moiety of NADH absorbs light at 340 ± 30 
nm and emits fluorescence at 460 ± 50 nm (Blacker & Duchen 2016), and because NADP is 
phosphorylated at a distant site within the molecule, the fluorescence properties of the 
nicotinamide ring of NADPH are identical to those of NADH (Figure 6.1; Blacker et al. 2014). 
Changes in autofluorescence intensity can thus reflect changes in either NADH or NADPH, 
and are collectively referred to as NAD(P)H due to the uncertain origin of the fluorescence 
(Duchen et al. 2003). The intrinsic fluorescence of these molecules have been used for label-
free monitoring of in vitro and in vivo metabolic states (Mayevsky & Barbiro-Michaely 2009), 
and have improved significantly with the advent of time-resolved fluorescence 
measurements  that allows the determination of autofluorescence lifetime in response to 
changes in the redox state (Blacker & Duchen 2016).  
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Figure 6.1: Schematic representation of NADH and NADPH. Panel A represents the molecular 
structure of NADH {(National Center for Biotechnology Information. PubChem Compound 
Database; CID=439153, https://pubchem.ncbi.nlm.nih.gov/compound/439153 (accessed Sept. 13, 
2018)} and the circle surrounds the nicotinamide moiety of NADH that absorbs light at 340 ± 30 
nm whereas panel B represents NADPH  that also absorbs light at the nicotamide moiety (in circle) 
that is identical to that of NADH.  
Fluorescence lifetime imaging microscopy (FLIM) can measure the rates of fluorescence 
decay of NAD(P)H.  This means that when the NAD(P)H moiety absorbs light at 340 ± 30 nm, 
the fluorophores are excited from their ground state into an excited state. On average, the 
time for the decay from this excited state to the ground state occurs on a nanosecond 
timescale, with the accompanying emission of a fluorescence photon. The timespan 
between the emission of these fluorescence photons and their excitation can be measured 
accurately with time-correlated single photon counting (TCSPC). This provides a 
measurement of the excited state lifetime of an ensemble of fluorophores, and is highly 
sensitive to the immediate environment of the fluorophore (Blacker et al. 2014). The use of 
multiphoton FLIM (such as two-photon FLIM; 2P-FLIM) rather than single-photon FLIM at 
near-infrared excitation, allows for greater penetration depths and resolution as well as 
improved tissue viability compared to single-photon excitation (Skala et al. 2007a). 
Multiphoton FLIM has been widely used to monitor energy metabolism in human breast 
cancer cells (Bird et al. 2005; Yu & Heikal 2009), precancerous epithelial cells (Skala et al. 
2007b), isolated mitochondria, hepatocytes and rat liver in situ (Wakita et al. 1995) as well 
as in cardiomyocytes (Huang et al. 2002) to name but a few.  
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The fluorescence decay lifetime of NADPH and NADH is identical in solution, and thus the 
fluorescence from free unbound pyridine nucleotides cannot be discriminated on the basis 
of their fluorescence lifetime (Blacker et al. 2013). However, the fluorescence decay lifetime 
can increase from 0.3 ns – 0.8 ns and from 1 - 6.5 ns when bound to an enzyme, dependent 
on the target to which the cofactor binds (Vishwasrao et al. 2005) as well as the 
simultaneous presence of a substrate molecule (Gafni & Brand 1976). Consequently, FLIM 
imaging can resolve two fluorescence lifetimes at each pixel, respectively at approximately 
0.4 ns and more variably at 2 ns (Skala et al. 2007a), which represent the freely diffusing 
(τfree) and enzyme-bound NAD(P)H (τbound) pools (Blacker et al. 2014) respectively. On 
average, the lifetime decay of free (τ1) NAD(P)H is  considerably shorter than that of bound 
(τ2), and it is thus possible to quantify the relative fractions of free (α1) and bound (α2) 
NAD(P)H in a cell (Lakowicz et al. 1992). The enzyme-bound NAD(P)H pool is the parameter 
that varies most with changes in metabolism (Skala et al. 2007) and  glucose homeostasis 
(Sharick et al. 2018). Moreover, it has been suggested that the enzyme-bound pool of NADH 
mainly localises in the mitochondria, whilst the free NAD(P)H pool is localised to the cytosol 
(Bird et al. 2005; Wakita et al. 1995) 
The varying effects of the [NADPH]/[NADH] ratio on τbound  have been quantified in a HEK293 
cell model in the absence and overexpression of NAD+ kinase (NADK), which is the key 
determinant of NADPH concentration in the cell (Blacker et al. 2014). Briefly, the authors 
found that the measured τbound lifetime reflects the proportion of the two co-factors 
present, and that an increase in NADPH will reflect an increase in τbound values. Inhibition of 
NADPH specifically, which does not interfere with NADH, significantly reduced τbound values 
but did not influence τbound values in either the absence of NADK or τfree values. This is 
consistent with a model where, when combining the enzyme-bound τbound NAD(P)H values 
in both the NADK+ and NADK- HEK293 cells, as well as the biochemically quantified [NADH] 
and [NADPH] concentration values in HEK293 cells (Pollak et al. 2007), the relative 
contribution of NADPH and NADH fluorescence decay to NAD(P)H enzyme-bound ratio can 
be defined as (Blacker et al. 2014; Supplementary material) : 
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Changes in the τbound lifetime values have been used to describe the shift from oxidative 
phosphorylation to glycolysis in cancer cells (Skala et al. 2007b), and chemical manipulation 
of HEK293 cells yielded similar results (Blacker et al. 2014). Inhibition of the ETC with 
rotenone (Complex I inhibitor) significantly decrease τbound lifetime values (ns) in both the 
cytosol and mitochondria, which suggests a relative increase in NADH, whereas uncoupling 
with FCCP did not change the τbound lifetime values and suggests equal oxidation of NAD
+ and 
NADH by the mitochondrial nicotinamide nucleotide transhydrogenase (Nnt). It is believed 
that the reversal of the Nnt, which is responsible for the production of NADPH in 
mitochondria, is responsible for ROS production in heart failure through the production of 
NADH for ATP production at the cost of NADPH-linked anti-oxidative function (Nickel et al. 
2015). Taken together, variation in τbound lifetime values seems to be specific to the type of 
metabolic disruption, such as mitochondrial dysfunction at Complex I (Blacker et al. 2014), 
or the utilization of different substrates following inhibition of glycolysis. Fluorescence 
lifetime of protein-bound NAD(P)H is also the most sensitive parameter to detect the  
diversion of carbon away from the TCA cycle to the PPP via G6PD, lactate production via 
LDH, as well as inhibition of carbon entry into the TCA cycle via pyruvate dehydrogenase 
kinase (PDK) by pyruvate dehydrogenase (PDH; Sharick et al. 2018). 
This study utilised 2P-FLIM to determine whether the inhibition of ATM with KU60019 can 
influence the fluorescence life-time decay of NAD(P)H or any of its associated parameters in 
the rat cardiomyoblast cell line, H9c2 and confirmed this as well as the relative contribution 
of [NADPH]/[NADH] to NAD(P)H τbound in HEK293 cells. 
6.1 Materials and Methods: 
 
These experiments were performed personally at the Rutherford Appleton Laboratory, 
Science and Technology Facility Council, Oxfordshire, UK under the supervision of Prof SW 
Botchway and Prof AW Parker. The purpose of this study was to determine the NAD(P)H 
lifetime decay in the presence and absence of the ATM inhibitor, KU60019 in an 
undifferentiated H9c2 model, and confirm this in HEK293 cells, as well as calculate the 
relative contribution of [NADPH]/[NADH] to the τbound value of NAD(P)H.  
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6.1.1 Reagents: 
 
The H9c2 cardiomyoblast cells were purchased from American Type Culture Collection 
(ATCC) at passage 14 and were maintained between passage 16 and 18 for experiments. 
Dulbecco’s Modified medium (DMEM, Gibco) was supplemented with 4.5g glucose/l and 4 
mM L-glutamine, fetal bovine serum (FBS) and penicillin-streptomycin. The SPCImage 
software was kindly made available by Becker and Hickel on a trail licence. 
6.1.2 Cell culture:  
 
H9c2 (2-1) cells were obtained from ATCC® (CRL-1446™, passage 14) and maintained in 
DMEM (GIbco) with 4 mM L-Glutamine, 4.5 g/L glucose, 10% FBS and 1% 
penicillin/streptomycin at 37°C and 5% CO2. Cells were seeded at a concentration of 2.4x10
4 
cells/ml on 35 mm MaTIK plates 48 hours prior to treatment, and treated with either DMSO 
(0.05%, n=3) or 3 μM KU60019 (n=3), 3-6 hours prior to imaging. HEK293 were obtained 
from ATCC, and cells were maintained in MEM (Gibco) and supplemented with 10% FBS, 1 % 
pen/strep and 2 mM L-Glutamine. Cells were seeded at a concentration of 1.5 X 105 cells/ml 
on 35 mm MaTIK plates 48 hours prior to treatment, and treated with either DMSO (0.05%, 
n=1) or 3 μM KU60019 (n=1), 3-6 hours prior to imaging. 
6.1.3 Fluorescence lifetime imaging microscopy:  
 
Fluorescence intensity and lifetime images were acquired using a custom-built multiphoton 
fluorescence lifetime system around a modified inverted microscope (TiE, Nikon). Samples 
were imaged using a 60× , NA 1.2 water-immersion objective (Stubbs et al. 2005; Botchway 
et al. 2015). Multiphoton excitation was generated from a titanium: sapphire laser, tuned to 
760 nm, operating at 76 MHz with 200 fs pulse width (Coherent, USA). A BG39 filter was 
used to block the near infra-red light before non-descan detection using a hybrid detector, 
HPM-100 (Becker and Hickl, GmbH). A pixel dwell time of 5.04 μs was used for 256 × 256 
pixel images over a 212 μm × 212 μm field of view. TCSPC electronics (SPC 830, Becker & 
Hickl, Berlin, Germany) were used to acquire fluorescence decay curves with 256 time bins. 
Following a 3X3 binning of photons and a threshold of 25, two-component fluorescence 
decay curves were used to fit the decay curves for FLIM images using iterative reconvolution 
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in SPCImage (Version 7.1, Becker and Hickl) (Blacker et al. 2014).  NAD(P)H fluorescence 
lifetime parameters were obtained from the FLIM data and reported as an average of 10 
pixels over at least three to five regions of three separate cultures imaged on different days.  
6.1.4 Statistical analysis:  
 
The data were analysed using GraphPad Prism 6.0 software (GraphPad Software, Inc., La 
Jolla, CA). Statistical comparisons were made using a two-tailed Student’s t-test or 2-way 
analysis of variance (ANOVA) followed by a Bonferroni post-hoc test where applicable. All 
values and error bars are presented as mean ± s.d, and the level of significance was set at p 
< 0.05. 
6.2 Results and discussion: 
 
In light of the finding that ATM is located on the inner mitochondrial membrane of cardiac 
mitochondria (Chapter 4), and that the inhibition thereof significantly decreases the 
Complex I mediated oxidative phosphorylation rate in a glutamate/malate buffer (Chapter 
5), this study hypothesised that a reduction in the redox centre of Complex I should lead to 
decreased NADH oxidation if ATM inhibition impacts complex I. This suggestion is based on 
previous studies that showed that the inhibition of ATM decrease ETC COX-IV (Patel et al. 
2011) and that the absence of ATM decreases Complex I in ATM-/- thymocytes (Valentin-
Vega et al. 2012).  Moreover, the inhibition of COX increases ROS production and electron 
leak at Complex I or III by reducing the redox centres of these complexes (Chen et al. 2003). 
To test this hypothesis, this study utilised two-photon fluorescence lifetime imaging 
microscopy (2P-FLIM) which is sensitive to microenvironment changes at the molecular level 
and can distinguish between free (τ1) and enzyme-bound NAD(P)H (τ2) based on 
fluorescence lifetime (where  τ1 > τ2), making it a useful tool for probing metabolism in 
living cells (Sharick et al. 2018).  Reduced NADH, and its phosphorylated form, NADPH are 
autofluorescent electron donors with an identical fluorescent spectra, and is referred to as 
NAD(P)H due to the uncertain origin of the signal (Blacker et al. 2014). Changes in the 
lifetime of NAD(P)H are determined by fitting an exponential function to the observed time-
resolved fluorescence decay, and have been used to distinguish between mitochondrial 
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protein localisation (Söhnel et al. 2016; Yadav et al. 2013), redox ratio (Bird et al. 2005; 
Chakraborty et al. 2016), and glucose carbon diversion (Sharick et al. 2018). It has been 
suggested that the protein-bound form of NADH localizes mainly within the mitochondria 
whilst free NADH is primarily located within the cytosol (Bird et al. 2005; Wakita et al. 1995). 
We observed a bound lifetime (τ-bound) of 2.76 ± 0.26 ns (Fig 6.2) in H9c2 myoblasts, in 
agreement with previously reported mean values (± s.d.) of 2.8 ± 0.2 ns in isolated liver 
mitochondria (Wakita et al. 1995), 2.7 ± 0.2 ns in HEK293 cells (Blacker et al. 2014), and 2.5 
ns in isolated mice cardiomyocytes (Blacker & Duchen 2016), whilst inhibition with KU60019 
resulted in a significant reduction of NAD(P)H fluorescence lifetime decay to 2.57 ± 0.14 ns 
(Fig 6.2).  
 
Figure 6.2: Inhibition of ATM decrease NAD(P)H fluorescence decay. Representative fluorescence 
decay images of H9c2 cells treated with DMSO (vehicle control; top; n=3) or KU60019 (3 μM; n=3), 
which decreased NAD(P)H τ-bound lifetime (ns) significantly (p=0.02, Student’s t-test, mean ± s.d.), 
but did not influence α-bound values (fraction of bound NAD(P)H). Error bars are presented as 
mean ± standard deviation. 
Inhibition of ETC respiration in cardiomyocytes with cyanide resulted in a similar significant 
decrease in NAD(P)H lifetime and caused an accumulation of NADH, which suggests that the 
NADPH/NADH balance defines the enzyme bound NAD(P)H lifetime(Blacker & Duchen 
2016). Inhibition of Complex I with rotenone in HEK293 cells resulted in a significant 
decrease of τ-bound from 2.7 ± 0.2 ns to 2.52 ± 0.05 ns in both the cytosol and mitochondria 
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of the cells, and suggests that the inhibition of Complex I, and thus inhibition of NADH 
oxidation, can increase the concentration of NADH present in the cell relative to the NADPH 
concentration (Blacker et al. 2014). 
The relative fraction of free (α1) NAD(P)H decreased in H9c2 cells when treated with 
KU60019 (74.38±3.202) compared to control cells (76.00±2.259, Fig 6.3), whereas the 
relative fraction of bound (α2) NAD(P)H increased (control: 24.00±2.26; KU60019: 
25.62±3.202; Fig 6.3), but these changes were negligible. The ratio of free and protein 
bound NAD(P)H  (α1/α2)  decreased, albeit not significantly (p=0.2, Fig. 6.3). No differences 
were observed in the autofluorescence lifetime decay of freely diffusing NAD(P)H (τfree; ns) 
between untreated and KU60019 treated H9c2 cells. This is consistent with the suggestion 
that enzyme-bound NAD(P)H variation in τbound lifetime values seem to be specific to the 
type of metabolic disruption, such as mitochondrial dysfunction at Complex I (Blacker et al. 
2014), or the utilization of different substrates following inhibition of glycolysis (Sharick et 
al. 2018). 
 
Figure 6.3 : The relative fractions of free and bound NAD(P)H in H9c2 cells (n=3). The relative 
fractions of free (α1) and bound (α2) NAD(P)H did not change significantly, nor did the ratio of free 
to bound NADPH  between control (n=3) and KU-treated cell cultures (n=3).  The autofluorescence 
lifetime of τfree decreased, albeit not significantly (p=0.1634). Stastical differences were 
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determined with a Student’s t-test (two-tailed) and error bars are presented as mean ± standard 
deviation. 
 A single experiment was performed in HEK293 cells with 0.03% DMSO (control) and 
compared to HEK293 cells treated with 3 µM KU60019 to determine if a similar trend is 
observed (Fig 6.4). A significant decrease was observed in the τ-bound NAD(P)H values for 
KU60019 treated HEK239 cells (2.663 ±0.1090 ns) compared to the control treated cells 
(2.990 ± 0.1122 ns; p= 0.0031) . These values are higher than was reported by  Blacker et al. 
(2014) but could merely be a reflection of the small sample size number as well as the 
combined analysis of the cytosolic and mitochondrial compartments in this study. However, 
similarly to the H9c2 cells, a significant reduction was observed in τ-bound NAD(P)H lifetime 
mean values (ns). The relative fractions of τ-bound NAD(P)H and τ-free NAD(P)H measured as 
α1(%) and α2(%) did not differ (Fig 6.4), which is similar to the observations made in H9c2 
cells (Fig 6.2 and Fig 6.3). Interestingly, the τ-free NAD(P)H lifetime decreases significantly 
(p=0.0474) in HEK293 cells but not in H9c2 cells, but this could again potentially be a sample 
size effect.  
When using the equation described by Blacker et al. (2014) and discussed previously, with 
the biochemically quantified [NADH] and [NADPH] concentration values in HEK293 cells 
(Pollak et al. 2007), a significant decrease (p=0.0351) is observed in the [NADPH]/[NADH] 
ratio in KU60019 treated cells (0.7043 ± 0.1122) compared to DMSO-treated HEK293 cells 
(1.411 ± 0.5257) and suggest that the decrease observed in the τ-bound NAD(P)H fluorescence 
lifetime decay is driven by an increase in the [NADH] concentration (Fig 6.4). 
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Figure 6.4: NAD(P)H fluorescence decay responses to KU60019 treatment in HEK293 cells. The 
relative fractions of free (α1) and bound (α2) NAD(P)H did not change significantly, nor did the 
ratio of free to bound NADPH  between control (n=1) and KU-treated cell cultures (n=1).  The 
autofluorescence lifetime of τfree decreased significantly (p=0.0474), as well as did the NAD(P)H τ-
bound lifetime (ns) (p=0.0031). When calculating the contribution of [NADPH]/[NADH] to the 
NAD(P)H τ-bound lifetime (ns), a significant decrease is observed in KU60019 HEK293 cells 
(p=0.0351), which suggests an increase in [NADH]. * p< 0.05; ** p < 0.005 versus Untreated with a 
two-tailed Student’s t-test. Error bars are presented as mean ± standard deviation. 
The previously observed decreased oxidative phosphorylation rate and decreased NADH 
oxidation in the presence of ATM inhibition, suggests that ATM plays a functional role in the 
ETC and oxidative phosphorylation. No significant changes were observed in either α-bound or 
τ-free, in line with previous reports that NAD(P)H τ2 can effectively and non-invasively 
quantify diversions of carbon away from the TCA cycle or the ETC (Sharick et al. 2018) (Fig 
6.4). The observed decrease in cellular NAD(P)H in the presence of the ATM inhibitor, 
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KU60019, in this study agrees with the observation that cells expressing the C2291L-ATM 
mutant construct has a decreased flux of glucose through the PPP, consequently increasing 
glucose consumption and lactate generation through glycolysis and accordingly decreasing 
NADPH (Zhang et al. 2018). In light of these results, we suggest that the absence or 
inhibition of ATM does not only result in metabolic disturbances, but also mitochondrial 
dysfunction.  This can be either through a decrease in NADPH because of an increase in 
NADH (as suggested in the HEK293 cells, Fig 6.4), which compromises the mitochondrial ROS 
scavenging systems or by shifting the cell metabolism towards glycolysis, and is often 
associated with pathological conditions in the heart.  
In conclusion, this study showed that ATM is located within cardiac mitochondria under 
normoxic conditions. It contributes towards a better understanding of the potential role of 
ATM in mitochondrial function through ETC complex I, as well as its contribution towards 
the development of cardiovascular dysfunction by decreasing oxidative phosphorylation 
efficiency. The results presented here emphasize the need to further establish the role of 
ATM and to determine whether ATM directly phosphorylates mitochondrial proteins, is 
activated in response to mitochondrial damage (Shiloh & Ziv 2013) and can be imported in 
response to stress. Our results do not exclude any of these possibilities. 
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Chapter 7  : Conclusion  
 
Mitochondrial dysfunction lies at the heart of the development of cardiomyopathy and T2D. 
Obesity and insulin resistance are associated with mitochondrial disturbances, and 
contribute towards the development of cardiac dysfunction. ATM has previously been 
associated with mitochondria, and the absence thereof results in decreased mitochondrial 
respiration, ATP synthesis and structural abnormalities. In the cytosol, ATM plays a role in 
insulin signalling, and is down-regulated in high fat conditions. Moreover, when ATM is 
absent, visceral fat accumulation increases under high-fat conditions.  
This study therefore investigated the role of mitochondrial ATM in obesity and the effect 
thereof on the heart, by evaluating whether (i) ATM can be down-regulated under high-fat 
conditions in cell culture; (ii) where ATM is localised in the mitochondria and if it affects 
mitochondrial oxidative phosphorylation and the redox status using H9c2 cells; and (iii) 
determine whether ATM plays a role in mitochondrial oxidative phosphorylation and 
mitophagy in obesity using ex vivo perfused hearts from fiet-induced obese rats. 
In view of the observation that ATM is down-regulated in high fat fed conditions and its role 
in insulin resistance and the Akt-pathway, this study set out to determine whether ATM can 
likewise be down-regulated in an undifferentiated H9c2 rat cardiomyoblast cell line in 
response to high levels of palmitic and oleic acid. The saturated fatty acid, palmitate, is 
commonly used to induce insulin resistance in cell culture, and additionally contributes 
towards apoptosis and toxicity. Interestingly, palmitate alone was not sufficient to 
significantly reduce total ATM, Akt or mTOR protein levels, however, when combined with 
insulin a significant reduction was noted in both these parameters. The combination of 
oleate and palmitate in the presence insulin (100 nM) increased ATM, Akt and mTOR 
protein levels.  This would suggest, specifically with regards to these proteins, that insulin 
resistance induced with either insulin alone, compared to insulin and high free fatty acids, 
differ in their mechanism. The combination of oleate and palmitate was sufficient to 
decrease insulin stimulated-glucose uptake, but increased both total ATM and Akt 
expression as well as the phosphorylation of these proteins. However, none of the 
treatments had any significant effect on the phospho-protein/total protein ratio.   Taken 
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together, this model provides an initial examination of ATM in a hyperlipidaemic insulin 
resistant H9c2 model that can be manipulated with the addition or combination of 
saturated and monounsaturated free fatty acids as well as insulin. This model has several 
shortcomings that are discussed in Section 7.3. 
Mitochondrial dysfunction has been associated with obesity, and although ATM has been 
associated with mitochondria, its location and precise function was yet to be determined. 
The use of a digitonin and Lubrol-WX based disruption of the outer and inner mitochondrial 
membrane identified the location of ATM on the inner mitochondrial membrane of cardiac 
mitochondria from male Wistar rats under normoxic conditions. This finding was further 
confirmed with SR-SIM microscopy, which although limited in resolution (approximately 120 
µm), revealed that ATM is evenly spread across the mitochondria prior to disruption with 
digitonin, whereafter it starts to form punctates that remain visible after 20 minutes of 
digitonin treatment, and is independent of the outer membrane. We concluded that this 
confirms ATM’s association with the mitoplast. The protein’s location on the inner 
membrane was however, also confirmed with western blotting and proteinase K digestion, 
and is, to the best of our knowledge, the first report of ATM localization on the cardiac inner 
mitochondrial membrane. 
The association of the protein with the IMM suggests a potential role in oxidative 
phosphorylation. This was initally investigated with ex vivo perfusion of young control male 
Wistar rat hearts with and without KU60019. Compared to controls, and in line with 
literature, a reduction in ATP synthesis, as estimated by oxidative phosphorylation process, 
as well as significant uncoupling (ADP/O) were observed in a carbohydrate medium (GM) 
with KU60019 compared to DMSO (vehicle) alone. No differences were observed when the 
fatty acid (PCM) was used as substrate.  These substrates respectively evaluate the 
glutamate-aspartate shuttle and β-oxidation in mitochondria. The downregulation of GM-
mediated oxidative phosphorylation in response to KU60019 suggests that the inhibition of 
ATM either influences Complex I mediated oxidation structurally or limits its ability to 
oxidize substrates. Moreover, ATM inhibition has previously been reported to contribute to 
the down-regulation of Complex IV, and decreased levels of Complex I has been reported in 
the absence of ATM. Complex IV inhibition can decrease the redox centre of Complex I and 
III, as well.  This study found that some proteins in the complexes were reduced when ATM 
Stellenbosch University  https://scholar.sun.ac.za
 
 
156 
 
was inhibited, which would suggest a post-transcriptional effect. It would be of value to do a 
co-immunoprecipitation with the complexes in order to determine whether ATM physically 
associates with Complex I.   
Lastly, if the inhibition of ATM has an inhibitory effect on Complex I, it would fail to explain 
the high mitochondrial oxidative stress that is observed in A-T in patients, and in the 
absence of ATM in cell culture and animal models. Complex I produces superoxide during 
substrate oxidation, which is released into the mitochondrial matrix.  Most of the 
superoxide is dismutated to hydrogen peroxide that is neutralised by NADPH-derived redox 
system within the matrix which is dependent on thioredoxin and glutathione. If the 
hydrogen peroxide is not neutralised in the matrix it will be released by Complex III into the 
cytosol. ATM has been implicated in the regulation of pentose phosphate pathway in the 
cytosol, where it contributes to the production of NADPH and thioredoxin through the PPP. 
It is thus possible that the inhibition of ATM can disrupt Complex I oxidation as well as 
decrease the availability of thioredoxin in the mitochondrial matrix, which could contribute 
towards higher hydrogen peroxide levels.  It would thus be of great value to monitor 
hydrogen peroxide production within each of the oxidative phosphorylation substrate 
buffers with KU60019 as well as inhibitors specific to each complex such as rotenone 
(Complex I inhibitor) and Antimycin C (Complex III inhibitor). This study evaluated NAD(P)H 
fluorescence in H9c2 cells treated with KU60019.  NADH that is associated with Complex I 
significantly contributes to overall NADH fluorescence. Although NAD(P)H lifetime 
fluorescence decay cannot distinguish between NADH and NADPH fluorescence, we 
observed a significant decrease in NAD(P)H lifetime when cells are treated with KU60019. In 
line with literature, this suggests that NADPH is decreased whilst NADH is increased, and 
was confirmed in HEK293 cells. An increase in NADH could potentially be the result of 
decreased NADH oxidation and consequently decrease NAD+ reduction, which would agree 
with a model where ATM inhibition interferes with Complex I substrate oxidation. 
This study used mitochondria of ex vivo perfused hearts from a well-characterised obese 
male Wistar rat model to determine the effect of the ATM activators, insulin and 
chloroquine in the presence and absence of KU60019 on oxidative phosphorylation and 
mitophagy. 
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The inhibition of ATM resulted in a general decrease in State 3 oxygen consumption and ATP 
synthesis, and agrees with literature in this regard. However, it did not decrease uncoupling 
(ADP/O levels) or resting respiration (State 4). It is important to note that the ADP/O values 
will not change unless the ETC complexes are changed, and will not change in response to 
altered substrate oxidation. A reduction in the subcomplexes of the mitochondrial ETC was 
observed, which suggests that the inhibition of ATM can alter substrate oxidation possibly 
through altering the ETC complexes, and consequently reducing their efficiency. This effect 
was observed in mitochondria from both chow-fed and DIO rat hearts. However, a 
significant decrease was observed in the ADP/O ratio of DIO hearts perfused with a 
combination of KU60019 and insulin in both the GM and the PCM substrate. Interestingly, 
this improved State 3 recovery after 20 minute of anoxia. Although this suggests uncoupling, 
it was not supported with an increase in UCP3, which remained at basal levels. The 
combination of insulin and ATM inhibition also significantly decreased the RCR value of 
mitochondria from chow-fed hearts in a GM substrate but had no effect in a PCM substrate 
when compared to hearts perfused with insulin alone. All other effects noted in the 
oxidative phosphorylation process were brought about by the use of either a carbohydrate 
or a fatty acid substrate rather than diet-induced obesity. In conclusion, the inhibition of 
ATM only had an effect in the mitochondria of obese rat hearts in the presence of insulin, 
but suggests that mitochondrial efficiency and the substrate utilisation by Complex I in the 
presence of insulin can be significantly affected when ATM is inhibited.  
Insulin overall improved all parameters of oxidative phosphorylation when a carbohydrate 
substrate was used. This agrees with literature that has shown improved oxidative 
phosphorylation in the presence of insulin, and was reflected by decreased fission (Drp1) 
which would suggest that fusion is increased. Moreover, no autophagy was detected, and 
PINK was decreased in mitochondria from both chow-fed and DIO hearts, whilst Parkin was 
increased. The loss of autophagy corresponds well with the activation of the Akt pathway 
that will, according to literature, result in upregulation of mTOR activity. Taken together, 
this might indicate that a consistently high presence of insulin could result in accumulation 
of defective mitochondria and increased oxidative stress in mitochondria from chow-fed 
hearts. This might lead to the recruitment of Parkin to depolarized mitochondria in an aim 
to re-establish homeostasis. In conclusion, it would thus indicate that ATM plays a role 
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downstream in insulin signalling within the Akt-mTOR pathway and its effects on 
mitochondrial oxidative phosphorylation. 
The inhibition of ATM did have a significant effect on autophagy , more so r than mitophagy, 
and although increased Parkin accumulation was seen in mitochondria from perfused chow-
fed rat hearts, this effect did not correlate with an increase in PINK. It can potentially 
suggest mitochondria might be targeted by a Parkin-dependent mitophagy pathway, but 
this result could not be duplicated when investigated using chloroquine. Taken together, 
these results would rather suggest that the inhibition of ATM results in decreased 
autophagy due to upregulation of the mTOR pathway activity in the cytosol, as was shown 
by the significant reduction in LC3-II protein accumulation, p62, as well as the loss of fission 
(Drp1) that were all independent of diet. 
Chloroquine had no effect on oxidative phosphorylation, except for an increase in State 4 
respiration. This did not however influence any of the other parameters, irrespective of diet. 
Regardless, it did result in a significant decrease in both PINK and Parkin as mitophagy 
markers, and increased LC3-II significantly in mitochondria from both chow-fed and DIO 
animals which are consistent with its role as a lysosomal inhibitor. The addition of KU60019 
in combination with chloroquine, increased ATP synthesis, State 3 and State 4 respiration 
but did not influence ADP/O or RCR values.  The underlying mechanism of this is unknown. 
The combination of KU60019 and chloroquine did shed light on the inhibition of ATM. The 
inhibition of ATM decreased the lipidated LC3-II significantly both in the presence and 
absence of chloroquine. This suggests that the autophagosomal membrane failed to form, 
potentially due to an increase in mTORCI. Interestingly, mTOR has recently been implicated 
in PINK and Parkin mitophagy, and highlights the negative feedback role of ATM on mTORCI. 
Taken together, this study showed that ATM is located on the inner mitochondrial 
membrane of cardiac mitochondria. The inhibition of ATM resulted in decreased 
carbohydrate stimulated oxidative phosphorylation in cardiac mitochondria, potentially 
through Complex I. This is supported by the observation that ATM inhibition decreased 
NADPH and increased NADH accumulation in H9c2 cells. The effect of ATM inhibition on 
oxidative phosphorylation was not influenced by obesogenic diet, except in mitochondria 
from insulin-perfused DIO hearts. The inhibition of ATM, as well the perfusion of chow-fed 
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rat hearts with insulin and insulin+ KU60019 had a significant effect on fission (DrpI). The 
decreased autophagy marker (LC3-II) seems to be associated with the cytosolic role of ATM 
which was highlighted by the significant decrease of LC3-II, and consequently the 
autophagosomal membrane formation even in the presence of chloroquine, rather than a 
mitochondrial role. 
7.2 Future work: 
 
The role of ATM as a potential regulator of ETC substrate utilisation and the effects of its 
inhibition on the redox status of the mitochondria is a very interesting result. Together with 
its potential role in Parkin-mediated mitophagy, the results justify further investigation into 
the mitochondrial role of ATM. 
This would require further evaluation with different substrates, such as succinate,  as well as 
an in-depth analysis of the underlying metabolomics within the ETC chain. Oxidative stress 
also needs to be evaluated, both within the mitochondrial matrix with regards to superoxide 
production as well as mitochondrial hydrogen peroxide production. This may initially be 
done in H9c2 cells. Oxidative stress can also influence mitophagy, and a more in depth 
analysis is required of both the autophagy as well as mitophagy markers other than PINK 
and Parkin. Mitophagy and autophagy markers including Beclin-1, Mfn1 and 2, Opa1, Rab 
and ULK1 will be further investigated based on the observation that dysfunctional 
mitophagy and autophagy, rather than oxidative phosphorylation might contribute to 
mitochondrial dysfunction in obesity. Moreover, the decrease observed in fission, would 
suggest a role for ATM in mitochondrial dynamics that will require further analysis with both 
mitochondrial fission (FIS1, Drp1) and fusion proteins(Mfn1, Mfn2, Opa1).  ATM is 
potentially an attractive microscopy target with regards to mitochondrial dynamics as well 
as autophagy, based on well-established microscopy techniques such as SR-SIM to monitor 
the formation, development and recruitment of the autophagosomal membrane.  
This project brought about an exciting collaboration with researchers at the Rutherford 
Appleton Laboratory  (UK), who’s research focus on mTOR. The project will aim to maintain 
the collaboration with RAL to extend the 2-P-FLIM results to include other known 
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mitochondrial ETC inhibitors, and monitor the change in the mitochondrial redox status in 
response to the free fatty acids evaluated in this study.  
The H9c2 model is currently under further development within our laboratory, and will gain 
from cell viability assays as well as a better characterisation of the effect of palmitic acid 
alone compared to a combination of palmitate and oleate. Moreover, an evaluation of the 
model with cell culture media in which adipocytes have previously been differentiated 
might result in a more applicable evaluation of the effect of obesity on ATM protein 
expression. 
7.3 Limitations: 
 
The H9c2 cell culture model currently poses the greatest limitation in this study and several 
aspects should be improved. The model will have to be optimised further to address the role 
of ATM levels in response to obesity and insulin resistance. The first aspect is the lack of a 
cell viability assay.  ATM is a known regulator of p53 which modulates apoptosis. Some of 
the protein level decreases that were observed, could well be due to cellular apoptosis in 
response to lipotoxicity, especially when compared to insulin alone, which is a known 
growth factor. Secondly, fatty acids tend to oxidise prior to their use in cell culture, which 
can influence their function. Moreover, conjugation with BSA tends to improve fatty acid 
solubility and uptake.  It is therefore pertinent to test this model with BSA-conjugated fatty 
acids and determine both uptake and fatty acid oxidation of palmitate and oleate 
respectively, as well as combined. A cell viability test using reagents such as propidium 
iodide (live/dead cells) or an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide)- assay that measure mitochondrial NAD(P)H-dependent cellular oxidoreductase 
enzymes will give an indication of apoptosis in treated H9c2 cells. Once these are 
established, the model should offer a more reliable assessment of the role of ATM in 
obesity.  
With regards to the localisation of ATM, SR-SIM microscopy is limited in its size detection 
resolution, which is currently approximately 120 nm. In order to conclusively use SR-SIM as 
a method to confirm ATM localisation, it would require the use of a fourth marker that is 
specific to the inner mitochondrial membrane. Moreover, and a major shortcoming 
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regarding the use of western blotting for the determination of location, is the lack of a 
matrix marker in this study. 
No other mitochondrial complex inhibitors were tested in this study, nor any other 
combinations of substrates such as succinate and malate, which would give a clearer 
indication which complex is influenced by ATM inhibition. The mitochondrial membrane 
potential can also impact ATP synthesis, and the effect of ATM inhibition on mitochondrial 
membrane potential was not investigated. The NAD(P)H values were only investigated in 
H9c2 cell culture, and no other controls such as rotenone that inhibits Complex 1 and is 
known to influence NAD(P)H lifetime decay, were included in the 2-P-FLIM study. The use of 
a colorimetric NAD/NADH kit would complement the 2-P-FLIM data obtained in this study. 
Colorometric and fluorescent detection of ATP production and ROS level detection, 
respectively would contribute significantly towards a better understanding of the role of 
ATM in oxidative phosphorylation. 
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Figure A1: Uncropped ATM (Fig A1.a) and its total protein membrane (Fig A2.b)  prior to being cut 
below the 170 kDa mark (1st lane, left; HiMark™ Pre-stained Protein Standard, Invitrogen, 
ThermoFischer) and probed overnight with anti-rabbit monoclonal ATM antibody(Cell Signalling 
Technologies, D2E2). Fig A1.c: Uncropped ANT 1/2/3/4 (left) and its total protein membrane (Fig 
A1.d) prior to being cut above the 41 kDa mark (1st lane, left; HiMark™ Pre-stained Protein Standard, 
Invitrogen, ThermoFischer) and probed overnight with anti-rabbit polyclonal ANT1/2/3/4 antibody 
(H-188, sc-11433, Santa Cruz Biotechnoglogy). Figure A1.e: Uncropped VDAC  and its total protein 
membrane (Fig A1.f) prior to being cut at the 41 kDa mark(1st lane, left; HiMark™ Pre-stained Protein 
Standard, Invitrogen, ThermoFischer) and probed overnight with anti-rabbit monoclonal VDAC (Cell 
Signalling technologies, D73D12). Due to the dark transfer the original 4–15% Mini-PROTEAN® TGX™ 
Precast Protein Gel (BioRad, #4561086) image is included (bottom). All the membranes were loaded 
as follows: HiMark™ Pre-stained Protein Standard, Invitrogen, ThermoFischer, Nucleus and cell 
membrane fraction(CN), cytosolic fraction(C), M/S isolated mitochondrial fraction(M), OMM fraction 
at 0 min, 15 min, 20 min and 30 min 1.2% digitonin permeabilisation, IMM(mitoplast consisting of 
inner mitochondrial membrane and matrix) fraction at 0 min, 15 min, 20 min and 30 min 1.2% 
digitonin treatment.  
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Figure  A2: Mitochondrial and mitoplast subfractionation and Proteinase K digestion: Isolated 
mitochondria was fractionated into outer mitochondrial (OMM) membrane and mitoplast fractions 
with 1.2% digitonin and the latter was further separated into inner mitochondrial membrane (IMM) 
and matrix fractions. The fractions and probed for ATM (Fig 3.a), ANT (Fig A2.c, same membrane as 
ATM, Fig A2b ) and VDAC (Fig A2.e).   The total protein membranes are shown respectively in Fig  
A2b (on which both ATM and ANT was probed), and Fig. A2.f. Figure A2d shows the corresponding 
4–15% Mini-PROTEAN® TGX™ Precast Protein Gel (BioRad, #4561086) for Fig  A2.b, which was 
loaded as follows: MM: HiMark™ Pre-stained Protein Standard, Invitrogen, ThermoFischer, Nucleus 
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and cell membrane fraction(CN), cytosolic fraction(C), M/S isolated mitochondrial fraction(M), OMM 
fraction at 0 min and 20 min 1.2% digitonin permeabilisation, IMM  at 0 and 20 min 1.2% digitonin 
treatment, and the matrix fraction at 0 and 20 min 1.2% digitonin treatment; mm (PageRuler™ 
Prestained Protein Ladder, 10 to 180 kDa, Thermo Fischer Scientific), 1 min, 3 min, 5 min and 10 min 
M/S isolated mitochondrial Proteinase K digest fractions. The gels were loaded with the same 
lysates, electrophoresed in the same chamber and transferred in the same chamber. Due to 
incomplete transfer in the 41 kDa size region (Fig A2f), it is not possible to exclude the presence of 
VDAC in the matrix fractions. 
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Abstract: 
The absence of Ataxia-Telangiectasia mutated protein kinase (ATM) is associated with 
neurological, metabolic and cardiovascular defects. The protein has been associated with 
mitochondria and its absence results in mitochondrial dysfunction. Furthermore, it can be 
activated in the cytosol by mitochondrial oxidative stress and mediates a cellular anti-
oxidant response through the pentose phosphate pathway (PPP). However, the precise 
location and function of ATM within mitochondria and its role in oxidative 
phosphorylation is still unknown. We show that ATM is found endogenously within 
cardiac myocyte mitochondria under normoxic conditions and is consistently associated 
with the inner mitochondrial membrane. Acute ex vivo inhibition of ATM protein kinase 
significantly decreased mitochondrial electron transfer chain Complex I-mediated 
oxidative phosphorylation rate but did not decrease coupling efficiency or oxygen 
consumption rate during β-oxidation. Chemical inhibition of ATM in rat cardiomyoblast 
cells (H9c2) significantly decreased the excited-state autofluorescence lifetime of enzyme-
bound reduced NADH and its phosphorylated form, NADPH (NAD(P)H; 2.77 ± 0.26 ns 
compared to 2.57 ±0.14 ns in KU60019-treated cells).  This suggests an interaction 
between mitochondrial ATM and the electron transfer chain in the mitochondria, and 
hence may have an important role in oxidative phosphorylation in terminally 
differentiated cells such as cardiomyocytes. 
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Acknowledgements: We acknowledge funding from the South African National Research 
Foundation  
Abstract:   
Purpose: Cardiotoxicity is a well-known side effect of Chloroquine.  Several studies have 
proposed chloroquine as a potential anti-diabetic treatment but did not address this 
problem. The current study investigated the effect of ex vivo chloroquine treatment on 1) 
heart function and glucose uptake, 2) mitochondrial function and 3) in vivo treatment on 
heart function. 
Methods: Control or obese male Wistar rats were used throughout. Dose responses of 
increasing chloroquine concentrations versus vehicle on cardiac function were measured 
using isolated, Langendorff perfused hearts while glucose uptake and cell viability were 
determined in ventricular cardiomyocytes. Mitochondrial function was assessed with a 
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Clark-type oxygraph (Hansatech) after ex vivo perfusion with 30 μM chloroquine vs vehicle.  
Animals were treated orally with 5 mg/kg/day chloroquine for 6 weeks.  
Results:  Acute chloroquine treatment of 10 μM was sufficient to significantly decrease 
heart function as determined by RPP (p<0.05) while 30 μM significantly reduced heart rate 
(p<0.05). Chloroquine became toxic to isolated cardiomyocytes at high concentrations (100 
μM), and could not induce cardiomyocyte glucose uptake.  Ex vivo treatment had no effect 
on mitochondrial function in DIO animals, but increased oxygen consumption in age-
matched control animals. Chronic low-dose in vivo chloroquine treatment significantly 
decreased aortic output and total work in hearts (p<0.005). 
Conclusion: Low and intermediate chloroquine doses administered either chronically or 
acutely is sufficient to result in myocardial dysfunction. 
Keywords: Chloroquine, cardiotoxicity, mitochondrial dysfunction, insulin resistance, 
diabetes 
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Addendum C : Insulin resistance in diet induced obese rats (DIO): 
 
The chow-fed age-matched rats and diet induced obese (DIO) rats used during this study 
were part of a much larger cohort of Wistar rats fed either rat chow or the DIO diet (Chapter 5, 
Table 5.1). A representative group of the larger cohort was subjected to an oral glucose intolerance 
test and a Homeostatic model assessment (HOMA) to determine insulin resistance (IR) from basal 
(fasting) glucose by Mr Sybrand Smith as part of his PhD study. The results are presented in Fig. C1 
and Fig C2. 
 
Figure C1: Oral glucose intolerance test of male Wistar rats at 16 weeks of age, after being fed a 
diet inducing obesity (DIO) diet for 6 weeks compared to chow-fed age-matched controls. 2-Way 
ANOVA, Bonferroni post-hoc test, *p<0.05 
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Figure C2: HOMA-IR of male Wistar rats at the age of 10 weeks prior to being fed a DIO-diet for 6 
weeks, and HOMA-IR after being fed  DIO  (shown as HCD on x-axis) for 6 weeks compared to their 
age-matched controls . 
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Addendum D: Mitochondrial respiration of hearts perfused with a combination 
of KU60019 and chloroquine compared to KU60019 alone 
 
 
Figure D1: Mitochondria from DIO hearts perfused with a combination of chloroquine and 
KU60019 compared to KU60019 alone, had an effect on State 3 and 4 respiration as well as ATP 
synthesis and recovery after anoxia (p<0.05 taken as significant, 2-Way ANOVA, Bonferonni post-
hoc test).  
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